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General introduction
NON-INVASIVE IMAGING
Non-invasive imaging of the heart has become the cornerstone of modern day 
cardiology. Non-invasive imaging of the heart can relate to the 12-lead electrocardiogram 
(ECG) that provides rapid information about the electrical processes in the heart, or to 
transthoracic echocardiography (TTE), magnetic resonance imaging (MRI) or computed 
tomography (CT), to evaluate the mechanical function of the heart. Research described 
in this thesis focusses on the development of a novel non-invasive imaging method 
through which electrical processes in the heart and thorax can be analysed.
BODY SURFACE POTENTIALS
The cardiac cells contract after stimulation by automatically generated electrical 
impulses. Potentials resulting from these electrical impulses can be recorded from the 
body surface. In 1887, a British physician named Augustus D. Waller published the first 
recording of human body potentials after numerous experiments on his dog Jimmy [1]. 
Later, the Dutch physician and physiologist Willem Einthoven developed a standardised 
12-lead ECG method that is indispensable for the evaluation of cardiac status in clinical 
practice to this day [2].
When more detailed information about the electrical processes in the heart is desired, 
an invasive electrophysiological study (EPS) can be performed. During an EPS, several 
recording catheters are inserted into the heart through veins or arteries. In this way, 
local depolarisation or repolarisation processes can be recorded and analysed in order 
to identify an arrhythmogenic substrate for ablation. An EPS is associated with exposure 
to radiation and risks of bleeding or stroke.
For years, clinicians and researchers have sought a non-invasive electrophysiological 
alternative that would provide more detailed information than the standard 12-lead 
ECG and would be applicable in routine daily clinical practice. Recording multiple 
potentials on the body surface using more than 12-leads, i.e. Body Surface Potential 
Mapping (BSPM), was explored by several research groups [3-5]. The resulting potential 
maps could be used to indicate regions of ischemia [6] or sources of arrhythmia [7], but 
the application of the individual torso electrodes (up to 252 in number) and processing 
of the data was very cumbersome and time consuming.
Subsequently, researchers discovered that potentials recorded on the body surface 
could be related to the potentials on the surface of the heart using a mathematical 
equation termed the Laplace equation [8]. This equation describes the relationship 
14867-vandergraaf-layout.indd   11 31/08/2017   09:37
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between potentials on two surfaces separated by regions that are electrically neutral. 
Patient-specific anatomy, in order to visualise the exact position of the two surfaces 
(body surface and cardiac surface) was obtained using CT. Rudy et al. performed 
numerous experiments and published several papers on the clinical application of 
this technique [9-12]. Using an electrode vest to record the body surface potentials, 
this technique is now commercially available and has been used in various hospitals 
throughout the world. Despite the favourable reports, the fact that CT (exposing the 
patient to radiation) was used to obtain anatomical information and doubts regarding 
the validity of assuming the region between the body surface and the cardiac surface is 
electrically neutral, prompted researchers to investigate alternative methods.
DEVELOPING A NOVEL MRI-BASED NON-INVASIVE MAPPING 
METHODOLOGY
The research in this thesis focusses on the development and application of a novel non-
invasive mapping approach. Since this approach is based on anatomical information 
obtained using MRI, it is not associated with exposure to radiation. MRI offers the 
advantage of obtaining detailed anatomical and functional information. In this way, 
the anatomy of a patient and the position of every electrode on the body surface 
could be observed on the MRI images. Regional differences in cardiac wall motion 
could be assessed thoroughly. Unlike CT, MRI can characterise local differences in the 
myocardium. Hence, the location and size of inflamed, infarcted or hypertrophic cardiac 
muscle as a arrhythmogenic substrate can be distinguished from normal cardiac tissue 
[13]. These features make MRI a very potent tool to guide clinical interventions.
The first step in the development of a novel non-invasive mapping methodology was 
the design of a software program that would allow analyses of both the MRI images 
and the potentials recorded from the body surface. Besides processing recorded human 
data, computer simulations could be carried out with the software. In this way, various 
experiments could be performed before the technique was tested in real humans 
(in-vivo). Numerous body surface electrode layouts were tested using the simulation 
software in order to find an optimal electrode configuration. After deciding on a 
definitive electrode layout, the technique was applied in volunteers and later in patients 
to record potentials from the body surface.
14867-vandergraaf-layout.indd   12 31/08/2017   09:37
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Using the software, personalised three dimensional (3D) models of the torso and the 
inner organs could be reconstructed from MRI images for every patient. Later, data 
obtained through body surface potential mapping was used to calculate the distribution 
of potentials inside the torso and on the surface of the heart. Eventually, the results of 
this calculation could be visualised in the 3D model of the heart and torso.
Instead of using the Boundary Element Method (BEM), used by most research group 
to calculate epicardial potentials from the recorded body surface potentials, the Finite 
Element Method (FEM) was applied. Unlike the BEM, the FEM enables the incorporation 
of volume information [14]. Using the FEM, experiments could be performed to 
investigate the impact of including or excluding electrical information from different 
thoracic organs between the body surface and the cardiac surface.
In order to investigate the localisation accuracy of the novel mapping technique, it 
was applied in patients with an implanted MRI-conditional cardiovascular implantable 
electronic device (CIED). In this patient category, the pacing site is fixed and can 
therefore serve as a reference point. The location of the tip of the pacing lead could be 
identified on the MRI images. In this way, the site of earliest activation as identified by 
the non-invasive mapping system could be correlated to the location of the tip of the 
pacing lead. Hence, a single MRI investigation provided information about the anatomy 
of the patient, the position of the recording body surface electrodes, the mechanical 
function and tissue characterics of the heart and the location of the pacemaker lead tip. 
In patients suffering from premature ventricular contractions scheduled for ablation, 
the site of earliest activation as identified by the non-invasive mapping system was 
compared to the site of ablation.
AIMS
The aims of this thesis are to 1) investigate the safety of using MRI in patients with 
implanted pacing devices, 2) develop software through which the electrical activity 
inside the heart and thorax can be realistically modelled, 3) perform simulation 
studies to investigate the impact on the end-result of using different torso electrode 
layouts for the recording of body surface potentials, 4) investigate the validity of the 
simulation studies by performing non-invasive mapping in volunteers using different 
torso electrode layouts, 5) apply the novel non-invasive mapping technique in patients 
with an implanted pacing devices and in patients suffering from premature ventricular 
contractions and 6) investigate the localisation accuracy and reproducibility of the 
results in these patients.
14867-vandergraaf-layout.indd   13 31/08/2017   09:37
14
Chapter 1
OUTLINE OF THIS THESIS
At the time the research described in this thesis was initiated, MRI-conditional CIEDs 
were only recently introduced. For this reason, the first part of this thesis discusses the 
possibility and safety of using MRI in patients with a CIED.
Chapter 2 focusses on the feasibility and potential hazards of performing MRI in patients 
with a CIED. A safety protocol was developed and proposed in order to minimise 
the chance of adverse events. Chapter 3 evaluates the use of MRI in patients after 
implantation of an MRI-conditional CIED, both pacemakers and internal cardioverter 
defibrillators (ICDs). Since implantation of MRI-conditional devices is not available 
for all patients, patient selection prior to implantation is a relevant topic. Ideally, MRI-
conditional CIEDs would be implanted in patients with the highest chance of requiring 
an MRI during the lifetime of their device. Chapter 4 illustrates that MRI can be used 
in patients with an MRI-conditional CIED to evaluate regional wall motion. Normally, 
global cardiac function is monitored using TTE in this patient category. However, global 
function measures are insensitive to early regional dysfunction. Therefore, it may be of 
advantage to evaluate local myocardial strain in these patients.
The second part of this thesis discusses the current status of non-invasive imaging of 
cardiac electrophysiology. Chapter 5 provides an overview from the time of the first 
ECG recordings to the use of inverse procedures to non-invasively reconstruct (intra-)
cardiac processes from potentials recorded on the thoracic surface. Chapter 6 describes 
the first experiments using the in-house developed software. The advantage of using 
the Finite Element Method instead of the Boundary Element Method is illustrated by 
experiments performed in a plastic tank model filled with water. Chapter 7 explores 
the possibility and the impact of including information on myocardial scar or oedema.
The third part of this thesis describes the application of the novel mapping technique 
in volunteers and patients. Computer simulations using various torso electrode layouts 
are described in Chapter 8. After deciding on a definitive electrode layout, it was 
applied in volunteers and later in patients to record potentials from the body surface. 
The localisation accuracy of the novel mapping technique is investigated in Chapter 9. 
The site of earliest activation as identified by the non-invasive mapping system was 
correlated to the actual location of the tip of the pacing lead on the MRI-images. 
In Chapter 10, the non-invasive mapping system was used to localise premature 
ventricular contractions in patients scheduled for ablation. The location of the identified 
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focus was subsequently compared to the ablation site on the electroanatomic maps. 
Finally, Chapter 11 discusses the most important findings of this thesis, places these 
into the context of current knowledge and suggests directions of further research.
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ABSTRACT
Magnetic resonance imaging (MRI) has evolved into an essential diagnostic modality 
for the evaluation of all patient categories. This gain in popularity coincided with an 
increase in the number of implanted cardiac implantable electronic devices (CIEDs). 
Therefore, questions arose with regard to the MRI compatibility of these devices. 
Various investigators have reported the harmless performance of MRI in patients with 
conventional (non-MRI-conditional) devices. The recently published European Society 
of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronisation therapy 
(CRT) indicate that MRI can be safely performed in patients with an implanted pacemaker 
or ICD (MRI-conditional or not), as long as strict safety conditions are met. This is a major 
modification of the former general opinion that patients with a pacemaker or ICD 
were not eligible to undergo MRI. This review paper attempts to elucidate the current 
situation for practising cardiologists by providing a clear overview of the potential life-
threatening interactions and discuss safety measures to be taken prior to and during 
scanning. An overview of all available MRI-conditional devices and their individual 
restrictions is given. In addition, an up-to-date safety protocol is provided that can be 
used to ensure patient safety before, during and after the scan.
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INTRODUCTION
Historically, magnetic resonance imaging (MRI) examination of patients with a cardiac 
implantable electronic device (CIED) has been considered hazardous due to potential 
life-threatening interaction between the MRI scanner and the pacemaker or internal 
cardioverter defibrillator (ICD) [1-2]. To increase patient safety and to anticipate the 
growing clinical need for MRI, an increasing number of MRI-conditional CIEDs have 
become available [3].
However, the recently published European Society of Cardiology (ESC) guidelines 
on cardiac pacing and cardiac resynchronisation therapy (CRT) [4] state that MRI can 
be safely performed in patients with an implanted pacemaker or ICD, irrespective of 
the MRI-conditional or non-specific MRI-conditional design, as long as strict safety 
conditions are met.
In order to clarify this somewhat confusing situation, this review paper provides an 
overview of the currently available data related to CIEDs and MRI, and attempts to offer 
an up-to-date and clinically useful summary for the practising cardiologist. In addition, 
a safety protocol applicable for patients with a CIED is provided that can be used to 
ensure a patient’s safety before, during and after an MRI scan.
MRI SYSTEM
Technical background
The fundamental components of an MRI system are the main magnet coils, three gradient 
coils and an integral radiofrequency transmitter coil. The main magnet coils generate a 
strong, constant magnetic field. The strength of this magnetic field is expressed in Tesla.
Mounted inside the main magnet, three gradient coils generate gradient magnetic 
fields that are rapidly switched on and off. The integral radiofrequency transmitter 
coil produces a radiofrequency magnetic field, used to deliver energy to a population 
of protons. The static magnetic field and radiofrequency field combine to generate 
magnetic resonance signals that are spatially localised and encoded by the gradient 
magnetic fields [5].
Receiving coils capture the energy released by resonating hydrogen protons. 
Subsequent analysis results in high-grade tissue characterisation and reconstruction of 
a detailed image.
14867-vandergraaf-layout.indd   23 31/08/2017   09:37
24
Chapter 2
The amount of energy administered to an individual is expressed in SAR (specific 
absorption rate). SAR values vary from 2.0 to 4.0 W per kilogram (W/kg). For reference 
purposes, SAR values of a modern mobile telephone are approximately 0.9 W/kg [6].
Over time, the strength of the static magnetic field of MRI systems has increased from 
less than 0.5 T to clinical scanners operating at 7.0 T and even 9.4 T. Today, the vast 
majority of clinical MRI exams are performed using a 1.5 T system, while a rapid growth 
of 3.0 T systems is observed [7]. Since the SAR is proportional to the square of the static 
magnetic field strength, the amount of energy absorbed by a patient increases rapidly 
in a scanner operating at a higher field strength. Therefore, application of higher field 
strengths poses constraints on the total scan time or the imaging sequences used.
INTERACTION BETWEEN MRI SYSTEM AND CIEDS
Pavlicek et al. [8] were the first (1983) to discuss the potential interaction between 
pacing devices and the NMR (at that time nuclear magnetic resonance) environment 
using ex-vivo pacemakers of deceased patients. These interactions can be subdivided 
into three categories.
a. Mechanical forces
The constant static magnetic field strongly attracts different types of metal. Implantable 
devices usually contain a small amount of one or more of these metals and are 
considered to be ferromagnetic. Therefore, there is the possibility of movement of the 
implanted pacemaker.
A 6-week interval between implantation and MRI examination is advised in international 
guidelines in order to ensure sufficient encapsulation of the device [9].
b. Induction (antenna function)
The several electromagnetic components used in MRI may cause electrical or thermal 
induction in implanted leads. Inducted electrical currents could initiate arrhythmias 
or lead to oversensing or undersensing of the pacemaker or ICD with potentially fatal 
consequences. In addition, since tissue near the lead tip has limited conductivity, energy 
will be converted to heat at this location. Subsequent thermal damage around the lead 
tip includes oedema or formation of scar tissue. In both situations, an increase in pacing 
thresholds or even complete loss of capture may occur [10].
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c. Defibrillators
The magnetic fields inside the MRI may have an unpredictable intermittent effect on the 
activity of the reed switch in a pacemaker or ICD. This may lead to either asynchronous 
pacing (reed switch closed) or unwanted inhibition of pacing in the presence of an open 
reed switch. In addition, the rapidly changing magnetic gradients can be registered 
as a life-threatening arrhythmia. The ICD can subsequently react with release of anti-
tachycardia pacing (ATP) or shock [11]. In the presence of the main static magnetic field, 
the core of the transformer, necessary to charge the high-energy storage capacitor, 
tends to saturate. Thereby, the storage capacitor is prevented from charging. Although 
this reduces the risk for the deliverance of inappropriate shocks during the scan, the 
battery will lose life.
d. Software interaction
Exposure to the electromagnetic fields may also directly affect or modify the electronic 
circuits and functional settings of the CIED. Use of external programmers may become 
impossible due to damaged electrical circuits inside the CIED.
e. Implantable loop recorders (ILR)
Several studies have indicated that MRI scanning of ILR patients can be performed 
without harm to patient or device. However, signal artifacts that can be mistaken for a 
tachyarrhythmia are seen frequently [12-13]. Of course, image artifacts arising from the 
presence of an IPL can degrade the image quality.
REVIEW OF LITERATURE
Non-conditional pacemakers and ICDs
In 1984, Fetter et al. [14] investigated the potential interactions using four pacemakers 
in vivo. The asynchronous (VOO) pacing mode was activated during the scan in one 
patient. The authors concluded that patients with single-chamber implantable 
pacemakers may undergo scanning with MRI, provided the patient is monitored during 
scanning and the risks of asynchronous pacing are taken into account.
Gimbel et al. (1996) performed an MRI scan with a field strength of 0.5  T in five 
patients [15]. A 2-s pause was observed in one pacemaker-dependent patient. The 
other patients were asymptomatic and did not report any discomfort. Fontaine et al. 
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(1998) demonstrated the development of an irregular ventricular rhythm in a 69-year-
old patient during RF pulsing on a 1.5 T scanner [16]. This rhythm terminated with the 
cessation of RF pulsing. The patient remained asymptomatic during the procedure.
In 2000, Sommer and co-workers examined 44 non-pacemaker-dependent patients 51 
times in a 0.5 T MRI without any impairment of pacing function [17]. Vahlhaus (2001) 
and co-workers postulate in a paper that ‘the general policy of never exposing a patient 
with a pacemaker to MRI should be revised’ [18].
Bartsch et al. (2003) reported four MRI-associated deaths in paced patients undergoing 
MRI (1.5  T) assessment [19]. Importantly, none of these patients were pacemaker 
dependent and in some cases ventricular fibrillation was proven to be the cause of 
death.
In 2005, Irnich et al. questioned 30 legal medicine departments in Germany with respect 
to casualties with a fatal outcome of pacemaker patients during an MRI examination 
(0.5–1.5  T) between 1992 and 2001 [20]. Six fatal cases occurred, in three cases 
ventricular fibrillation (VF) was proven to be the cause of death. In the other three cases 
the pacemakers were removed from the deceased patient’s body and introduced in the 
MRI scanner. The pacemaker showed a magnetic asynchronous rate of 100/min. It was 
suspected that the asynchronous pacing had induced VF in these patients.
In the following years, several investigators collected and published data on MRI 
examinations in patients with conventional (non-MRI-conditional) pacemakers and 
ICDs. Naehle et al. (2009) reported the safe scanning of 18 ICD patients at 1.5 T [21]. No 
significant change in pacing capture threshold, lead impedance or serum troponin I was 
observed. In two MRI examinations, oversensing of radiofrequency noise as ventricular 
fibrillation occurred. However, no attempt at therapy delivery was made.
More recently, Nazarian et al. (2011) published the most elaborate study [22]. A total of 
555 MRI scans (1.5 T) were performed in 438 patients with a CIED (54 % pacemakers, 
46  % defibrillators). Of the 555 MRI examinations, 222 (40  %) were of the brain, 122 
(22 %) were of the spine, 89 (16 %) were of the heart, 72 (13 %) were of the abdomen or 
pelvis, and 50 (9 %) were of an extremity. Only small changes in programming, sensing 
and impedance were reported. The observed changes did not ever require device 
revision. Unfortunately, no data are available on the possible effects of repeated MRI 
examinations in individual patients. However, it must be noted that although a large 
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number of different models were studied, the numbers for each individual model were 
small. Patients were enrolled during a long period of time (from 2003 to 2010) and CIEDs 
were constantly evolving. Last but not least, a control group was lacking in this study.
Despite these limitations, it is only this paper that is exclusively referred to in the 
recently published ESC guidelines on cardiac pacing and CRT. MRI-conditional CIEDs 
were developed in order to decrease potential life-threatening hardware interactions.
MRI-conditional pacemakers and ICDs
These systems contain specially developed components, tested and approved for 
usage in an MRI environment. Improved lead design reduces the risk of complications, 
such as lead-tip heating. In addition to the modified hardware design, MRI-conditional 
pacemaker systems are provided with a special MRI software mode. Upon activation, the 
most appropriate settings are switched on automatically. These settings include bipolar 
stimulation instead of unipolar pacing and an increased electrical output. Specific 
filters inside the device prevent sensing of external non-cardiac signals. Furthermore, 
recording of arrhythmic episodes is temporarily disabled during the scan.
It must be noted that due to constant technological improvements the size of the 
available implantable pulse generators has substantially decreased and leads have 
become more sophisticated. Together with a reduction of ferromagnetic components 
in contemporary CIEDs, the chance of hardware interactions is therefore substantially 
diminished.
Medtronic commercialised the first MRI-conditional pacemaker system (Enrhythm MRI®) 
in 2008. Several trials reported the safe performance of MRI scans in patients with an 
implanted Enrhythm MRI system [23-24]. However, scanning of the thorax region was 
prohibited. Different manufacturers initiated comparable clinical trials to demonstrate 
the safety of their own MRI-conditional devices. Currently, several MRI-conditional 
pacemakers are commercially available that enable full body MRI examination. Table 
1 provides a complete overview of currently available MRI-conditional pacemakers and 
ICDs.
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Table 1. Currently available MRI-conditional pacemakers and ICDs.
Medtronic
St Jude 
Medical
Biotronik Boston
Enrhythm 
MRI / 
Revo MRI
Advisa 
MRI
Accent 
MRI
Evia 
ProMRI
Lumax ProMRI 
/ Iforia ProMRI / 
Ilesto ProMRI
Ingenio 
MRI
Restrictions Full body Full body Full body No chest scans Full body
MRI machine Cylindrical bore magnet, clinical MRI systems with a static magnetic field of 1.5 T
SAR limitation
(whole-body)
≤ 2.0 W/kg ≤ 2.0 W/kg ≤ 4.0 W/kg ≤ 2.0 W/Kg ≤ 2.0 W/Kg
Maxixum number 
of scans
No No No
Yes: each scan ≤ 30 min
Total scan time max: 10 
hours
No
Published Clinical 
Trial evidence on 
MRI enviroment
Yes Yes No No No
Current clinical trials
An overview of clinical trials currently enrolling patients is given in table 2. Apart from 
demonstrating the safety of a device in an MRI environment, contemporary studies 
are more focused on the influence on image quality and artifacts caused by the CIED 
(Figure 1).
Table 2. An overview of currently enrolled clinical trials on MRI-conditional pacing devices.
Medtronic St Jude Medical Biotronik Boston
Study Advisa II Accent ProMRI AFFIRM Samurai
Number of 
participating sites
40 80 21 45
Estimated number 
of patients
270 800 245 363
Implantable Pulse 
Generator - Lead
Advisa - 5076 Accent - Tendril
Evia/Entovis - 
Safio S
Image Ready 
System
Estimated date of 
completion
October 2014 July 2014 December 2013 July 2014
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A	 B	
LA 
LV 
LV RV 
Lead tip 
Figure 1. Steady State Free Precession CINE images. Typical artifacts as can be observed in 
patients with an implanted impulse generator (A) and pacing leads (B). Note that the image 
quality in the short axis cine (B) is sufficient to allow reliable calculation of left ventricular 
ejection fraction.
Biventricular (CRT) devices
The presence of three leads in patients treated with biventricular (CRT) therapy 
increases the risk of interactions between MRI and the pacing system. Only a small and 
inconsistent amount of literature on MRI examinations in CRT patients is available at this 
time. The scanning of patients with an implanted biventricular pacing device is strongly 
discouraged.
RISK ASSESSMENT
Pacemaker dependent patients
Patients with an implanted pacemaker or ICD and an absent or insufficient intrinsic 
heart rhythm constitute a special group, because potential interaction between 
pacemaker and MRI can have life-threatening consequences. It must be ascertained 
that the potential benefit of an MRI examination outweighs the potential risks and no 
diagnostic alternative is available. Close monitoring of the patient using pulse oximetry 
is warranted.
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MRI-conditional markers and MRI mode
Vendor-specific markers on CIEDs can facilitate the identification of MRI-conditional 
systems on routine chest X-rays (Figure 2). Certain CIEDs contain an optional MRI mode, 
which automatically activates the most appropriate settings. After the scan, the original 
settings can be reprogrammed easily. Other (non-conditional) CIEDs mandate a manual 
selection of some of these settings and reprogramming.
A B 
C D 
Figure 2. Vendor specific markers on MRI-conditional pacing systems as can be identified on 
routine X-rays. A: Medtronic, B: St. Jude Medical, C: Biotronik, D: Boston Scientific.
Various combinations of implantable pulse generators and leads
A more complex situation occurs when implantable pulse generators and leads from 
different vendors, each bearing their own MRI restrictions, are combined together in 
individual patients. In this case the MRI compatibility of all parts of the CIED needs 
to be ascertained. An individualised approach is mandatory in these patients. When 
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abandoned pacing leads are present, for example after recent coronary bypass grafting 
(CABG), scanning is strongly discouraged. The absence of an implantable pulse generator 
increases the chance of current induction in the leads of these patients.
PREPARATION AND MONITORING DURING MRI EXAMINATION
An MRI examination of a patient with a CIED is preferably performed exclusively in 
centers with extensive experience and expertise in this area. Written informed consent 
should be obtained from the patient after extensive notification of the procedural 
risks. Application of a safety protocol (Appendix  1) and appropriate monitoring are 
mandatory to perform an MRI scan in patients with a CIED.
Prior to the examination, proper functioning of the CIED needs to be assured. The 
pacing threshold is one of the most important issues and should always be determined. 
An already elevated stimulation threshold (>2.0 V) increases the risk of loss of capture 
during the examination. Pacemaker output should be increased and the examination 
should be suspended in case of a severely elevated threshold and/or deviated lead 
impedance <200 ohms or >1,500 ohms.
During the examination careful monitoring of the patient using a heart rate monitor 
and pulse oximetry is warranted. The recorded ECG signal in the scanner is subject to 
disturbances and therefore unreliable. Pulse oximetry is not affected by the MRI scanner 
and should always be used to monitor the patient. Cardiopulmonary resuscitation 
equipment including a cardiac defibrillator, along with staff experienced in resuscitation, 
should be available on site.
The nature of the cardiac MRI examination, especially in pacemaker patients, mandates 
routine verbal communication between operator and patient during the scan and 
is of vital importance. During and after the MRI examination, the patient should be 
asked about any discomfort or complaints. When the MRI examination is finished, the 
original settings of the CIED should be restored after confirming that these are still safe 
and provide adequate margins. In order to exclude any late side effects or symptoms, 
a control visit (3–6  months after the scan) to the outpatient department may be 
recommended [25].
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DISCUSSION
The recently published ESC guidelines on cardiac pacing and CRT somewhat trivialised 
the absolute necessity of MRI-conditional CIEDs by stating that MRI can be safely 
performed in patients with an implanted pacemaker or ICD (MRI-conditional or not), as 
long as strict safety conditions are met.
Despite abundant literature [26–31] reporting the harmless performance of MRI 
investigations in patients with conventional (non-MRI-conditional) pacemakers and 
ICDs, it is still considered potentially hazardous. Only a limited number of prospective 
studies are available. Long-term studies are confounded by the use of several generations 
of CIEDs. The variety of tested devices in these studies affects the conclusions and 
decreases the clinical value.
Therefore, it remains difficult to state whether a specific conventional CIED can be 
introduced into the MRI room without possible consequences. For MRI-conditional 
CIEDs, the possibilities, limitations and required safety measures to be taken are more 
uniform and described in detail.
In daily practice, an increasing number of clinicians are confronted with questions on 
MRI compatibility of CIEDs. The value of a safety protocol, approved by the cardiology 
and radiology department, cannot be stressed enough.
It is expected that the role of MRI in clinical decision-making will gain even more clinical 
importance. There is an emerging role for MRI in identifying arrhythmogenic substrates 
and this modality has an expanding role in guiding electrophysiological therapies.
Now that the patient’s safety seems to be conditionally guaranteed, a new challenge is 
the reduction of the impact of CIEDs on the image quality, especially with regard to the 
identification and modification of an arrhythmogenic substrate.
Finally, it is important to realise that almost all published data are only valid for scanning 
on 1.5 Tesla machines. The application of 3.0 Tesla machines is rapidly emerging, 
especially for orthopaedic and neurological patients, due to the higher signal-to-noise 
ratio (SNR). With the advance of 3.0 T machines, new technical challenges arise.
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CONCLUSION
MRI-conditional CIEDs are designed to cope with the challenges introduced by the 
electromagnetic MRI environment. Various papers have demonstrated the safe and 
harmless performance of MRI examination in patients with CIEDs, MRI-conditional or 
not. With appropriate monitoring and application of a safety protocol, MRI can be safely 
performed in patients with CIEDs. For patients equipped with a conventional CIED or 
those who are pacing dependent it must be ascertained that the potential benefits of 
an MRI examination outweigh the potential risks.
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APPENDIX 1.
CIED - MRI checklist 
	  
CIED_MRI protocol_v5_feb2015 
 
 
 
	  
Pre – MRI        
       CIED technician (name): …………………… 
Only proceed when all conditions are met: 
• Implant > 6 weeks? 
• MRI conditional device? 
         (√ when OK)  
• X-ray post implant available? 
• No abandoned (epicardial) leads? 
     
Measurements Atrial Ventricular 
Pacing threshold < 2.0 V?                    V @                 ms                          V @              ms    
Lead impedance 200-1500 ohm ohm ohm 
P/R wave amplitude in normal range? mV mV 
Battery voltage? V 
• Activate MRI safe mode and print proof 
 
• Is the patient pacing dependent? (consult cardiologist, if not sure) 
a. Yes !  VOO/DOO       CIED tech: *81 3471  
b. No !  OVO/ODO        MRI: tst 4915 
 
• ICD: check whether tachycardia detection and therapies are deactivated 
 
	  MRI - scan       MRI technician (name): ……………………… 
       
• No contraindications for MRI? 
      (√ when OK) 
• Resuscitation equipment available on site? 
 
 
• During the scan: monitor ECG, pulse oximetry and symptoms  SAR < 2.0 W.kg 
Post - MRI        CIED technician (name): …………………… 
• Compare pre & post values:        
Measurements         Atrial Ventricular 
Pacing threshold               V @             ms             V @          ms    
Lead impedance ohm ohm 
P/R wave amplitude mV mV 
Battery voltage V 
• Deactivate MRI safe mode and restore original programming 
	  
Visit after …...  week(s) 
Patient ID:    Date: 
 
 
 
 
Device: 
Manufacturer:…………..……………………….……….. 
Type:…………………………………………………....… 
Date of implant:…..………………………...……………. 
Abnormalities 
Yes No 
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ABSTRACT
Purpose: This study investigated the use and safety of Magnetic Resonance Imaging 
(MRI) for several pathologies in patients with an implanted MRI-conditional pacing 
system.
Methods: This was a retrospective, single center study. All patients with an MRI-
conditional pacemaker or Internal Cardioverter Defibrillator (ICD) implanted in our 
center between June 2011 and March 2015 were enrolled. All MRI examinations 
performed in these patients were evaluated. For all patients, pacing thresholds, P- and 
R-wave amplitude, lead impedance and battery longevity were monitored during the 
entire follow-up.
Results: In total, 214 patients with an implanted MRI-conditional device (mean age 65 
± 14; 64% male; 138 pacemakers; 76 ICDs) were enrolled. At the time of implant, 94% of 
these patients suffered from a co-morbidity that may lead to a future indication for MRI. 
In 24 patients (11%), 36 MRI investigations were safely performed during a mean follow-
up period of 406 days (51-1353 days).
Conclusion: The majority of the post-implant MRI scans (57%) were performed to 
confirm, exclude or follow-up on neurological disease. Further research is needed 
to facilitate the identification of patients with a high likelihood of requiring MRI 
investigations following implantation of a pacing device.
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INTRODUCTION
Through recent years, Magnetic Resonance Imaging (MRI) has evolved into an important 
diagnostic modality for the evaluation of a wide variety of diseases. This increase 
in utilisation of MRI coincided with an increase in the number of implanted Cardiac 
Implantable Electronic Devices (CIEDs) [1]. To improve patient safety and to anticipate 
the growing clinical need for MRI, MRI-conditional CIEDs have been developed [2].
Currently, implantation of an MRI-conditional system is not (yet) the standard of care for 
all patients. Therefore, identification of suitable patients is mandatory. Based on earlier 
research, various patient characteristics indicating a higher probability of requiring an 
MRI examination during the lifespan of the device can be determined, including; age 
(above 65 years old); prior MRI examinations in life; desired follow-up on hereditary 
or congenital diseases [3-4]. The objective of this retrospective study was to evaluate 
whether these characteristics are indeed associated with a higher use of MRI in patients 
with an implanted CIED.
Therefore, the general clinical use of MRI in patients with an implanted MRI-conditional 
CIED was investigated. In addition, device parameters measured directly after MRI and 
during the follow-up period were compared to the device parameters of patients in 
whom no MRI was performed.
METHODS
Patient population
This was a retrospective, single center study. The study complies with the Declaration of 
Helsinki. The local medical ethical committee and the hospital scientific board approved 
this study. Only patients with an MRI-conditional pacemaker or ICD system implanted in 
our center were evaluated. Devices were implanted between June 2011 and December 
2014.
MRI examinations
Only routine clinical MRI examinations were evaluated. Research scans were excluded 
from this study. MRI studies were performed between August 2011 and February 2015 
on either a 1.5 Tesla Philips Intera system (Philips Healthcare, Best, The Netherlands) or a 
1.5 Tesla Siemens Aera system (Siemens, Erlangen, Germany).
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MRI scans were performed according to a standardised safety protocol [5]. The 
MRI compatibility of the devices was confirmed through patient records and chest 
radiography. Before entering the MRI room, pacing thresholds, P- and R-wave amplitude 
and lead impedances were determined and the CIED was programmed into the device 
manufacturer MRI compatible setting with an appropriate pacing mode; DOO/VOO for 
pacemaker dependent patients and VVI/DDI for non-pacemaker dependent patients 
[6-7]. During the MRI examination, patients were monitored using pulse-oximetry and 
verbal communication. In addition, when a cardiac MRI scan was performed, the ECG 
signal was also used for monitoring purposes.
After the examination, pacing thresholds, P- and R-wave amplitude and lead impedances 
were measured and compared to the initial values. Finally, original programming of the 
CIED was restored.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics for Windows (version 20.0, 
Chicago, USA). Continuous variables were expressed as mean ± standard deviation (SD). 
Pacing thresholds, sensing amplitude, lead impedance and battery life were compared 
using a paired Student’s t-test. All tests were two-tailed and a p-value <0.05 was 
considered significant.
RESULTS
Device implants
A complete overview of the patients enrolled in this study is provided in figure 1.
A total of 253 patients (mean age 66 ± 14; 64% male) with an implanted MRI-conditional 
impulse generator (165 pacemakers; 88 ICDs) were identified.
In 39 patients (mean age 75 ± 12, 62% male), an MRI-conditional impulse generator (27 
pacemakers; 12 ICDs) was connected to previously implanted conventional leads (i.e. 
non-MRI-conditional). In these patients, the complete pacing system (impulse generator 
and leads) could not be classified as MRI-conditional. The remaining 214 patients (mean 
age 65 ± 14; 64% male; 138 pacemakers; 76 ICDs) were further analysed in this study.
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Total implanted MRI conditional IPGs 
-  mean age 66 ± 14 years 
-  165 pacemakers 
-  88 ICDs     n= 253 
New IPG connected to conventional leads 
-  mean age 75 ± 12 years 
-  27 pacemakers 
-  12 ICDs     n= 39 
Total implanted MRI conditional systems 
-  Mean age 65 ± 14 years 
-  138 pacemakers 
-  76 ICDs     n= 214 
MRI exams pre-implant 
 
-  Neurological  108  (48%) 
-  Cardiac   78  (34%) 
-  Orthopedic  29  (13%) 
-  Abdominal  12  (5%) 
 
Total   227  scans 
  128  patients 
MRI exams post-implant 
 
-  Neurological  21  (58%) 
-  Orthopedic  8  (22%) 
-  Cardiac   6  (17%) 
-  Abdominal  1  (3%) 
 
Total   36  scans 
  24  patients 
Figure 1. A complete overview of the patients enrolled in this study and the MRI exams 
performed prior to and after implantation of the device. Thirty-nine patients were excluded from 
the analysis, because an MRI-conditional impulse generator was connected to conventional (i.e. 
non-MRI-conditional) leads.
In the patients with an implanted pacemaker (n=138), the most common indication for 
pacing was complete heart block (54%). In the ICD group (n=76), primary prevention 
(61%) was the main reason for implantation. Baseline characteristics of the study 
population and the implanted devices are summarised in table 1.
MRI examinations
In 128 (60%) of the 214 patients with a complete MRI-conditional pacing system, 227 
MRI examinations were performed prior to implantation. The majority of these scans 
(48%) was performed to confirm or rule out a neurological disorder. The complete 
distribution of scans per referring department is shown in figure 1.
The mean follow-up period for patients in this study was 406 ± 302 days (51-1353 days). 
The number of implants of conditional devices is shown in figure 2.
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Table 1. Patient and device characteristics.
Patient characteristics N = 214
Age (years) 65 ± 14
Male (% male) 138 (64%)
Indication for device
- Pacemaker (n= 138)
2nd degree / complete heart block 75
Sinus node dysfunction 48
Atrial fibrillation and bradycardia 15
- ICD (n= 76)
Primary prevention 46
Secondary prevention 30
Relevant co-morbidity N = 202 (156 pts)
Hemochromatosis 2
Sarcoid 1
Heart / vessel disease 43
CVA / TIA 28
Neurologic disorder 80
Orthopaedic 15
Urologic 17
Gastro-enteric 16
Device characteristics
- Pacemaker (n= 138)
Medtronic Advisa MRI / Evia 72
St Jude Accent MRI 45
Boston Ingenio MRI 21
- ICD (n= 76)
Medtronic Evera ICD MRI 44
Biotronik Lumax ICD MRI 14
Biotronik Ilesto ICD MRI 18
- Leads
Medtronic Capsure 5086/5076/6935 228
St Jude Tendril 84
Boston Fineline / Flextend 36
Biotronik Solia / Linox / Corox 67
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Figure 2. Increase in number of MRI-conditional pacing devices implanted through recent 
years.
In 24 (mean age 62 ± 12 years old) of the 214 patients who received a complete MRI-
conditional pacing system, 36 MRI examinations were performed during follow-up. The 
mean time between CIED implantation and MRI was 222 ± 160 days (range: 50-572 days). 
The indication for the MRI scan was directly related to the pre-existent comorbidity in 19 
of the 24 patients (76%) as can be observed in table 2.
Table 2. MRI examination and relation to co-morbidity.
Co-morbidity Nr of patients Type of MRI examination(s)
Hemochromatosis 1 Heart, Liver
Previous neurological disease/tumor 12 Cerebrum, Spine, Leg, Hip
Previous trauma 3 Spine, Knee, Ankle
Congenital heart defect 3 Heart, Aorta
Not related to co-morbidity Nr of patients Type of MRI examination(s)
Indication for MRI scan
Myocarditis, follow-up on function 3 Heart
Diplopia, headache 2 Cerebrum
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Safety
There were no significant changes in lead impedance or sensing threshold between 
the pre- and immediate post-procedural measurements. There was also no evidence of 
battery voltage depletion following MRI (table 3).
MRI studies were safely performed in all cases. There was no electrical pacemaker reset 
or any unexpected changes in heart rate or heart rhythm during the MRI scan. No 
patients reported pain or heating over the device site or symptoms that may indicate 
arrhythmia such as dizziness or palpitations. Figure 3 shows typical artifacts that can be 
observed when performing cardiac MRI in patients with an implanted CIED.
A B
C D
*
LV LV 
RV 
RV 
LA 
RA 
LV 
RL 
LL 
LL 
Figure 3. Typical artifacts that may be observed when performing cardiac MRI in patients with 
an implanted CIED. A: coronal T1 weighted sequence with artifact induced by the presence of 
the RV lead (white arrow) and artifact induced by the impulse generator in the pectoral region 
(asterisk). B: axial T1 weighted image with an artifact near in the area of the impulse generator. 
C: four/five chamber view with artifacts induced by the pacing leads in the right atrial and right 
ventricular. D: short axis image from a steady state free precession sequence with an artifact 
caused by the RV lead.
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Device parameters during follow-up
Pacing thresholds, P- and R-wave amplitude and lead impedances were documented 
during long-term follow-up for all patients (table 4). There were no significant 
differences in device parameters between patients in whom an MRI examination was 
performed during follow up and those in whom no MRI was performed.
Table 3. Device parameters directly before and after MRI examination.
Pre-MRI Post-MRI p-value
P-wave amplitude (mV) 2.9 ± 18 2.9 ± 1.8 0.71
Atrial lead impedance (Ohm) 476.1 ± 78.9 474.7 ± 92.7 0.36
Pacing threshold (V@0.4ms) 0.66 ± 0.2 0.7 ± 0.2 0.49
R-wave amplitude 13.5 ± 5.2 14.2 ± 5.2 0.55
Ventricular lead impedance 533.2 ± 96.6 536.4 ± 84.8 0.06
Pacing threshold 0.7 ± 0.2 0.7 ± 0.2 0.68
Battery life (months) 120.7 ± 19.9 113.6 ± 20.6 0.54
Table 4. Device parameters during follow-up.
Clinical MRI scan(s) during follow-up (n=24 patients; 36 MRI exams)
Implant 3 months 12 months 18 months
P-wave amplitude (mV) 3.2 ± 1.6 3.1 ± 1.3 3.0 ± 1.4 2.8 ± 1.3
Atrial lead impedance (Ohm) 770.4 ± 204.8 500.1 ± 137.6 506.0 ± 127.2 537.2 ± 282.7
Pacing threshold (V@0.4ms) 0.9 ± 0.4 0.7 ± 0.3 0.6 ± 0.2 0.7 ± 0.3
R-wave amplitude 13.4 ± 5.5 13.0 ± 5.3 13.5 ± 5.5 13.2 ± 5.5
Ventricular lead impedance 904.0 ± 305.9 545.9 ± 93.6 545.8 ± 87.1 540.1 ± 78.3
Pacing threshold 0.8 ± 0.4 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.3
Battery life (months) 103.5 ± 32.0 102.9 ± 27.2 95.5 ± 23.0
No clinical MRI scan during follow-up (n=190 patients)
Implant 3 months 12 months 18 months 
P-wave amplitude (mV) 3.2 ± 1.9 2.9 ± 18 2.9 ± 1.8 3.1 ± 1.9
Atrial lead impedance (Ohm) 645.7 ± 186.9 476.1 ± 78.9 474.7 ± 92.7 481.9 ± 83.5
Pacing threshold (V@0.4ms) 1.06 ± 0.6 0.66 ± 0.2 0.7 ± 0.2 0.7 ± 0.2
R-wave amplitude 13.1 ± 5.7 13.5 ± 5.2 14.2 ± 5.2 14.1 ± 5.2
Ventricular lead impedance 778.7 ± 249.8 533.2 ± 96.6 536.4 ± 84.8 527.5 ± 84.1
Pacing threshold 0.85 ± 1.1 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.3
Battery life (months) 120.7 ± 19.9 113.6 ± 20.6 114.6 ± 20.2
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DISCUSSION
Of the 214 patients analysed, the majority of the patients (n=128) had undergone 
a previous MRI scan. A total of 36 clinical MRI examinations (in 24 patients) were 
performed in the years following implantation. The majority of these scans were 
performed to confirm, exclude or follow-up a neurological disease. This is in accordance 
with previously published data.
In line with previously published reports, this data demonstrates MRI can be safely 
performed in patients with implanted (MRI-conditional) CIEDs [8-12]. MRI offers the 
advantage of radiation-free, clear anatomic imaging, soft tissue characterisation and 
functional assessment such as in cardiac MRI. Indications for MRI have expanded, 
particularly in the follow-up of chronic diseases or hereditary disorders.
Although it can be expected that all devices will be MRI-conditional in the future and 
limitations will only concern the applied field strength or scan duration, the current 
situation may be confusing for referring physicians. Despite the efforts to clearly indicate 
MRI compatibility of the device, e.g. on the patient’s device card or by symbols that can 
be identified on chest radiography, it may be a challenging topic for non-cardiologists. 
In order to eliminate potential risks, current guidelines advise to adhere to a strict safety 
protocol when performing MRI scans in patients with implanted devices.
Image quality
The possible effects MR imaging may have on the function of the implanted device have 
been thoroughly investigated. Only when adhering to manufacturer’s instructions, safe 
scanning of patients can be guaranteed.
In addition, the impact of the device on image quality has become an area of research 
[13-16]. In general, structures outside the thorax can be investigated without difficulties. 
Furthermore, recent studies have demonstrated the satisfactory performance of cardiac 
MRI in patients with implanted devices. Despite the presence of artifacts caused by the 
impulse generator and the pacing leads, biventricular volume and function assessment 
and late enhancement imaging was carried out with an acceptable image quality.
Study limitations
This is a single-center retrospective study in which the use of MRI in patients with 
implanted MRI-conditional pacemakers or ICDs was evaluated. Patients may have 
undergone MRI examinations in other centers. Therefore the number of scans after 
implantation may be underestimated.
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The mean follow-up period in this study demonstrated a high variance. This is mainly 
due to the fact that implantation rates have increased dramatically in the year 2014, 
resulting in a relatively limited follow-up period in these patients.
MRI was only performed using a field strength of 1.5 Tesla. Therefore, the presented data 
regarding the safe performance of MRI cannot be translated to application of higher 
field strengths.
CONCLUSION
Patients with a high risk of requiring an MRI scan in the near future are eligible for 
implantation of an MRI-conditional pacing device. In this study, MRI-conditional pacing 
devices were implanted in 214 patients of whom 94% suffered from a co-morbidity that 
may lead to a future indication for MRI. During a mean follow-up period of 406 days 
(51-1353 days), 36 MRI investigations were safely performed in 24 (11%) patients. The 
diagnostic yield was not affected by the presence of the device.
14867-vandergraaf-layout.indd   49 31/08/2017   09:37
50
Chapter 3
REFERENCES
1. Kuck KH, Hindricks G, Padeletti L, Raatikainen P, Arnar DO. The EHRA White Book 2014: The 
Current Status of Cardiac Electrophysiology in ESC Member Countries. 2014.
2. Ferreira AM, Costa F, Tralhão A, Marques H, Cardim N, Adragão P.MRI-conditional pacemakers: 
current perspectives. Med Devices (Auckl). 2014 May 7;7:115-24.
3. Nordbeck P, Ertl G, Ritter O. Magnetic resonance imaging safety in pacemaker and 
implantable cardioverter defibrillator patients: how far have we come? Eur Heart J. 2015 Jun 
21;36(24):1505-11.
4. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator 
patients. Pacing Clin Electrophysiol. 2005;28:326–328.
5. van der Graaf AW, Bhagirath P, Götte MJ. MRI and cardiac implantable electronic devices; 
current status and required safety conditions. Neth Heart J. 2014 Jun;22(6):269-76.
6. Shenthar J, Milasinovic G, Al Fagih A, Götte M, Engel G, Wolff S, Tse HF, Herr J, Carrithers J, 
Cerkvenik J, Nähle CP. MRI scanning in patients with new and existing CapSureFix Novus 
5076 pacemaker leads: Randomized trial results. Heart Rhythm. 2015 Apr;12(4):759-65.
7. Maglia G, Curnis A, Brieda M, Anaclerio M, Caccavo V, Bonfanti P, Melissano D, Caravati 
F, Giovene L, Gargaro A; the Really ProMRI Study Group. Assessing access to MRI of 
patients with magnetic resonance-conditional pacemaker and implantable cardioverter 
defibrillator systems: the Really ProMRI study design. J Cardiovasc Med (Hagerstown). 2015 
Oct;16(10):715-20.
8. Wollmann CG, Thudt K, Kaiser B, Salomonowitz E, Mayr H, Globits S.Safe performance 
of magnetic resonance of the heart in patients with magnetic resonance conditional 
pacemaker systems: the safety issue of the ESTIMATE study. J Cardiovasc Magn Reson. 2014 
May 6;16:30.
9. Muehling OM, Wakili R, Greif M, von Ziegler F, Morhard D, Brueckmann H, Becker A. Immediate 
and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with 
conventional cardiac pacemakers. J Cardiovasc Magn Reson. 2014 Jun 5;16:39.
10. Ainslie M, Miller C, Brown B, Schmitt M. Cardiac MRI of patients with implanted electrical 
cardiac devices. Heart. 2014 Mar;100(5):363-9.
11. Marinskis G, Bongiorni MG, Dagres N, Dobreanu D, Lewalter T, Blomström-Lundqvist C; 
Scientific Initiative Committee, European Heart Rhythm Association. Performing magnetic 
resonance imaging in patients with implantable pacemakers and defibrillators: results of a 
European Heart Rhythm Association survey. Europace. 2012 Dec;14(12):1807-9.
12. Nazarian S, Beinart R, Halperin HR. Magnetic resonance imaging and implantable devices. 
Circ Arrhythm Electrophysiol. 2013 Apr;6(2):419-28.
13. Kaasalainen T, Kivistö S, Holmström M, Peltonen J, Pakarinen S, Hänninen H, Sipilä O. Cardiac 
MRI in patients with cardiac pacemakers: practical methods for reducing susceptibility 
artifacts and optimizing image quality. Acta Radiol. 2016 Feb;57(2):178-87.
14867-vandergraaf-layout.indd   50 31/08/2017   09:37
51
Clinical use of MRI in patients with MRI-conditional pacemaker systems
14. Martinelli M. Magnetic resonance imaging and cardiac implantable electronic devices: 
safety barrier overtaken--is the image quality the current target? Heart Rhythm. 2013 
Jun;10(6):873-4.
15. Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, Calkins H, Halperin 
HR, Nazarian S. Quantitative assessment of artifacts on cardiac magnetic resonance imaging 
of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc 
Imaging. 2011 Nov;4(6):662-70.
16. Schwitter J, Kanal E, Schmitt M, Anselme F, Albert T, Hayes DL, Bello D, Tóth A, Chang Y, 
van Osch D, Sommer T; Advisa MRI System Study Investigators. Impact of the Advisa MRI 
pacing system on the diagnostic quality of cardiac MR images and contraction patterns of 
cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results. Heart 
Rhythm. 2013 Jun;10(6):864-72.
14867-vandergraaf-layout.indd   51 31/08/2017   09:37
04
14867-vandergraaf-layout.indd   52 31/08/2017   09:37
MR-FEATURE TRACKING IN PATIENTS 
WITH MRI-CONDITIONAL PACING 
SYSTEMS: THE IMPACT OF PACING
van der Graaf AW, Bhagirath P, Scheffer MG, Robles de Medina R, Götte MJ.
Journal of Magnetic Resonance Imaging. 2016;44(4):964-71.
14867-vandergraaf-layout.indd   53 31/08/2017   09:37
54
Chapter 4
ABSTRACT
Purpose: To perform strain analysis using use feature tracking (FT) software on 
conventional (non-tagged) cardiac magnetic resonance imaging (MRI) function images. 
With the advent of MRI-conditional pacemaker systems, effects of cardiac pacing on 
myocardial strain can be studied using MR. In this study the impact of pacing on left 
ventricular (LV) strain was investigated using MR-FT in patients with an MRI-conditional 
cardiac implantable electronic device (CIED).
Material and methods: FT was performed on 32 1.5T MR studies (16 patients with 
an MRI-conditional CIED and 16 control patients with normal scans). Short- and long-
axis steady state free precession (SSFP) cines were used for the FT analysis. Strain was 
assessed using CVI42 software (Circle Cardiovascular Imaging, Alberta, Canada). In 
addition, the intra- and interobserver variability was determined using the intraclass 
correlation coefficient.
Results: Of the 16 patients with an MRI-conditional CIED, five patients were paced 
during the MRI exam. Despite the occasional presence of susceptibility artifacts induced 
by the CIED, radial, circumferential, and longitudinal strain parameters could be derived 
for all patients. Peak radial strain and peak circumferential strain were reduced during 
pacing when compared to the control group; for radial strain: 20.1 ± 4.7% vs. 33.1 ± 
6.9%, P < 0.001, and for circumferential strain -7.5 ± 3.5% vs. -14.9 ± 3.2%, P < 0.05. Peak 
strain parameters were reproducible on an intra- and interobserver level.
Conclusion: MR-FT is feasible in patients with an MRI-conditional CIED and can be used 
to quantify regional wall motion.
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INTRODUCTION
Due to the induced abnormal pattern of mechanical activation, right ventricular (RV) 
pacing is associated with regional remodelling and deterioration of left ventricular (LV) 
function [1-2]. Therefore, patients with a single-chamber pacing device are carefully 
followed using echocardiography in order to monitor global cardiac function. However, 
global function measures are insensitive to early regional dysfunction [3]. Therefore, it 
may be of advantage to evaluate local myocardial strain during the cardiac cycle in this 
patient category.
Magnetic Resonance Imaging (MRI) is the current reference standard for the accurate 
assessment of regional wall motion [4]. MR tissue tagging provides highly reproducible 
data of 3D myocardial strain [5]. However, due to the need for a dedicated pulse sequence 
and cumbersome post-processing procedure, tissue tagging and strain analysis have 
not become routine clinical tools [6].
Recently developed feature tracking (FT) software allows for retrospective detailed 
regional myocardial strain analysis on routine MR cine images [7]. Hence, acquisition 
of tagged images to derive strain parameters is not required. A study by Kuetting et al. 
compared the FT technique to tagged Harmonic Phase (HARP) imaging and revealed a 
good agreement for global strain assessment between the two techniques [8].
With the introduction of MRI-conditional cardiac implantable electronic devices (CIED), 
MRI has become applicable in patients with CIEDs [9-10].
The purpose of this study was to investigate the impact of pacing on LV strain using 
FT software applied on cardiac MR cine images of patients with MRI-conditional CIEDs.
METHODS
Patient population
This was a retrospective, single-center study. The study complies with the Declaration of 
Helsinki. The local medical ethical committee and the hospital scientific board approved 
this study.
A total of 32 MR studies were analysed; 16 studies of patient with an implanted CIED and 
16 control studies.
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The 16 consecutive MR investigations in CIED patients were derived from a previous 
study [11]. In total, 14 patients had a Medtronic Advisa MRI pacemaker system and a 
structurally normal heart; 2 patients without a history of coronary artery disease had 
a Medtronic Evera MRI Internal Cardioverter Defibrillator (ICD) system for primary 
prevention.
The 16 MR exams of healthy volunteers were collected from the local database. These 
individuals did not have any cardiovascular history or symptoms of cardiac disease. The 
control group was sex and age adjusted to the CIED patients. Baseline characteristics of 
the study population are summarised in table 1.
Table 1. Baseline characteristics of study population.
Parameters CIED patients
(n=16)
Controls
(n=16)
Age (years) 59 ± 11 59 ± 12
Male gender, n (%) 15 (94) 15 (94)
BSA (m2) 2.1 ± 0.2 2.1 ± 0.2
Days after device implant 271 ± 289
Pacing indication
- Asystole 4
- Bradycardia 3
- AV-block 5
- SSS 2
- Primary prevention (ICD) 2
Device characteristics (impulse generator and leads)
- Medtronic Advisa MRI & Medtronic CapSure 5086/5076 14
- Medtronic Evera ICD MRI & Medtronic CapSure 6935 2
Device programming during MR exam
- VOO/DOO (asynchronous pacing) 5
- VVI/DDI (pacing inhibited) 11
SSS sick sinus syndrome; LVEDV left ventricular end-diastolic volume; LVESV left ventricular end-systolic volume; LVSV left 
ventricular stroke volume; LVEF left ventricular ejection fraction; RVEDV right ventricular end-diastolic volume; RVESV right 
ventricular end-systolic volume; RVSV right ventricular stroke volume; RVEF right ventricular ejection fraction
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Device programming
Before entering the MRI room, pacing thresholds, P- and R-wave amplitude and lead 
impedance were determined and the CIED was programmed into MRI SureScan® 
mode [12]. During the MRI examination, the ECG signal and pulse-oximetry were 
used to monitor the patients and to verify continuous pacing, if applicable. After the 
examination, pacing thresholds, P- and R-wave amplitude and lead impedance were 
determined and compared to the values prior the MR investigation. Finally, original 
programming of the CIED was restored.
Cardiovascular magnetic resonance imaging
MR studies were performed between March 2012 and September 2014. Six examinations 
(four scans in the CIED group and two scans in the control group) were performed on a 
1.5 Tesla Philips Intera system (Philips Healthcare, Best, The Netherlands). The remaining 
26 scans were performed on a 1.5 Tesla Siemens Aera system (Siemens, Erlangen, 
Germany). The mean time between CIED implantation and acquisition of images was 
271 days (range: 50-1109 days).
After survey scans, a retrospective triggered balanced Steady State Free Precession 
(SSFP) gradient echo sequence was used for cine imaging. SSFP cine images were 
acquired in a single breath-hold during expiration for 8-10 seconds. In all patients, a 
stack of short-axis (SAX) and two, three, and four-chamber long-axis (LAX) cines were 
obtained.
Typical image parameters were: slice thickness 6mm, slice gap 4mm, temporal 
resolution <50ms, repetition time 32ms, echo time 1.54ms, flip angle 57 degrees and 
a typical image resolution of 1.4 by 1.4mm. The number of phases within the cardiac 
cycle was set at 20.
The image quality and the feasibility of delineating endocardial and epicardial contours 
were evaluated for all scans. In the two patients with an implanted ICD system, additional 
Gradient Echo (GRE) LAX and SAX cines were acquired to reduce the amount of artifacts 
induced by the device. Typical image parameters were: slice thickness 6mm, slice gap 
4mm, temporal resolution <50ms, repetition time 48ms, echo time 3.16ms and flip 
angle 15 degrees.
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Magnetic resonance - feature-tracking
Strain analysis was performed using MR-FT software (Circle Cardiovascular Imaging, Inc, 
Alberta, Canada). End-diastolic and end-systolic LV contours were manually drawn on 
the epicardial and endocardial wall of the myocardium in LAX cine images and on basal, 
mid and apical levels of SAX cine images, as described previously [13].
Strain is expressed as the percentage of shortening or lengthening of a small element 
of myocardium in relation to its original length. Radial, circumferential and longitudinal 
peak strain (%), time to peak strain (ms) and degree of torsion (deg/cm) were derived. 
For analysis purposes, the American Heart Association (AHA) 16-segment model was 
used [14].
Besides strain analysis, function measures including left- and right ventricular end-
diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction 
(EF) and LV mass were determined. Two independent observers with over five years of 
experience in interpreting MR analysed four cases (2 SSFP and 2 GRE studies) to assess 
inter-observer variability (AWM & PB), while intra-observer variability was derived from 
the repeated analysis by the first observer (AWM).
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics for Windows, version 
17.0. Data are expressed as mean ± standard deviation (SD). MR function and strain 
parameters were compared between the different groups using an unpaired Student 
t-test, after the data was tested for normal distribution. The intra- and inter- observer 
variability for strain measurements was assessed by the intraclass correlation coefficient 
(ICC). All statistical tests with p values < 0.05 were considered statistically significant.
RESULTS
Image quality
The mean duration of an MRI examination was 49 ± 9 min in CIED patients and 29 ± 4 min 
in the control group. In patients with an implanted pacemaker system, the occasional 
presence of artifacts, induced by the presence of the device, did not hamper endocardial 
and epicardial contour delineation. A typical example representing the average image 
quality of a SAX cine used for the drawing of contours is provided in figure 1.
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End-diastole End-systole 
* * 
A	 B	
Figure 1. End-diastolic (A) and end-systolic (B) still of a short-axis cine from a patient with an 
implanted CIED. Despite the presence of the susceptibility artifact (indicated by the asterisks), 
LV and RV function could be assessed.
In the two patients with an implanted ICD system, the artifacts were more prominent 
due to the larger device and the presence of the RV shock-lead. In these patients, an 
additional GRE pulse sequence was applied. The GRE images did show fewer artifacts 
and allowed for a clinically relevant quantitative analysis. The difference in image 
quality between a standard four-chamber SSFP sequence and a GRE sequence is shown 
in videos 1 and 2.
Ventricular volumes and function
In all patients, LV and RV function could be assessed. MR-derived function measures are 
listed in table 2. Compared to controls, mean left and right ventricular function were 
reduced in patients with a CIED (LVEF 47 ± 10% vs 56 ± 6%, p<0.05 and RVEF 44 ± 6% 
vs.55 ± 6% , p<0.001)
Myocardial strain analysis
The mean post-processing time was 23 ± 4 min in the patients with a CIED and 18 ± 
3 min in the control group. A total of 512 (16 x 32) heart segments were analysed. In 
table 3, results of the strain analysis are provided. Of the 16 patients in the CIED group, 
5 patients underwent MRI during DOO pacing (4 patients with a total AV block and 1 
patient with a symptomatic sick sinus syndrome), the remaining 11 patients had an 
intrinsic rhythm while image acquisition was performed. Figure 2 provides an example 
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of a 16-segment bulls eye plot visualising the regional differences in time to peak radial 
strain and radial strain during pacing and during intrinsic rhythm. RV pacing results in 
an asynchronous activation pattern and decreased myocardial strain.
Table 2. Ventricular volumes and function.
MR parameter
CIED - pacing
(n=5)
CIED - non-pacing 
(n=11)
Controls
(n=16)
LVEDV (ml) 164 ± 24 177 ± 43 160 ± 30
LVESV (ml) 97 ± 21 93 ± 42 71 ± 20
LVSV (ml) 67 ± 13# 84 ± 14 90 ± 15
LVEF (%) 41 ± 7# 49 ± 10 56 ± 6
LV mass (g) 121 ± 17# 119 ± 18§ 93 ± 24
LV mass/BSA (g/m2) 57 ± 7# 56 ± 9§ 45 ± 11
RVEDV (ml) 158 ± 17 175 ± 38 161 ± 35
RVESV (ml) 92 ± 15 96 ± 26§ 74 ± 24
RVSV (ml) 66 ± 8# 79 ± 17 87 ± 15
RVEF (%) 42 ± 5# 46 ± 6§ 55 ± 6
# CIED-pacing vs. control, p<0.05; § CIED non pacing vs. control, p<0.05.
Table 3. Myocardial strain parameters
Strain parameters CIED - pacing
(n=5)
CIED - non-pacing
(n=11)
Controls
(n=16)
Peak radial strain (%) 20.1 ± 4.7# 22.3 ± 5.8§ 33.1 ± 6.9
Time to peak radial strain (ms) 364.9 ± 31.3 401.5 ± 49.0§ 344.0 ± 38.8
Peak circumferential strain (%) -7.5 ± 3.5# -8.5 ± 6.1§ -14.9 ± 3.2
Time to peak circumferential strain (ms) 358.6 ± 33.7 407.0 ± 53.7§ 340.2 ± 44.7
Peak longitudinal strain (%) -5.1 ± 1.5 -6.6 ± 2.3 -8.5 ± 1.4
Time to peak longitudinal strain (ms) 361.2 ± 32.3 403.2 ± 50.7 342.2 ± 39.4
Torsion (deg/cm) 0.5 ± 0.3 0.6 ± 0.4 0.7 ± 0.7
# CIED-pacing vs. control, p<0.05; § CIED non pacing vs. control, p<0.05.
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Figure 2. American Heart Association (AHA) 16-segment bulls eye plot of radial strain in a 
CIED patient and a healthy control. Time to peak radial strain increased and radial strain was 
decreased during pacing (upper panel) compared to intrinsic rhythm (lower panel). RV pacing 
results in delayed and decreased myocardial strain. This is most evident in the antero-lateral 
segments of the basal region of the heart.
Peak radial strain and peak circumferential strain were reduced during pacing (n=5) 
when compared to patients in the control group (radial strain: 20.1 ± 4.7% vs. 33.1 ± 
6.9%; p<0.001 and circumferential strain: -7.5 ± 3.5% vs. -14.9 ± 3.2%; p<0.05). A trend 
towards a decrease in longitudinal strain (-5.1 ± 1.5%) was observed during cardiac 
pacing (n=5) when compared to CIED patients (n=11) scanned during intrinsic rhythm 
(-6.6 ± 2.3%, p=0.25) and healthy controls (-8.5 ± 1.4%, p=0.38). Figure 3 visualises the 
differences observed in myocardial strain between CIED patients with a paced rhythm 
during image acquisition and healthy controls. Radial, circumferential and longitudinal 
strain was decreased during pacing.
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Figure 3. Whole-cycle circumferential, radial and longitudinal strain during pacing (upper 
panel) compared to strain measured in healthy volunteers (lower panel). In general, the 
amount of myocardial strain was reduced and more delayed during RV pacing.
A trend towards a decrease in time to peak radial and circumferential strain was 
observed during pacing when compared to CIED patients scanned during intrinsic 
rhythm (time to peak radial strain: 364.9 ± 31.3ms vs. 401.5 ± 49.0ms; p=0.12 and time to 
peak circumferential strain: 358.6 ± 33.7ms vs. 407.0 ± 53.7ms; p=0.06.
Reproducibility of MR-FT analysis
Peak strain parameters were reproducible on an intra- and inter-observer level. Table 
4 shows ICC for repeated measurements within the single and between observers. 
Correlations between peak strain derived from SSFP images were higher compared to 
the parameters derived from GRE sequences.
14867-vandergraaf-layout.indd   62 31/08/2017   09:37
63
MR-feature tracking in patients with MRI-conditional pacing systems:  the impact of pacing
Table 4. Intra- and inter-observer variability for SSFP (upper panel) and GRE series (lower panel).
SSFP sequence
Intra-observer variability Inter-observer variability
Mean 
difference ± SD
ICC (95% CI)
Mean 
difference ± SD
ICC (95% CI)
Peak radial strain 4.72 ± 20.16 0.70 (0.33-0.89) -2.05 ± 12.50 0.76 (0.56-0.87)
Peak circumferential strain 0.86 ± 7.15 0.92 (0.80-0.97) -2.41 ± 12.58 0.71 (0.49-0.85)
Peak longitudinal strain 0.65 ± 0.88 0.99 (0.98-0.99) -0.88 ± 3.83 0.72 (0.55-0.83)
Gradient echo sequence
Intra-observer variability Inter-observer variability
Mean 
difference ± SD
ICC (95% CI)
Mean 
difference ± SD
ICC (95% CI)
Peak radial strain -1.23 ± 17.24 0.01 (-0.47-0.48) 1.05 ± 10.79 0.62 (0.35-0.80)
Peak circumferential strain 1.63 ± 20.77 -0.10 (-0.56-0.40) 7.78 ± 16.50 0.37 (0.02-0.63)
Peak longitudinal strain 1.71 ± 1.01 0.93 (0.85-0.97) 0.61 ± 1.56 0.88 (0.80-0.93)
DISCUSSION
This study investigated the impact of pacing on regional wall motion using MR-FT in 
patients with MRI-conditional pacemakers and ICDs.
For all patients in this study, strain analysis could be performed. In patients with a CIED, 
a delay and decrease of peak radial, peak circumferential and longitudinal strain was 
observed. Peak strain parameters were reproducible on an intra- and inter-observer 
level and comparable to results published in normal volunteers [15] and patients with 
ischemic cardiomyopathy [16].
In the CIED patients, adequate endocardial and epicardial delineation was possible, 
despite the presence of susceptibility artifacts induced by the CIED. Although additional 
GRE sequences in two patients with an implanted ICD system resulted in images with 
fewer susceptibility artifacts, the reproducibility of strain parameters was lower when 
compared to strain parameters derived from SSFP sequences. This may be due to the 
fact that the borders of the endocardium and epicardium are more difficult to discern 
on GRE cine images.
Assessment of regional wall motion that can be performed on routinely acquired MR 
images could facilitate the monitoring of myocardial strain in patients with CIEDs. This 
may be especially beneficial for patients receiving long-term RV pacing or in patients 
with poor acoustic windows for echocardiography. From literature, it is known that long-
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term RV pacing is associated with deterioration of LV function [17]. Therefore, it is crucial 
to detect early signs of local remodelling or impaired function. For this patient category, 
MR-FT is a promising tool that allows follow-up and evaluation of serial changes in 
strain parameters. In addition, MR-FT may facilitate the incorporation of routine strain 
assessment in clinical practice.
Feature tracking and tissue tagging are currently available for the evaluation of 
myocardial strain.
In MR tissue tagging, non-invasive myocardial markers are applied by saturation planes. 
Subsequently, the movement of these markers is quantified during the cardiac cycle.
Cardiac MR tissue tagging provides highly reproducible data of myocardial deformation 
in three directions and is the current reference standard [18]. Besides the need for an 
advanced pulse sequence and cumbersome post-processing, tagging may be limited 
by the rapid fading of tags. Tag fading may hamper evaluation of the entire cardiac 
cycle. Scanning on a 3.0 Tesla scanner can reduce this problem [19]. However, this is 
not possible with current available MRI-conditional CIEDs, since these devices are only 
approved for 1.5T.
Feature-tracking imaging was originally designed for echocardiographic image analysis 
[20] and was later introduced in the field of MR. MR-FT does not require the acquisition of 
additional MRI images. After contour delineation of the ventricular myocardium on cine 
images, MR-FT calculates the motion of a tissue voxel. In contrast to speckle-tracking 
echocardiography or MR tissue tagging, only the border between myocardium and 
blood is available for tracking. Therefore, sufficient contrast between these structures 
is required.
Previous studies [7,8,21] have indicated that 3D myocardial deformation may be difficult 
to analyse using MR-FT, since the tracking of the border between myocardium and the 
blood pool merely represents wall thickening and epicardial-endocardial motion. This 
may explain the limited amount of torsion observed in this study.
 MR-FT has been applied in several groups of patients e.g. dilated cardiomyopathy 
[22], ischemic cardiomyopathy [16], during dobutamine stress [23] and in patients 
with repaired tetralogy of Fallot [24]. In a more recent study by Taylor et al. [25] 100 
healthy individuals underwent MR-FT assessment in order to define a normal range for 
the most commonly used strain parameters. In addition, this study demonstrated an 
excellent intra- and inter-observer variability for all circumferential and longitudinal 
based variables.
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A limited number of studies have compared the two techniques [26-27]. A study by Hor 
et al. [28] reported a strong correlation between the global strain assessed with the two 
methods. A recent study by Wu et al. [29] confirmed this finding, but concluded that 
the intra- and inter-observer agreement of MR-FT was lower compared with MR tissue 
tagging. Based on the available literature, the value of MR-FT needs to be proven with 
respect to regional strain.
In this study, the feasibility of performing MR-FT is demonstrated in a limited number 
of patients with an MRI-conditional pacing device. In order to assess the long-term 
impact of pacing using MR-FT, however, a larger number of patients and a prospective 
study design are required. Preferably, the MR-FT results would be compared to strain 
measurements obtained using MR-tagging or echocardiography.
The cine images used in this study (SSFP and GRE) were acquired with a temporal 
resolution < 50ms. To evaluate the effect of cardiac pacing on the timing of mechanical 
activation in more detail, the temporal resolution used for the acquisition of the cine 
images is of importance [30]. Further research is needed in order to determine whether 
MR-FT in patients with an implanted CIED may benefit from images obtained user a 
higher temporal resolution. Since the border between myocardium and blood is used 
for tracking purposes in MR-FT, through-plane motion may affect the measurements, 
especially in the basal segments. Assessment of RV myocardial strain is currently not 
possible with the available software. Future studies are required to demonstrate the 
feasibility of integrating this analysis in the daily clinical practice.
CONCLUSION
Magnetic Resonance Feature Tracking is feasible in patients with an MRI-conditional 
pacing device. In this study, cardiac pacing was associated with a decrease in peak radial 
and circumferential strain. This technique may be used to monitor regional wall motion 
and myocardial strain in this group of patients. Further research is needed to evaluate 
the potential benefits of this technique in daily clinical practice.
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ABSTRACT
Non-invasive imaging of cardiac excitation using body surface potential mapping 
(BSPM) data and inverse procedures is an emerging technique that enables estimation 
of myocardial depolarisation and repolarisation. Despite numerous reports on the 
possible advantages of this imaging technique, it has not yet advanced into daily clinical 
practice. This is mainly due to the time consuming nature of data acquisition and the 
complexity of the mathematics underlying the used inverse procedures. However, the 
popularity of this field of research has increased and non-invasive imaging of cardiac 
electrophysiology is considered a promising tool to complement conventional invasive 
electrophysiological studies. Furthermore, the use of appropriately designed electrode 
vests and more advanced computers has greatly reduced the procedural time. This 
review provides descriptive overview of the research performed thus far and the 
possible future directions. The general challenges in routine application of BSPM and 
inverse procedures are discussed. In addition, individual properties of the biophysical 
models underlying the inverse procedures are illustrated.
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INTRODUCTION
Through the years, various non-invasive electrocardiographic imaging techniques 
have emerged that estimate epicardial potentials or myocardial activation times from 
potentials recorded on the thorax [1-8]. The recording of potentials from a large number 
(32-256) of torso electrodes is referred to as Body Surface Potential Mapping (BSPM) [9]. 
The BSPM data can later be used in mathematical inverse procedures to calculate local 
epicardial potentials or myocardial activation times [10].
Although a vast amount of research illustrates the possible clinical advantages of this 
non-invasive imaging method, the time consuming nature of BSPM and the complexity 
of the mathematics underlying the inverse procedures have thus far hampered these 
techniques to advance into daily clinical practice.
Nevertheless, non-invasive imaging of cardiac excitation is still gaining popularity as 
a field of research and is considered a promising tool to complement conventional 
invasive electrophysiological studies [11]. The use of appropriately designed electrode 
vests and more advanced computers has greatly reduced the procedural time. Recently, 
a non-invasive imaging technique based on Electrocardiographic Imaging (ECGI) has 
been commercialised and has become available for clinical use in Europe [12]. Although 
ECGI estimates the time course of unipolar epicardial electrograms only, several studies 
have demonstrated that the epicardial potentials and electrograms provide substantial 
information about intra-myocardial activity [13-14].
This review discusses the general challenges in routine application of BSPM and inverse 
procedures. Descriptive overview is given to the research performed thus far and the 
future direction of non-invasive imaging of cardiac excitation. In addition, individual 
properties of the biophysical models underlying the inverse procedures are illustrated.
BODY SURFACE POTENTIAL MAPPING
Waller was the first to report on the recording of human body surface potentials in 
1887 [15]. He used a capillary electrometer to systematically investigate the potential 
distribution associated with the beating heart. Einthoven published the first surface 
electrocardiogram (ECG) constructed with the string galvanometer in 1903 and later 
described the method for clinical 12-lead electrocardiography [16]. The use of the 
12-lead ECG made it possible to study potential fields over designated areas and to 
investigate their variations over time.
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Although the efficacy of the 12-lead ECG had been widely recognised, several 
researchers felt that information was lost when the recording of potentials was limited 
to only nine sites [17-18]. In the following years, alternative configurations using 16 
to 256 torso electrodes were proposed [19-24]. Nevertheless, BSPM has never been 
incorporated into daily clinical practice because of uncertainty about the clinical utility. 
In the meantime, much experience had already been gained with the interpretation of 
the 12-lead ECG and this configuration continues to be the standard of routine clinical 
practice today.
INVERSE PROCEDURE
The forward problem of electrocardiography refers to estimation of body surface 
potentials from potentials measured on the surface of the heart. Therefore, the effect 
that different types of body tissue have on the cardiac potentials is simulated [25]. In 
contrast, the inverse problem of electrocardiography describes the opposite (figure 1A). 
Through an inverse procedure, the potentials on the heart surface or activation times 
of the myocardium are estimated using the recorded body surface potentials as source 
data.
In order to calculate cardiac activation times from potentials recorded on the body 
surface, potentials that are generated by the cardiac electrical activity in the torso 
volume need to be modelled. Unlike the forward problem that can be solved uniquely, 
the inverse problem in terms of sources is not unique [26]. Many different source 
configurations in the heart can correspond to the same potentials on the body surface, 
even for noise-free and error-free data. These different sources are termed equivalent 
sources because they generate the same potentials on the body surface. Therefore, the 
inverse problem is said to be “ill-conditioned” [27].
In order to cope with this ill-conditioned nature, most inverse procedures employ 
a combination of two types of models: a biophysical source model and a volume 
conductor model (VCM). In a biophysical source model, the heart is represented as a 
generator of electrical currents (figure 2).
The VCM reproduces the influence of different types of tissues in the thorax on the 
potential waveforms.
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Figure 1. Forward and inverse computation. A: The principle of forward and inverse computation 
is illustrated in a VCM from a lateral view (H: heart, L: lung). In the EDL source model (B), the 
wavefront separating resting heart cells in the myocardium from those that have undergone 
depolarisation, is regarded as an activation layer that moves through the heart during the 
cardiac cycle. In the PPS model (C), a unique relationship exists between the potentials on the 
body surface and the potentials on the epicardium.
In order to reproduce this influence, a detailed anatomical model of the patients’ 
thorax, incorporating the conductivity properties of the main thoracic structures, is a 
prerequisite. Anatomy is usually provided by a Computed Tomography (CT) or Magnetic 
Resonance Imaging (MRI) scan. The conductivity values used for the thorax, ventricular 
muscle, lungs and blood cavities can be found in literature, e.g. 0.2 S/m, 0.2 S/m, 0.04 
S/m, and 0.6 S/m respectively [28-29]. The resulting simulated body surface potentials 
are then compared to the actual potentials recorded by the torso electrodes. Finally, 
the activation times and the resulting potential curves are tuned in order to obtain 
an optimal match between the measured and simulated ECG. Eventually, the most 
favourable match between simulated and measured thorax potentials is considered to 
be a true reflection of local cardiac activation.
The inverse problem in terms of potentials is unique; that is, in the absence of noise and 
errors only one epicardial potential distribution corresponds to a given body surface 
potential distribution. This inverse problem does not employ a model representation of 
the source; instead, it uses the actual epicardial potentials as a source [30].
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Figure 2. Triangulated mesh of a patient’s heart. A triangulated heart model developed and 
used at our institution. This model can be used for simulations of cardiac activation. After 
segmentation of the different cardiac compartments on CT or MRI anatomic images, specialised 
software divides the volumes in triangles of equal size. The nodes and interconnecting spines 
of the mesh can subsequently be used to calculate probable excitation pathways.
Inverse problems are regarded to have an ill-posed nature, i.e. the desired solution 
is unstable and can vary significantly with the slightest noise or perturbation in the 
BSPM data. In order to circumvent this issue, investigators have developed several 
regularisation methods that impose constraints to the outcome [31]. The chosen 
constraints can have a tremendous influence on the outcome and are therefore a 
subject of constant debate. Nevertheless, regularisation is a key issue in contemporary 
used inverse procedures [32].
BIOPHYSICAL SOURCE MODELS
A biophysical source model represents the heart as a generator of electrical currents. 
The first source model to be introduced was the current dipole (CD).
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Current dipole
The electrical field generated by the heart was considered equivalent to a single rotating 
dipole, visualised as a vector of varying strength during the cardiac cycle [33]. Hence, 
usage of this model is known as vectorcardiography. The effect of an approaching 
or receding excitation wave can be described using this model. However, multiple 
excitation wavefronts, spreading simultaneously through the myocardium, and regional 
electrical activity cannot be discriminated due to the total lack of spatial resolution of 
this model. Following the introduction of the current dipole, Wilson et al. introduced 
another source model in 1933; the equivalent double layer (EDL) [34].
Equivalent double layer model
The wavefront separating resting heart cells in the myocardium from those that have 
undergone depolarisation, can be regarded as a surface double layer. This activation 
layer moves through the heart during the cardiac cycle, reflecting cardiac electrical 
activity (figure 1B). Observed from some distance, this double layer is electrically 
equivalent to the net effect of the currents generated at the cellular membrane during 
depolarisation with a strength proportional to the local transmembrane potential 
[35]. However, the validity of the EDL model is disputed; in particular the assumption 
that ventricular cells constitute a homogeneous syncytium. In addition, an equal 
anisotropy (directional dependence) ratio is assumed, while fiber architecture inside the 
myocardium is heterogeneous with major regional variations in fiber arrangement [36].
Pericardial potential source model
Among the biophysical source models, the Pericardial Potential Source (PPS) model has 
been investigated most extensively [37-38]. In order to inversely compute the pericardial 
potential distribution from recorded potentials, the PPS model exploits a common 
physical fact (figure 1C). A unique relationship exists between the potentials on the 
body surface and the potentials on the epicardium, as long as the model descriptions 
of both surfaces are closed and no other electrical sources are present in between [39]. 
The entire time course of unipolar epicardial electrograms is estimated. This enables 
mapping depolarisation, repolarisation and other electrophysiological processes that 
are reflected in the S-T segment. Moreover, it has been demonstrated that the epicardial 
potentials and electrograms provide substantial information about intra-myocardial 
activity [40].
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Cellular automaton (CA)
In a Cellular Automaton (CA) model, the myocardial tissue is considered to be a set of 
discrete elements (in either active or inactive state) connected to each other. States vary 
as a function of the preceding state and the state of the neighbouring elements. CA are 
relatively easy to program and allow fast simulations, but have serious limitations when 
seeking to reproduce the effects of curvature on an activation front [41]. This in turn 
may results in less accurate estimations on cardiac activation times to be made.
VOLUME CONDUCTOR MODELS
A VCM reproduces the influence of the different types of tissues in the thorax on the 
potential waveforms. The models most often used are discussed here.
Spherical element model
The spherical element model considers the volume-conducting medium to be a 
symmetrical homogeneous sphere. Therefore, it is not suited for accurate localisation of 
electrical foci, but has proven to be an efficient and fast model in vectorcardiography [42]. 
The attractiveness of this model relies in the fact that in such a simplistic configuration, 
the differential equations involved can be solved analytically, rather than by a computer.
Boundary element method
The Boundary Element Method (BEM) is a frequently used model that approximates 
the volume conductor properties of realistic shaped compartments. When using 
this approach for forward or inverse computation, it is essential to accurately obtain 
a patient’s heart and thorax geometry. The boundaries of the organs involved are of 
particular interest. The properties of the enclosed tissue (e.g. anisotropy) are purposefully 
neglected. Hence, the influence of various types of tissues on the distribution of 
potentials through a volume cannot be determined. The BEM allows relatively fast 
calculations as long as only a limited number of boundaries are present [43].
Finite element method
On the contrary, the Finite Element Method (FEM) fully appreciates the volume and 
architecture of the tissue rather than just its boundaries. Although historically hampered 
by limited computational resources, this model is used more frequently nowadays. The 
ability to incorporate the effects of inhomogeneity on the transmission of electrical 
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impulses through the thorax is an important incentive to investigate the FEM. Although 
its efficiency in localizing epileptic foci in neurological patients has been demonstrated 
previously [44], little research has thus far been performed in cardiac patients.
NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING TECHNIQUES
Through the years, various methods using different combinations of BSPM and inverse 
procedures (source and volume conductor model) have been proposed. Numerous 
experiments were performed to determine a technique’s localisation accuracy. Validation 
studies in humans with various pathologies are an on-going effort that should continue. 
The mean resolution of currently used non-invasive electrocardiographic imaging 
techniques is approximately 1-2 cm, though some have obtained better results [45-50].
Electrocardiographic imaging
Electrocardiographic Imaging (ECGI) uses 250 torso electrodes and combines the 
PPS and BEM [51]. Recently, this technique has been commercialis by CardioInsight™ 
(CardioInsight Technologies Inc., Ohio, USA). The clinical applicability of ECGI is currently 
being investigated in a multi-center trial and the first reports have been published. 
ECGI effectively predicted which patients would respond to Cardiac Resynchronisation 
Therapy (CRT), based on differences between estimated left ventricular (LV) and 
right ventricular (RV) mean activation times. A greater difference was associated with 
clinical CRT response and appeared to be a more powerful predictor than 12-lead ECG 
parameters [52]. The feasibility of CRT optimisation by using ECGI had been reported 
earlier [53].
Another study demonstrated the clinical utility in mapping simple and complex atrial 
tachycardia’s (AT) [54]. The overall diagnostic accuracy of the non-invasive system 
compared to invasive EP diagnosis, as the gold standard, was 92% (100% in patients 
with de novo ablations and 83% in patients with previous AF ablations).
The ability of ECGI to map atrial fibrillation (AF) was investigated in several studies 
[55-56]. Body surface signals generated by AF are typically of low amplitude and the 
volume conductor smoothens the potential distribution. Because ventricular signals are 
typically of much greater magnitude than the atrial signals, it might be necessary in some 
patients with normal atrioventricular (AV) conduction to remove the ventricular signals. 
This can be achieved by using QRS(T) subtraction algorithms or by the administration of 
AV blocking agents. Hence, it can be challenging to acquire long continuous recordings 
of atrial signals of adequate quality.
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In 2011, Wang el al. reported on the application of ECGI in a series of 25 patients 
undergoing catheter ablation procedures for various types of VT (figure 3) [57]. BSPM 
were recorded during episodes of sustained VT in nine patients. The remaining patients 
were imaged during premature ventricular contractions (PVC). The sites of origin as 
determined by ECGI were in agreement with the invasive electrophysiological study 
(EPS) in 10 of 11 RV sites (91%) and in 11 of 12 LV sites (92%). ECGI correctly categorised 
both focal and re-entrant mechanisms of VT, but was not able to differentiate between 
focal activity and micro re-entry.
Figure 3. Non-invasive ECGI isochrone maps for localisation of VT site of origin. Epicardial 
isochrone maps are shown for four patients, with earliest epicardial activation marked with an 
asterisk. EP-study-determined sites of origin are indicated under the ECGI maps. Yellow arrows 
point to VT origin on a representative CT scan. RA: right atrium; LA: left atrium; AO: aorta; LAD: 
left anterior descending coronary artery; LV: left ventricle; RVOT: right ventricular outflow tract. 
From Wang Y et al. Non-invasive electroanatomic mapping of human ventricular arrhythmias 
with electrocardiographic imaging. Sci Transl Med. 2011;31;3(98):98ra84. With permission. 
Copyright AAAS / Science 2011
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Electrical remodelling due to right ventricular pacing was investigated in 9 patients with 
an implanted dual-chamber pacemaker system [58]. This remodelling resulted in action 
potential prolongation near the site of abnormal activation and a marked dispersion of 
repolarisation. This dispersion of repolarisation is potentially arrhythmogenic and was 
less evident during continuous RV pacing.
When recording the atria, the ventricular signal is a problem when the ventricular rate 
is rapid. Analysis requires that a few cycles do not conduct to the ventricles. AT with 2:1 
conduction to the ventricles pose an analytic challenge in the absence of reliable QRST 
subtraction software program. It can be difficult to estimate signals around the mitral 
annulus, which can be problematic for peri-mitral atrial flutter. In most studies, a CT 
scan was performed that includes the abdomen in order to register the location of all 
BSPM electrodes on the image. The inclusion of the abdominal region is associated with 
substantially higher patient radiation doses [59].
Non-invasive imaging of cardiac electrophysiology
Non-invasive Imaging of Cardiac Electrophysiology (NICE) employs 64 electrodes, 
the EDL and BEM [60]. NICE has been performed in 7 patients with WPW syndrome 
undergoing catheter ablation of the accessory pathway [61]. All ventricular accessory 
pathway insertion sites were identified with an accuracy of 18.7 ± 5.8 mm. In CRT and 
control patients, endocardial and epicardial ventricular activation were visualised non-
invasively [62].
However, the atria cannot be analysed using the NICE technique and the model does 
not account for ventricular repolarisation. The small number of study subjects in which 
NICE was applied makes it difficult to fully appreciate the quality of this system. Studies 
on functional electrocardiographic imaging are generally limited by the small number 
of study subjects owing to the complexity of data acquisition and image segmentation 
procedures for reconstruction of patient-specific anatomical models.
AMYCARD
AMYCARD uses 83 electrodes, PPS and BEM [63]. It has been commercialised by 
AMYCARD LLC (AMYCARD LLC, Moscow, Russia). Since AMYCARD has only recently been 
installed in several Russian research centers, no data on the accuracy of this technique 
is yet available.
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Current density reconstruction (CDR)
Another method developed by He and co-workers uses Current Density Reconstruction 
(CDR) to estimate the current density distribution on the endocardial surface of the 
LV from measured body surface potentials [64]. The dipole source model and BEM are 
employed in combination with 90 torso electrodes. The first report on in-vivo validation 
has recently been published by Lai et al. [65]. BSPM was performed in six patients with 
monomorphic PVC. Compared with the successful ablation site, the mean localisation 
error of the CDR approach was 13.8 ± 1.3 mm.
FUTURE PERSPECTIVE
Non-invasive imaging of cardiac excitation has been the focus of several investigators, 
but it has not yet evolved into a clinical technology that is usable in daily clinical practice. 
This is mainly due to technical challenges in the recording, processing and interpretation 
of the data. To enter the clinical arena, the physical validity of the simulations and 
robustness of the method must be undisputed. As far as validation is a key issue, there 
is a need for continued validation in humans. In addition, practical aspects of handling a 
great number of electrodes must be considered. Until now several multi-electrode vests 
have been developed, but it remains unclear to what extent these vests allow routine 
clinical application of BSPM.
More reliable simulations of greater physical validity are aspired in the near future. 
In order to achieve this, high-resolution imaging techniques and improved inverse 
algorithms need to be developed and integrated. For example, the integration of patient 
specific MRI data on cardiac fiber orientation into biophysical models (FEM) poses new 
challenges [66]. The selection of an appropriate source and volume conductor model 
may prove to be of utmost importance to construct highly accurate, patient-specific 
3D simulation models for clinical use. Therefore substantial knowledge on the general 
challenges regarding the use of inverse procedures seems imperative.
Despite these challenges, non-invasive imaging of cardiac electrophysiology is 
considered a promising tool to complement conventional EPS. For example, in patients 
suffering from arrhythmias, ectopic foci may be localised non-invasively prior to 
entering the catheterisation suite. Reducing the duration of an invasive procedure and 
to decrease the associated exposure to radiation could be an important advantage of 
this application.
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With regard to optimisation of pacing therapy, detailed simulation studies may be 
performed using patient-specific 3D computer models prior to implantation of a cardiac 
pacing device. By incorporating knowledge on anatomy, location of scar tissue and the 
site of latest mechanical activation, optimal sites for lead placement may be determined 
non-invasively.
In case of atrial fibrillation (AF), these techniques may offer new insights in the extent 
of structural and functional remodelling of the atria. Especially, when incorporating 
information on the extent and location of atrial fibrosis in patients undergoing 
Pulmonary Vein Antrum Isolation (PVAI). Through follow-up investigations, therapeutic 
effects or progression of substrate remodelling can be assessed and monitored carefully.
CONCLUSION
The development of robust inverse procedures has kindled renewed interest in BSPM. 
The combined use of inverse procedures and BSPM, referred to as non-invasive imaging 
of cardiac electrophysiology, is considered a promising tool to complement conventional 
EP studies. To enter the clinical arena, the physical validity of the simulations and 
robustness of individual methods must be undisputed. The selection of appropriate 
biophysical models may prove to be of utmost importance to construct highly accurate, 
patient-specific 3D simulation models for clinical use.
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ABSTRACT
Background: In non-invasive imaging of cardiac excitation, the use of body surface 
potentials (BSP) rather than body volume potentials (BVP) has been favoured due 
to enhanced computational efficiency and reduced modelling effort. Nowadays, 
increased computational power and the availability of open source software enable the 
calculation of BVP for clinical purposes. In order to illustrate the possible advantages of 
this approach, the explanatory power of BVP is investigated using a rectangular tank 
filled with an electrolytic conductor and a patient specific three-dimensional model.
Methods: MRI images of the tank and of a patient were obtained in three orthogonal 
directions using a turbo spin echo MRI sequence. MRI images were segmented in 
three-dimensional using custom written software. Gmsh software was used for mesh 
generation. BVP were computed using a transfer matrix and FEniCS software.
Results: The solution for 240,000 nodes, corresponding to a resolution of 5 mm 
throughout the thorax volume, was computed in 3 minutes. The tank experiment 
revealed that an increased electrode surface renders the position of the 4 V equipotential 
plane insensitive to mesh cell size and reduces simulated deviations. In the patient-
specific model, the impact of assigning a different conductivity to lung tissue on the 
distribution of volume potentials could be visualised.
Conclusion: Generation of high quality volume meshes and computation of BVP 
with a resolution of 5 mm is feasible using generally available software and hardware. 
Estimation of BVP may lead to an improved understanding of the genesis of BSP and 
sources of local inaccuracies.
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INTRODUCTION
Non-invasive imaging of cardiac excitation using recorded body surface potentials 
(BSP) and mathematical inverse procedures is an active field of research that has yielded 
some clinical applications [1-4]. In an inverse procedure, local epicardial potentials or 
myocardial activation times are computed from recorded BSP. In contrast, a forward 
procedure estimates BSP from potentials measured on the surface of the heart [5-6].
The Boundary Element Method (BEM) has been favoured for electrocardiographic 
forward procedures due to enhanced computational efficiency and reduced modelling 
effort [7-9]. In contrast to the BEM, which yields potential information on predefined 
surfaces, the Finite Element Method (FEM) provides body volume potentials (BVP) 
(figure 1) [10].
BEM	 FEM	
LL	RL	
H	
Thorax	
LL	RL	
H	
Thorax	
Figure 1. The Boundary Element Method (BEM) yields potential information on predefined 
surfaces only. Hence, no information on the areas between the compartments can be derived 
when using the BEM. The Finite Element Method (FEM) on the contrary, provides body volume 
potentials (BVP). Volume potentials can be computed as well using the BEM, by increasing the 
number of model compartments. However, the FEM is typically more efficient, especially when 
the number of model compartments is high or when anisotropic conductivity is modelled. (RL 
right lung; LL left lung; H heart; L liver)
Utilizing knowledge on the spatial potential field may lead to improved insight in the 
potential distribution throughout the thorax. Although potentials can be computed 
everywhere in a volume as well using the BEM by creating multiple surfaces inside the 
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volume, the FEM is typically more efficient for this purpose. Especially when the number 
of model compartments is high or when anisotropic conductivity is modelled, the FEM 
is recommended [11].
Although the application of BVP has been studied previously [12-13], it has never 
advanced into clinical practice due to its time consuming and elaborative nature. 
Increased computational power and the introduction of open source software enable 
the calculation of BVP for clinical purposes. In this study the explanatory power of 
BVP is illustrated by experiments performed in a simple rectangular tank. In addition, 
simulations in a 3D patient specific model demonstrate the possible advantage of using 
BVP.
METHODS
Rectangular tank
A rectangular tank of 33 x 25 x 25 cm filled with an electrolytic conductor was used. 
Electrodes with a surface of 2 x 2 cm were positioned in the middle of opposing sides. 
To block interference from nearby power sources, a 1000 Hz 8 V peak-to-peak sinusoidal 
power source was used. Measurements were performed using a dual beam oscilloscope, 
enabling monitoring the source voltage while measuring the resulting potential in the 
tank. The accuracy of the measurements approximated 2%, which was considered 
sufficient for validation purposes.
MRI images
MRI images of the rectangular tank and the patient were acquired using a Turbo Spin 
Echo (Black Blood) sequence in three orthogonal directions (slice thickness 8mm). 
Electrode positions in the tank and on the body surface were marked using liquid-filled 
vitamin D capsules, appearing hyper intense on MRI. The MRI scan was performed on a 
Siemens Aera 1.5 Tesla MRI scanner (Siemens Healthcare, Erlangen, Germany).
The study complied with the declaration of Helsinki and received approval from the 
local ethical committee and the institutional scientific board. Written informed consent 
was obtained from the patient.
Meshing
In order to achieve topological propriety, MRI images were segmented in 3D using 
bounding planes. No spatial smoothing was applied. The Gmsh tool [14], freely available 
on the Internet for non-commercial use, was used for mesh generation.
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Computing BVP
Given the source potential distribution on the epicardial surface, the resulting volume 
potential distribution is governed by the equations below.
The current density J as a function of conductivity s and field strength E is given by 
ohms law:
J = s E = s grad(P), where P is the potential [1]
Apart from the heart there are no current sources in the thorax so:
div(J) == 0 [2]
From [1] and [2] follows Laplace’s equation:
div(s grad(P)) == 0 [3]
Multiplying by a test function T leads to the following variational form:
∫ div(s grad(P)) T dV == ∫ 0 * T dV == 0 [4]
Partial integration yields (n is the unit surface normal):
∫ div (s grad(P) T dV == ∫ s grad(P).grad(T)dV - ∫ s grad(P).n T dS [5]
From [4] and [5] follows:
∫ s grad(P).grad(T) dV == ∫ s grad(P).n T dS  [6]
With J.n = 0 and [1] at the skin this becomes:
∫ s grad(P).grad(T) dV = 0  [7]
To yield a non-trivial solution, the source potentials at the heart surface are applied 
as boundary conditions. There are many general-purpose FEM tools available to solve 
these equations. FEniCS [15], freely available for research purposes, was selected.
This software package allowed the aforementioned equation to be specified in a very 
natural form. All work is done by the following lines of code:
RHS=sigma*inner(grad(trialFunction),grad (testFunction)) * dx [1]
LHS = Constant (0)* testFunction * dx [2]
A,b = assemble_system(LHS,RHS,boundaryCond,keep_diagonal = True) [3]
solve(A,potential.vector(),b,’gmres’,’default’)  [4]
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Note the close correspondence between lines [1] and [2] of the code and equation [6] 
by substituting them in equation LHS = RHS.
Computing platform
All analyses were performed on a 2.4 GHz quadcore laptop running Windows 8 OS. 
Solving the potential equations was delegated to a an Ubuntu 12.10 virtual machine 
running on this laptop, communicating with the activation modelling software by the 
use of synchronised message file sharing. Reference times were computed using a 
single core.
RESULTS
Rectangular tank
Figure 2 shows the 3D mesh of the tank. A potential of 4V peak to peak was observed 
in the middle of the tank. The computations using a tetrahedral mesh with 1.5 cm edge 
length, demonstrated a deviation of the 4V plane from the middle by about one grid 
cell. By refining the mesh to an edge length of 0.5 cm, this deviation was expected to 
diminish. Paradoxically, the deviation from the middle actually increased by about 2.5 
cm, to a total deviation about 10 times larger than the mesh size (figure 2a).
Figure 2b and c reveal the potential gradients to increase near to the electrode. This is 
caused by the small contact area between the fluid and the electrodes introducing a 
high resistivity: R = 1 / (area x sigma) [Ohm/m]. Because R is large, the potential drop U 
is large according to Ohms law. Moreover, a relative misrepresentation of the electrode 
area by 5% leads to a relative error in this potential drop in the same order of magnitude.
Figure 2d illustrates that minor errors in the potential drop near the electrodes 
yield large deviations in the 4V equipotential plane. In the middle of the tank the x 
coordinate varies rapidly with small potential changes. By using volume information, 
the counterintuitive effect shown in figure 2a can be understood. For large electrodes, 
misrepresentations of their area by the mesh are relatively small. This should render the 
position of the 4V equipotential plane insensitive to the mesh cell size (figure 2e).
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RL	 LL	
RV	
L	
A	 B	
S	
RA	
Electrode	
Figure 3. A 3D computer model of the human thorax with the positions of the body surface 
electrodes (A). The electrode positions were derived from the positions of the liquid-filled 
vitamin D capsules, appearing hyper intense on MRI. The thorax model contains multiple 
compartments (B). (RA right atrium; RV right ventricle; S spleen)
RL	 LL	
H	
L	
Thorax	
RL	 LL	
LA	
L	
Thorax	
LV	
A	 B	
Figure 4. Locally refined multi compartment thorax 3D mesh (A) and volume mesh (B). The 
mesh is error free and was generated in 25 seconds using freely available software on a 2.4 
GHz single core on a laptop. No spatial smoothing was applied. (LA left atrium; LV left ventricle)
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Patient torso
Figure 3 shows a multi compartment 3D computer model of a human thorax. The 
positions of the electrodes on the body surface were derived from the anatomic markers 
on MRI. Figure 4 demonstrates the resulting 3D mesh. As can be observed the mesh is 
highly regular and is locally refined in the vicinity of details.
Shortest Paths of Activation
The computation of all possible shortest paths of the activation wavefront through 
the cardiac wall resulted in a set of epicardial isochrones yielding a time dependent 
epicardial potential as shown in figure 5. 
Computing BVP
Potential equations for 13,000 mesh nodes were solved in 3 seconds utilizing a 2.4 
GHz single core. Solving these equations for a mesh consisting of 240,000 nodes, 
corresponding to a resolution of 5 mm throughout the thorax volume, lasted 3 minutes. 
Two sequences of computed BVP are shown in figure 6, one using a mesh edge size of 
0.5cm (a-j) and one using a mesh edge size of 1.5cm (k-t). The potential field permeates 
the lungs without visual deformation, even if their sigma is only half that of their 
environment.
Impact of lung tissue on BVP
The impact of variable organ conductivity on BVP was investigated using forward 
simulations in the human torso model. Figure 7 illustrates the impact on the electric 
field when a smaller sigma (conductivity) is assigned to lung tissue (A). The BVP field 
is compared to simulations in a homogeneous torso model (B). A smaller sigma of the 
lung tissue leads to an increased breakthrough of the potential field.
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Mesh	size	0.5	cm	 Mesh	size	1.5	cm	
Le/	Right	
RL	
L	
H	
Figure 6. Anterior view of the thorax. Shown are the computed BVP during one heartbeat. (a-
j) Mesh edge size is 0.5 cm. (k-t) Mesh edge size is 1.5 cm. The crude edges are artifacts from 
segmentation, performed in 3D. Since topology had to be preserved, no spatial smoothing was 
applied.
RL	 LL	H	
L	 S	
RL	 LL	H	
L	 S	
A	 B	
Figure 7. The impact of variable organ conductivity on BVP. A smaller sigma of the lung tissue 
leads to an increased breakthrough of the potential field (A), compared to simulations in a 
homogeneous torso model (B).
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DISCUSSION
In this study the feasibility of computing BVP for non-invasive imaging of cardiac 
excitation is illustrated. So far, volume potentials have been considered to be of limited 
value. However, computing BVP using the FEM is efficient if the number of bounding 
surfaces between organs taken into account is high. In addition, using the FEM 
rather than the BEM enables the incorporation of different anisotropies, local tissue 
characteristics and sigma gradients over different regions. BVP may be used to gain a 
better insight in the genesis of BSP and sources of local inaccuracies.
Figure 6 suggests that the computed BVP hardly depend on the mesh cell characteristic 
length for a ratio as big as 1:3. However, the tank experiment indicates that there are 
geometries where the mesh size does have a significant influence on the outcome. 
The FEM could be used to understand which aspects of the geometry caused the large 
misrepresentation of the 4V equipotential plane. By visualizing the large potential 
gradient near the electrodes and the small potential gradient in the middle of the box, 
the FEM contributed to understanding the inaccuracy of the computed position of the 
4V equipotential plane.
Computation of BVP
From a computational standpoint, computing a potential field by means of the FEM is not 
a problem. The computation time of a 240,000 points potential field was approximately 
3 minutes. Graphics processors with hundreds of computation units combined with 
quadcore main CPU’s are becoming available at consumer prices. Generally available 
FEM packages are able to benefit from this just by setting some parameters and no 
custom coding. While the performance gain by computing the FEM in parallel may 
easily be tenfold. The FEniCS package has been selected because this tool has a lot of 
mindshare, a vivid user community and excellent documentation.
Meshing 
Generating high quality meshes and solving differential equations have been part 
of engineering disciplines for decades. In many articles on biomedical computing, 
generation of a computational mesh is taken for granted. Early experiments revealed 
that generation of a surface mesh from a labelled voxel set often leads to irregular 
meshes with topological errors that are hard to repair. Several groups have developed 
their own meshing software and others have proposed to do away with meshing 
altogether [16-18]. However, the meshing itself does not appear to be the problem. 
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General-purpose mesh generation tools can generate high quality volume meshes in 
a matter of seconds for an arbitrarily complex segmentation result, provided that the 
segmentation contains no topological errors.
Fast generation of volume meshes and FEM solutions with generally available means 
has brought computation of BVP as part of non-invasive imaging of cardiac excitation 
within practical clinical reach. This route will further be explored, hoping to gain direct 
and visual insight in the sources of inaccuracies, including the so called “ill conditioning” 
of the inverse problem, in the required number of electrodes, numbers of less than 20 
to more than 200 currently being advocated in literature [19-20], and in the optimal 
placement of these electrodes in individual patients.
CONCLUSION
This study illustrates that efficient generation of high quality volume meshes and 
computation of BVP with a resolution of 5 mm is feasible using generally available 
software and hardware. With the computational effort decreasing dramatically, 
estimation of BVP may be seasonable when the number of model compartments is high 
or when anisotropic conductivity is modelled. Observing the potential field everywhere 
in the thorax may lead to an improved understanding of the genesis of BSP and sources 
of local inaccuracies. In the near future, computation of BVP for non-invasive imaging of 
cardiac excitation may evolve towards clinical application.
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ABSTRACT
Background: Integration of whole-heart activation simulations and inverse potential 
mapping (IPM) could benefit the guidance and planning of electrophysiological 
procedures. Routine clinical application requires a fast and adaptable workflow. These 
requirements limit clinical translation of existing simulation models. This study proposes 
a comprehensive finite element model (FEM) based whole-heart computational 
workflow suitable for IPM and simulations.
Methods: Three volunteers and eight patients with premature ventricular contractions 
underwent body surface potential (BSP) acquisition followed by a cardiac MRI scan. The 
cardiac volumes were segmented from the MRI images using custom written software. 
The feasibility to integrate tissue-characteristics was assessed by generating meshes 
with virtual edema and scar. Isochronal activation maps were constructed by identifying 
the fastest route through the cardiac volume using the Möller–Trumbore and Floyd–
Warshall algorithms. IPM’s were reconstructed from the BSP’s.
Results: Whole-heart computational meshes were generated within seconds. The first 
point of atrial activation on IPM was located near the crista terminalis of the superior 
vena cave into the right atrium. The IPM demonstrated the ventricular epicardial 
breakthrough at the attachment of the moderator band with the right ventricular free 
wall. Simulations of sinus rhythm were successfully performed. The conduction through 
the virtual edema and scar meshes demonstrated delayed activation or a complete 
conductional block respectively.
Conclusion: The proposed FEM based whole-heart computational workflow offers an 
integrated platform for cardiac electrical assessment using simulations and IPM. This 
workflow can incorporate patient-specific electrical parameters, perform whole-heart 
cardiac activation simulations and accurately reconstruct cardiac activation sequences 
from BSP’s.
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BACKGROUND
Inverse potential mapping (IPM) and simulations of cardiac activation are promising 
computational techniques for non-invasive assessment of rhythm disorders [1-2]. 
Recent studies have examined the role of simulation models for personalizing catheter 
ablation strategies [3-4]. Furthermore, catheter ablation guidance by IPM shows a higher 
accuracy when compared to conventional mapping procedures [5-6].
In general, IPM requires a (computational) mesh representing the thoracic and cardiac 
volumes to reconstruct cardiac activation sequences from body surface potentials 
(BSP). Similarly, realistic simulations demand for a patient-specific mesh, incorporating 
functional information about tissue characteristics such as electrical conductivity, 
mechanical deformation and fiber orientation [3,4,7]. In contrast to meshes used 
solely for visualisation (shells), the computational meshes for these purposes require 
topologically correct segmentations.
Although the currently available models are useful, they are very time consuming [4], 
or too comprehensive (multiple parameters) [7], and therefore not ready for use on a 
routine basis in the clinical arena.
In addition, none of the currently available methods provide an integrated whole-heart 
(topologically correct) mesh, incorporating both the atria and ventricles. This limits a 
comprehensive and integrated study of whole-heart electrical interaction.
This article proposes a comprehensive finite element model based whole-heart 
computational workflow suitable for IPM and efficient personalised simulations. The 
clinical feasibility of reconstructing IPM was explored using BSP’s of healthy volunteers 
and patients with premature ventricular contractions (PVC’s).
Subsequently, the simulation features were explored by generating activation maps 
(isochrones) in different models of human hearts, both normal and with structural heart 
disease.
14867-vandergraaf-layout.indd   111 31/08/2017   09:37
112
Chapter 7
METHODS
The computational workflow for whole-heart electrical assessment consists of four 
steps (figure 1). These steps involve (1) acquisition of BSP, (2) acquisition of subject 
specific geometry using cardiac magnetic resonance imaging (MRI), (3) topologically 
correct segmentation and generation of the computational mesh and (4) utilizing the 
mesh for reconstructing cardiac surface potentials or conducting simulations.
Study population
Three healthy volunteers and eight patients with symptomatic or therapy resistant 
premature ventricular contractions (PVC) participated in this investigation. The study 
complied with the declaration of Helsinki and received approval from the local ethical 
committee (METC Zuidwest Holland study number NL38156.098.11) and the institutional 
scientific board. Written informed consent was obtained from the volunteers.
Body surface potential acquisition
An MRI scout scan was performed to approximate the position of the heart with respect 
to the thorax. Subsequently, 62 (+3 limbs) electrodes were applied to the subject’s 
torso, centralised over the heart. Body surface potentials (BSP) were acquired using a 
65 channel ActiveTwo system (BioSemi B.V., Amsterdam, The Netherlands). Once the 
acquisition was completed, the electrode locations were marked with MRI markers 
enabling accurate identification of the electrode positions.
Image acquisition
MRI studies were obtained on a 1.5 Tesla Aera scanner (Siemens Healthcare, Erlangen, 
Germany). Blackblood imaging was performed using a Half-Fourier Acquisition Single 
Shot Turbo Spin Echo (HASTE) pulse-sequence to acquire three perpendicular stacks 
(axial, coronal and sagittal). The scan provides coverage from the neck till lower abdomen. 
Images were acquired during free breathing using navigator gating (diaphragm) with 
1 mm window. ECG gating was used to acquire views during the diastolic phase of the 
cardiac cycle. Typical imaging parameters were: a spatial resolution of 1.2 × 1.2 × 6 mm, 
TR/TE 744/42 ms and flip angle = 160°.
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WHOLE-HEART COMPUTATIONAL MODEL
Anatomical and electrical components
A topologically correct description of the whole-heart anatomy was constructed 
using the different cardiac structures such as atrial and ventricular endocard and 
epicard, the inter-ventricular septum (IVS) and inter-atrial septum (IAS), and tricuspid 
and mitral valvular plane (Additional file 1: Video 1). These different structures were 
used to generate the cardiac volumes required to represent a whole-heart. In order to 
incorporate the electrical pathways and to account for the differences in conductivity, 
the conduction system of the heart was also modelled. The origin of activation for sinus 
rhythm was defined at the lateral border of the superior vena cava and right atrium 
junction, approximating the location of the sinus node. The right and left bundle 
branches were also defined.
Topology
A formal description was composed to define the topological properties of the 
segmentation result. This description contained a definition of all tissue volumes 
involved in terms of topological elements, i.e. patches, shells and hulls.
Patch
A patch is a set of facets denoting an elementary surface part. Example: patches.heart_
LA_outer = Patch (index) denotes the outer surface of the left atrium. A unique colour 
index describes the relation between the topological description and the coloured 
planes that make up the segmentation.
Shell
A shell is a set of patches denoting a closed surface. Example: shells.heart_outer = Shell 
patches.heart_LA_outer,_patches.heart_RA_outer,_patches.heart_LV_outer,_patches.
heart_RV_outer) denote the whole outer surface of the heart.
Hull
A hull is a three dimensional piece of tissue having uniform properties which may be 
irregularly shaped. A hull is bound by one or more shells where the first-mentioned 
shell is the outer surface of the hull and remaining shells are the inner surfaces of holes 
in the hull. Example: hulls.heart = Hull (shells.heart_outer, shells.heart_LA_inner, shells.
heart_RA_inner, shells.heart_LV_inner, shells.heart_RV_inner) denote the hart walls. In 
this example the heart is simplistically pictured as a closed volume with four holes, two 
for the atria and two for the ventricles.
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Image segmentation and mesh generation
The three perpendicular stacks of MRI images were loaded in a custom developed 
software tool. Subsequently, the pre-defined anatomical and electrical components 
were segmented. The extra-cardiac thoracic volumes (lungs and thorax) were assigned 
conductivity values (Σ) described in the literature; lungs (0.04 S/m) and thorax (0.2 S/m) 
[8]. To investigate the feasibility of incorporating tissue properties, two segmentations 
were created containing pre-defined regions of edema (speed 0.2 m/s and Σ 0.0325 S/m) 
and scar tissue (speed 0 m/s and Σ 0 S/m) respectively.
The software tool was used to generate a script containing the geometrical description 
of the topologically correct segmentation result. From this script input a high quality 
2D/3D mesh can be instantly generated. This mesh is compound, i.e. it is divided in 
labelled sub-meshes conforming organ boundaries, and suitable for computational 
use e.g. sub-volume properties and boundary conditions. The script generated by the 
segmentation tool was used as input to the GMSH mesh generator to construct the 
computational mesh [9].
Inverse potential mapping and simulation of cardiac activation
The IPM’s were reconstructed by multiplication of the BSP’s with (TTT+λ2I)-1TT where 
T is the transfer matrix and λ = 0.01. As described previously, this provided the cardiac 
surface potentials from which the IPM was derived [10]. Simulations were performed 
using a fixed conduction velocity model. In concordance with the literature, an effective 
conduction velocity of 0.6 m/s was defined for both atrial and ventricular myocardium 
[11]. Based on the same literature the bundle branches were assigned a speed (2 m/s) 
and delay (0 m/s).
The simulations were performed (1) computing direct connections between all mesh 
nodes using the Möller–Trumbore algorithm [12] followed by (2) solving the shortest 
path problem amongst the computed paths using the Floyd–Warshall algorithm [13]. 
The mesh nodes were assigned a potential versus time activation curve. A standard 
potential curve was chosen for this purpose. For each individual node, this curve was 
offset by the local activation time which was computed by the first come first serve 
principle. Based upon the results of the simulations an isochronal activation map was 
generated.
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RESULTS
Baseline characteristics of the three volunteers and eight patients (N = 11) are provided in 
table 1. All volunteers had normal electrocardiograms. In both volunteers and patients 
the MRI examination was performed in 12 ± 2 min; there were no complications. Clinical 
characteristics are provided in table 1.
Table 1. Clinical characteristics of study patients.
Volunteers Patients
n 3 8
Age (years) 28 ± 3 46 ± 13
BMI 22.1 ± 1.4 25.2 ± 6.7
Female (%) 1 (33 %) 7 (88 %)
LVEF (%) 55 ± 2 50 ± 3
Whole-heart computational model
For each individual, five different volumes were defined at the atrial level consisting of 
the left and right atrium, IAS and the mitral and tricuspid valvular planes. The ventricular 
volumes were defined as the left and right ventricle and IVS (Additional file 1: Video 1). 
Limited interaction (<5 min) was required to create the meshes with (virtual) structural 
heart disease.
Mesh generation was typically completed in seconds and required no further post-
processing.
IPM in sinus rhythm
During sinus rhythm, the first point of activation on the potential map of all study 
patients was located near the crista terminalis of the superior vena cave into the right 
atrium (figure 2a). The first point of ventricular epicardial breakthrough was located at 
the right ventricular free wall. This corresponds to the location where the moderator 
band was attached to the ventricular myocardium (figure 2b). During this time, a 
high potential distribution is observed at the right atrial wall, indicating the atrial 
repolarisation (figure 2a).
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Simulations
The cardiac activation cycle (sinus rhythm) was successfully simulated on all healthy 
computational meshes. The generated virtual isochrones maps depicted cardiac 
activation patterns in accordance with the literature (Figure 3; Additional file 2: Video 
2) [14]. The simulations for computational meshes with structural abnormalities (edema 
and scar), were also completed successfully. The mesh with a pre-defined virtual edema 
region demonstrated a delayed activation pattern (figure 4), whereas, a complete 
conductional block was observed for the computational mesh containing virtual 
transmural scar (figure 4).
Figure 3. Simulation of normal cardiac activation on whole-heart computational meshes. Top 
row depicts computational volume meshes generated from the three different segmentations. 
Bottom row depicts isochrone maps generated after performing a cardiac activation simulation 
on the computational mesh.
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Figure 4. Feasibility of cardiac activation simulation on customised meshes with pre-defined 
structural abnormalities. Top row depicts the segmentations created using the custom made 
tool. The middle and right column segmentations have a pre-defined structural abnormality. 
The impact of these abnormalities is visible on the corresponding simulations. A delayed 
activation can be observed in the isochrone map for regions with edema (solid black arrows). 
The computational mesh containing a transmural scar (black arrowheads and dotted black 
arrows), demonstrates a total conduction block.
DISCUSSION
To our knowledge, this is the first study to integrate and evaluate IPM and cardiac 
activation simulations within a clinically applicable whole-heart workflow. The proposed 
computational workflow provided accurate IPM reconstructions and enabled patient-
specific simulations to be performed.
The use of MRI enables visualisation and incorporation of tissue-characteristics in 
computational meshes. In addition, an integrated IPM and simulation based approach 
facilitates a comprehensive assessment of arrhythmias and underlying substrate. These 
two factors significantly contribute towards the clinical applicability of this workflow 
and offer a unique environment for the development and evaluation of patient tailored 
therapeutic strategies.
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Inverse potential mapping
The IPM localised the origin of atrial activity to the anatomically known location of the 
sinus node [15], suggesting the correctness of the model. These results imply that sinus 
node function and also dysfunction may be non-invasively characterised and assessed 
using IPM.
Simulations
The simulations of sinus rhythm performed on the computational meshes generated 
reliable results when compared to measurements reported in the literature [14]. 
Simulations performed on the personalised meshes incorporating virtual edema and 
scar resulted in a different activation pattern with delayed conduction and conduction 
block respectively.
These observations illustrate the wide range of simulations which can be obtained 
utilizing this simulation model. This can be clinically relevant for patients presenting 
with arrhythmias with a history of a disease associated with fibrosis such as myocardial 
infarction and myocarditis.
The ability to reconstruct atrial depolarisation and repolarisation can also contribute 
to novel clinical insights in the electrical substrate of complex supra-ventricular 
tachycardias such as left atrial flutter and atrial fibrillation.
Whole-heart computational model
Although only a few pathologies involve the atria and ventricles simultaneously, a 
combined assessment remains relevant for a comprehensive study of atrio-ventricular 
electro-mechanical coupling and electrical interaction.
The atrial contraction presents such an example. It has been reported that pressure 
modulation due to atrial contractions can remotely alter the electrical behaviour 
and activation pattern of the ventricular myocytes [16-17]. A whole-heart model is 
required to incorporate such complex relations and to provide physiologically accurate 
simulations.
Limitations
The simulations performed in this study used a standardised set of epicardial potentials 
recorded in a structurally normal human heart. Furthermore, the currently used 
simulation algorithm applied fixed conduction velocities for the cardiac volumes. 
However, the aim of the current study was to develop a clinically applicable and 
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reliable method for isochrones generation. The evaluation of this algorithm could be 
successfully performed using one set (atrial and ventricular) of epicardial potentials. The 
generated simulation results were accurate for all subjects when compared to previous 
descriptions in the literature [14]. Therefore, the absence of patient specific epicardial 
potentials and usage of a fixed conduction model was not considered as a limitation.
The customised meshes were constructed to test the feasibility of incorporating tissue 
properties. The conductivity and speed values for edema and scar tissue were based on 
estimates. Although, this can be considered as a substantial limitation, the simulations 
with patient-specific geometries (incorporating scar and edema) demonstrated realistic 
results, and underline the feasibility of the simulation algorithm.
A next step would be combining simulations with reconstructed IPM in order to non-
invasively characterise tissue.
Future directions
Future research will focus on evaluating the IPM algorithm for patients undergoing 
catheter ablation for ectopic ventricular beats. The simulation algorithm will be further 
evaluated and optimised in patients with structural heart disease and arrhythmias. 
Furthermore, future work will perform comparison between simulations, reconstructed 
IPM and invasively acquired epicardial potentials to evaluate potential reconstruction 
errors related to patient specific differences in epicardial potentials.
CONCLUSION
The proposed finite element model based whole-heart computational workflow offers 
an integrated platform for cardiac electrical assessment using IPM and simulations. 
The IPM algorithm can accurately reconstruct reliable cardiac activation sequences 
from BSP’s. The simulation model was able to incorporate patient-specific electrical 
parameters and rapidly perform whole-heart cardiac activation simulations. The use of 
MRI substantially contributes towards the clinical applicability.
This workflow offers the prospect to improve patient selection and personalise 
therapeutic strategies for interventional electrophysiological procedures. Future studies 
should investigate the role of this innovative approach for analysis of complex atrial and 
ventricular arrhythmias.
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ABSTRACT
Introduction: In inverse potential mapping, local epicardial potentials are computed 
from recorded body surface potentials (BSP). When BSP are recorded with only a limited 
number of electrodes, in general biophysical a priori models are applied to facilitate 
the inverse computation. This study investigated the possibility of deriving epicardial 
potential information using only 62 torso electrodes in the absence of an a priori model.
Methods: Computer simulations were used to determine the optimal in vivo positioning 
of 62 torso electrodes. Subsequently, three different electrode configurations, i.e., 
surrounding the thorax, concentrated precordial (30 mm inter-electrode distance) and 
super-concentrated precordial (20  mm inter-electrode distance) were used to record 
BSP from three healthy volunteers. Magnetic resonance imaging (MRI) was performed 
to register the electrode positions with respect to the anatomy of the patient. Epicardial 
potentials were inversely computed from the recorded BSP. In order to determine the 
reconstruction quality, the super-concentrated electrode configuration was applied 
in four patients with an implanted MRI-conditional pacemaker system. The distance 
between the position of the ventricular lead tip on MRI and the inversely reconstructed 
pacing site was determined.
Results: The epicardial potential distribution reconstructed using the super-
concentrated electrode configuration demonstrated the highest correlation (R = 0.98; 
p < 0.01) with the original epicardial source model. A mean localisation error of 5.3 mm 
was found in the pacemaker patients.
Conclusion: This study demonstrated the feasibility of deriving detailed anterior 
epicardial potential information using only 62 torso electrodes without the use of an a 
priori model.
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INTRODUCTION
Inverse potential mapping (IPM) is a promising technique that may complement 
conventional invasive electrophysiological (EP) studies [1-2]. In IPM, local epicardial 
potentials are inversely computed from recorded body surface potentials (BSP) [3]. 
Typically, 252 electrodes surrounding the thorax are used to record BSP [4-5].
When a smaller number of recording electrodes is used, optimal electrode positioning 
is important. In the past, several studies have addressed this topic. Early studies focused 
on the detection and elimination of redundant information in the recorded BSP [6–
10]. Later, biophysical a priori models, i.e., computer models that enable the in silico 
mimicking of in vivo conditions by using pre-programmed settings relating to physical 
properties, e.g., conduction velocity, fiber orientation, anisotropy, activation pathways, 
were introduced to compensate for the limited BSP data actually recorded [11]. In 
general, inverse procedures involving 64 or fewer electrodes always apply an a priori 
activation model.
The purpose of this study was to investigate the feasibility of IPM using only 62 torso 
electrodes in the absence of an a priori model. A simulation using 252 electrodes served 
as a reference for desired image quality. Simulations were performed using various 
electrode configurations. Three different electrode positions using 62 electrodes were 
subsequently applied on healthy volunteers to record BSP. From the recorded BSP, 
epicardial potentials were reconstructed. The amount of detail and the correlation with 
the original source model were assessed. To evaluate the localisation error and size of 
the smallest visible detail, this mapping technique was applied in four patients with an 
implanted MRI-conditional DDD pacemaker system.
METHODS
Computer simulations
3D model
Simulations were performed using a 3D thorax model. This model was constructed 
after manual segmentation of different structures and organs on anatomic magnetic 
resonance imaging (MRI) images using custom written software. The model incorporated 
the whole-heart (including atria, ventricles, septum), liver, lungs, spleen, and torso 
surface. To each of these tissue elements conductivities were assigned as reported in 
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literature (thorax: 0.2 S/m, lungs: 0.04 S/m, liver: 0.03 S/m and spleen: 0.04 S/m) [12]. 
Gmsh software [13] was used for the generation of a volume mesh, required for the 
simulations (figure 1).
RV	
RA	
LA	
RL	 LL	
LV	
Figure 1. Example of a 3D volume mesh used for the simulations. This volume mesh was 
generated after segmentation of the thoracic organs on the MRI images. RL right lung, LL left 
lung, RA right atrium, LA left atrium, RV, right ventricle, LV left ventricle.
Forward simulation
Figure 2 provides a complete overview of the forward and inverse procedures used in 
this research, as described previously [14].
Propagation of electrical activity through the tissue elements of the whole-heart model 
was simulated using Moller-Trumbore [15] and Floyd-Warshall algorithms [16], yielding 
isochrones. From these isochrones, time dependent epicardial source potentials were 
computed by applying location specific activation curves. From the source potentials 
and in conjunction with the different tissue conductivities, BSP were computed by 
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multiplication with the transfer matrix T. From these BSP, ECG potentials were computed 
by spatial sampling. In order to approximate real-life conditions, noise was added to the 
simulated ECG potentials with a signal-to-noise ratio (SNR) of 21 dB.
Figure 2. Flowchart visualizing the processes associated with forward simulations and inverse 
computations.
Inverse reconstruction of epicardial potentials from simulated ECG potentials
Epicardial potentials (Pepi) were calculated from the ECG potentials (Pbs) using 
Pepi = (TTT + λ2I)−1TTPbs where T is the forward transfer matrix and λ is the regularisation 
strength, initially determined by simulation with patient-specific geometries. For all 
electrode configurations, the correlation between the initial source epicardial potentials 
(used for the simulation of ECG potentials) and the reconstructed epicardial potentials 
was computed. In addition, for all electrode configurations, correlation was calculated 
for 16 identical points on the anterior epicardium. These values were plotted in a graph 
to visualise correlation trends. To exclude systematic errors due to grid artifacts, all 
computations were performed on different grids. Four different electrode configurations 
were used in the simulations (figure 3).
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Electrode	conﬁgura/ons	
252	surrounding	
62	concentrated	 62	super-concentrated	
62	surrounding	
Figure 3. Anterior view of the thorax. Four different electrode configurations were used for the 
simulation part of the study: 252 electrodes surrounding the thorax, 62 surrounding the thorax, 
62 concentrated (inter-electrode distance 30mm) and super-concentrated (inter-electrode 
distance 20mm). The yellow markers on the 3D thorax model represent the electrodes.
Reference configuration 252 electrodes surrounding the thorax. This configuration 
served as a reference, since this number of electrodes is the current standard in body 
surface potential mapping (BSPM).
• Configuration I 62 electrodes surrounding the thorax.
• Configuration II 62 concentrated (30  mm inter-electrode distance) electrodes 
directly overlaying the heart.
• Configuration III 62 super-concentrated (20 mm inter-electrode distance) electrodes 
directly overlaying the heart.
Inverse reconstruction of recorded human data
Study population
Three different electrode layouts were subsequently used to record data in three healthy 
volunteers (mean age 28 ± 1 year).
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To evaluate the localisation error and size of the smallest visible detail, four male patients 
(mean age 58 ± 12 years old) with an implanted MRI-conditional DDD pacemaker system 
(Advisa MRI™ Surescan®, Medtronic Inc., Minneapolis, MN, USA) and a structurally 
normal heart were enrolled. Patient characteristics are provided in table 1. The RV lead 
tip was positioned either in the RV apex (2 patients), or in the right ventricular outflow 
tract (RVOT) (2 patients).
Table 1. Patient characteristics.
Patient Age (yrs) Sex
RV lead tip 
location
Pacing indication
Relevant 
comorbidity
1 66 M Apex Asystole Hypertension
2 42 M Apex Asystole Hemochromatosis
3 69 M RVOT AV-block -
4 54 M RVOT Chronotropic Incompetence -
Written informed consent was obtained from all participants. This study complied with 
the declaration of Helsinki and received approval from the local ethical committee and 
the institutional scientific board.
Body Surface Potential Mapping
Three different electrode layouts were used to record data in the healthy volunteers.
• Configuration I 62 electrodes surrounding the thorax.
• Configuration II 62 concentrated (30  mm inter-electrode distance) electrodes 
directly overlaying the heart.
• Configuration III 62 super-concentrated (20 mm inter-electrode distance) electrodes 
directly overlaying the heart.
BSP were recorded using a 65-channel (62 thorax electrodes) ActiveTwo BSPM system 
with passive electrodes and shielded cables (BioSemi BV, Amsterdam, The Netherlands). 
A sampling rate of 2048 Hz was selected and every data acquisition was performed for 
60 s.
In the pacemaker patients, BSP were recorded using the 62 super-concentrated electrode 
configuration (configuration III). Potentials were recording during right ventricular (RV) 
pacing at a rate exceeding the intrinsic rate with at least 15 beats/min (paced AV-delay 
70 ms).
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Every BSP recording was immediately followed by an MRI scan in order to register the 
electrode positions to the anatomy of the volunteer.
Magnetic Resonance Imaging
After each BSPM recording, MRI markers were applied to replace all torso electrodes. 
These markers were used to locate the electrode positions on the MRI images, thereby 
minimizing the systematic error in the inverse procedure.
Axial, coronal and sagittal anatomical images were obtained using a Turbo Spin Echo 
(black blood) sequence during breath hold (slice thickness 6  mm, no gap between 
slices).
MRI was performed on a Siemens Aera 1.5 Tesla MRI scanner (Siemens Healthcare, 
Erlangen, Germany).
For patients with an implanted pacemaker, pacing thresholds, P- and R-wave amplitude 
and lead impedance were determined before entering the MRI room and the pacemaker 
system was programmed into MRI SureScan® mode [17]. These parameters were again 
determined after the examination and compared to the initial values. Finally, original 
programming of the pacemaker was restored.
Inverse reconstruction of recorded ECG data
From the MRI images, a 3D thorax model was constructed comprising the epicardial 
surface and the thorax volume conductor, accounting for lungs, liver and spleen. 
Epicardial potentials were calculated from the recorded BSP (Pbs) using Pepi = (T
T T + λ2 I)-1 
TT Pbs, where T is the forward transfer matrix and λ is the regularisation strength. Following 
each BSP recording, epicardial activation sequences were inversely reconstructed and 
visualised
Evaluation of the quality of the inverse results
To evaluate the quality of the results, ECGs were reconstructed from the inverse by 
forward transformation. The correlation between the recorded ECG potentials and the 
computed ECG potentials was subsequently determined.
Note that while an a priori activation model was used for simulations to optimise the 
electrode positioning, no such model was used to perform the inverse reconstruction 
from recorded human BSP.
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Patients with an implanted pacemaker system
Localisation error
An investigator blinded to the actual ventricular lead tip position, identified the site of 
earliest depolarisation on the colour-coded epicardial potential map. Subsequently, the 
distance between this site and the position of the ventricular lead tip on the MRI images 
was determined. Hence, the localisation error was quantified as the distance between 
the true pacing location and the pacing location projected from the inverse.
Amount of true detail
The amount of detail was evaluated by performing a threshold-test on the epicardial 
potential peak induced by a pacing stimulus at a well-known electrode location. When 
the threshold was set too high, the potential peak would split, suggesting false detail.
The minimum size of the inversely mapped potential peak induced by pacing is 
determined by the highest threshold value that does not cause the peak to split. The 
detail shown in this case is true, rather than false (figure 4).
The smallest visible detail was quantified as the maximum point spread cross-section in 
mm of the potential peak due to pacing.
Computing platform
All analyses were performed on a 2.4 GHz quadcore laptop running the Windows 8 OS. 
Solving the potential equations was delegated to an Ubuntu 12.10 virtual machine 
running on this laptop. Correlation coefficients were determined using Pearson’s 
product moment correlation coefficients as computed by the NumPy library.
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Figure 4. The amount of detail was evaluated by performing a threshold-test on an epicardial 
potential peak induced by a pacing stimulus. When the threshold is set too high, the potential 
peak will split, suggesting false detail (upper panel). The highest threshold value that does not 
cause the potential peak to split, reflects the minimum amount of true detail in the inversely 
reconstructed potential (lower panel).
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RESULTS
Computer simulations
252 electrodes surrounding the thorax     
This electrode layout provided a high image quality (figure 5a, video 1). Right ventricular 
breakthrough could be easily discerned. An overall high correlation (R = 0.96; p < 0.01) 
with the source model was found. The correlation map (figure 5b) clearly demonstrated 
a reduced correlation in areas with increased electrode spacing.
62 electrodes surrounding the thorax
This electrode configuration resulted in a poor image quality (figure 5d, video 2). 
Several gaps appeared in the epicardial potential map, indicating loss of information 
in these areas. A reduced overall correlation compared to the source model was found 
(R = 0.92; p < 0.01) (figure 5e).
62 electrodes concentrated (30mm inter-electrode distance)
When concentrating all available electrodes on the anterior part of the thorax in the 
region directly overlaying the heart, a clinical relevant image of the potentials on the 
anterior epicardium was obtained (figure 5g, video 3). Figure 5h shows that the 
correlation with the source model greatly improved (R = 0.97; p < 0.01), compared to 
the configuration using 62 electrodes surrounding the thorax.
62 electrodes super-concentrated (20mm inter-electrode distance)
By reducing the inter-electrode distance to 20  mm, image quality improved. The 
depolarisation front appeared to be more homogeneous (figure 5j, video 4). This was 
confirmed by a slightly higher correlation with the source model (R = 0.98; p < 0.01), 
compared to that obtained using the 30 mm electrode spacing configuration. As can 
be observed in figure 5k, IPM using the super-concentrated electrode configuration 
provided the highest correlation with the source model.
Inverse reconstruction of recorded human data
The BSP recording and MRI examination lasted approximately 60 min. Segmentation 
and data processing lasted approximately 150  min. Correlation coefficients between 
measured and reconstructed ECGs were >0.94 for all leads used in the inversion and 
>0.97 for 85 % of those leads.
14867-vandergraaf-layout.indd   137 31/08/2017   09:37
138
Chapter 8
Figure 5. Epicardial source model at 30ms into the QRS (upper panel). Epicardial potential map 
at 30ms into the QRS, temporal correlation map and correlation plot of 16 sampling points for 
every simulated electrode layout (lower panel). A-C: 252 electrodes surrounding the thorax, D-F: 
62 surrounding the thorax, G-I: 62 concentrated, J-L: super-concentrated. A reduced correlation 
was observed in areas between two electrodes (encircled in 4B). The highest correlation with 
the epicardial source model was obtained with the super-concentrated electrode placement.
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62 electrodes surrounding the thorax
The 62 electrodes surrounding the thorax did not provide clinical sufficient information 
(video 5). Only ventricular epicardial activation could be reconstructed using this 
configuration. Regions with no or low signal variance were observed as gaps in the 
reconstructed epicardial potentials.
62 electrodes concentrated (30mm inter-electrode distance)
Concentrated positioning of the 62 available electrodes, directly above the heart, 
improved the overall resolution (video 6). Although reduced in size and number, areas 
of low signal were still present when using this electrode configuration.
62 electrodes super-concentrated (20mm inter-electrode distance)
Higher concentration of the electrode configuration (20 mm inter-electrode distance) 
resulted in a substantial increase of image resolution (video 7). Atrial and ventricular 
activation could be clearly distinguished and spatially localised in the reconstructed 
epicardial activation sequence. Figure 6 shows epicardial potential maps for six instants 
of time during the QRST interval. In all three volunteers, similar results were obtained.
Reconstruction of pacing sites
None of the patients reported any complaints during or after the MRI examination. 
Pacing thresholds and leads impedances remained unaffected by the MRI scan in all 
patients.
For all patients, the site of earliest ventricular depolarisation could be identified. In two 
patients, depolarisation started in the superior part of the right ventricular septum. In 
remaining patients, the site of earliest depolarisation was located in the apical region of 
the right ventricle.
In vivo evaluation of localisation error and amount of detail
A mean localisation error of 5.3 mm was found. The mean size of the smallest visible 
detail during pacing, determined by a threshold test, was 7 mm. Individual values are 
listed in table 2.
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Figure 6. Epicardial potentials during a QRST interval inversely estimated from human 
BSP recorded using the super-concentrated (20mm inter-electrode distance) electrode 
configuration. Right ventricular breakthrough can be observed in panel C.
Table 2. Localisation errors and amount of detail in pacemaker patients.
Localisation error (mm) Max point spread (mm)
Patient 1 (RV apex) 5 7
Patient 2 (RV apex) 5 8
Patient 3 (RVOT) 5 7
Patient 4 (RVOT) 6 6
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DISCUSSION
This study investigated the optimal positioning of only 62 torso electrodes for IPM in 
the absence of an a priori model. Computer simulations were used to improve insight 
and predict image quality of different electrode configurations. A configuration of 62 
electrodes positioned on the anterior part of the thorax, with a 20 mm inter-electrode 
distance, provided the highest amount of detail in the epicardial potential maps of the 
anterior side of the heart.
In addition, the epicardial potential distribution reconstructed using this configuration 
demonstrated the highest correlation (R = 0.98; p < 0.01) with the original epicardial 
source model. Using this configuration, a minimum occurring at 10  ms into the QRS 
near V1, reflecting right ventricular breakthrough could be discerned. This finding is in 
accordance with previous observations reported by Taccardi in 1963 [18] and Okamoto 
et al. in 1990 [19].
The results of application of this method in patients with implanted pacemakers 
indicated a clinically relevant reconstruction quality. A mean localisation error of 5.3 mm 
was found in the pacemaker patients.
Clinical relevance of this study
Inverse potential mapping is a promising but also challenging modality to gain further 
insight into cardiac substrates and arrhythmia mechanisms in a non-invasive fashion. 
This study focused on simplification of the procedure by applying a reduced number 
of recording electrodes. The ventricular paced beats analysed in this study served as 
ectopic ventricular foci. The mapping approach presented in this paper may help to tailor 
the invasive electrophysiological procedure to the individual patient. The concentrated 
electrode configuration may make it an attractive clinical alternative in situations where 
this specific view is required.
Importance of simulations
The possibility to simulate epicardial potentials from random electrode configurations 
facilitated a stepwise approach towards optimal electrode positioning. In this way, the 
simulations guided the placement of the electrodes. In addition, the validity of the 
simulations could be determined by application of the selected configurations in vivo. 
The validity of the simulations was subsequently confirmed by the results obtained in 
patients with implanted pacemaker systems.
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A-priori model
In literature [20–22], inverse procedures involving 64 or fewer electrodes always apply 
an a priori activation model. Although detailed images may be obtained using even <20 
electrodes, the number of degrees of freedom in this situation fundamentally limits the 
number of pathology related activation patterns that can be represented. This is further 
elaborated upon in appendix and in figure 7.
Figure 7. Linear mapping M denotes the ideal reconstruction, reflecting the unknown but 
exact linear quasi-stationary field equations. M maps n independent electrode signals onto at 
most n independent epicardial base vectors. Note that, by definition of M, no reconstruction 
method can do better. In practice, ill conditioning will render certain subsets of epicardial 
patterns indistinguishable, reducing the dimension of the solution space.
Obtaining detailed images of cardiac surface potentials using a limited number of 
electrodes, without excluding a wide variety of pathological activation patterns by 
constraining the solutions using an a priori activation model derived from healthy 
myocardial tissue, requires focusing all degrees of freedom on a limited region of 
interest on the cardiac surface.
MRI
Although computed tomography (CT) is frequently preferred due to the speed of the 
acquisition process, MRI allows reliable function analysis, assessment of wall motion 
abnormalities and highly detailed characterisation of tissue [23–26]. Unlike CT, MRI 
does not use radiation. Hence, MRI is the preferred imaging modality to be repeatedly 
used in patients. In recent years, the safe performance of MRI in patients with non-MRI-
conditional pacing devices has been demonstrated [27–29]. In addition, MRI-conditional 
devices have been introduced, decreasing the risk of potential hardware or software 
interactions [30].
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Limitations of this study
Application of 62 anterior electrodes with an inter-electrode distance of 20 mm enables 
detailed reconstruction of an anterior view of the epicardial potentials in the absence 
of an a priori model. Information on the posterior area of the heart could not be 
reconstructed from the BSP recorded using the anterior positioned super-concentrated 
electrode configuration. By increasing the total number of recording electrodes and by 
positioning electrodes on the back of the thorax this can be resolved. But since the 
application of a large number of electrodes is time consuming, implementation in the 
clinical arena may still be challenging. Hence, an optimal balance between information 
content and clinical utility is pursued. Parallel computation of the inverse solution will 
further reduce the post-processing time.
In the presence of a limited number of electrodes, electrode positioning is crucial. In 
order to achieve a high resolution, it is very important to position the electrodes directly 
overlaying the heart. Because this may be difficult to determine, a rapid exploratory 
MRI scan (scout anatomical images) prior to BSPM may help to optimise electrode 
positioning. Regarding the small number of patients in this study, further research is 
needed to further evaluate the clinical benefits of this non-invasive mapping strategy.
Future perspective
Although IPM is considered a promising technique to complement conventional invasive 
electrophysiological procedures, it has not yet advanced to routine clinical application. 
This is mainly due to the time consuming nature of the acquisition and post-processing 
of the data. The possibility to derive detailed information on cardiac excitation from a 
rapid and simplified BSPM procedure may facilitate clinical implementation. The ability 
to perform detailed simulations using patient data may provide clinicians valuable 
insight into the potential impact of their treatment. Non-invasive characterisation 
of arrhythmogenic foci or substrates, prior to invasive electrophysiological or device 
implant procedures, may help to increase therapeutic outcome. Further research is 
required to provide evidence of the effectiveness and accuracy of this approach to IPM.
CONCLUSION
The purpose of this study was to investigate the feasibility of IPM using only 62 torso 
electrodes without the aid of an a priori model. By concentrating the available electrodes 
in the area directly overlaying the heart, a high-resolution anterior view of the epicardial 
potentials can be obtained. Application of this mapping approach in patients with 
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implanted MRI-conditional pacemakers demonstrated a clinically relevant inverse 
reconstruction accuracy. Further research needs to be performed to further evaluate 
the clinical benefits of this technique.
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APPENDIX I
Let n be the number of electrodes, let a be the dimension of the linear span A of the 
electrode potential vectors and let b be the dimension of the linear span B of the 
reconstructed epicardial potential vectors. Then a = n and b <= a, since the base vectors 
of B are, by linearity of the quasi stationary electrical field equations, obtained by a linear 
mapping M from the base vectors of A, that may have a kernel K of dimension k > 0. In 
general b = a, since M will be non-degenerate as is illustrated in figure 7. Note that the 
exact nature of the parameter estimation procedure plays no role in this fundamental 
relationship.
14867-vandergraaf-layout.indd   148 31/08/2017   09:37
14867-vandergraaf-layout.indd   149 31/08/2017   09:37
09
14867-vandergraaf-layout.indd   150 31/08/2017   09:37
NON-INVASIVE FOCUS LOCALISATION; 
RIGHT VENTRICULAR EPICARDIAL 
POTENTIAL MAPPING IN PATIENTS 
WITH AN IMPLANTED MRI-
CONDITIONAL PACEMAKER SYSTEM
van der Graaf AW, Bhagirath P, de Hooge J,  
Rammana H, van Driel VJ, de Groot NM, Götte MJ.
Journal of Interventional Cardiac Electrophysiology. 2015;44(3):227-234.
14867-vandergraaf-layout.indd   151 31/08/2017   09:37
152
Chapter 9
ABSTRACT
Background: With the advent of magnetic resonance imaging (MRI) conditional 
pacemaker systems, the possibility of performing MRI in pacemaker patients has 
been introduced. Besides for the detailed evaluation of atrial and ventricular volumes 
and function, MRI can be used in combination with body surface potential mapping 
(BSPM) in a non-invasive inverse potential mapping (IPM) strategy. In non-invasive IPM, 
epicardial potentials are reconstructed from recorded body surface potentials (BSP). In 
order to investigate whether an IPM method with a limited number of electrodes could 
be used for the purpose of non-invasive focus localisation, it was applied in patients with 
implanted pacing devices. Ventricular paced beats were used to simulate ventricular 
ectopic foci.
Methods: Ten patients with an MRI-conditional pacemaker system and a structurally 
normal heart were studied. Patient-specific 3D thorax volume models were reconstructed 
from the MRI images. BSP were recorded during ventricular pacing. Epicardial potentials 
were inversely calculated from the BSP. The site of epicardial breakthrough was 
compared to the position of the ventricular lead tip on MRI and the distance between 
these points was determined.
Results: For all patients, the site of earliest epicardial depolarisation could be identified. 
When the tip of the pacing lead was implanted in vicinity to the epicardium, i.e. right 
ventricular (RV) apex or RV outflow tract, the distance between lead tip position and 
epicardial breakthrough was 6.0 ± 1.9 mm.
Conclusion: In conclusion, the combined MRI and IPM method is clinically applicable 
and can identify sites of earliest depolarisation with a clinically useful accuracy.
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INTRODUCTION
Invasive electrophysiological procedures are often complicated by considerable 
fluoroscopic time, non-inducibility of the arrhythmia or hemodynamic instability of the 
patient [1]. Therefore, pre-procedural and non-invasive localisation of arrhythmogenic 
foci may improve the clinical outcome and reduce the duration of the invasive 
procedures [2].
To this intent, over the last decade various non-invasive mapping strategies, 
e.g. electrocardiographic imaging (ECGI) [3], non-invasive imaging of cardiac 
electrophysiology (NICE) [4] and AMICARD [5] have been introduced. Despite numerous 
reports on the possible advantages of non-invasive mapping, this approach has not 
yet advanced into daily clinical practice as a routine tool. This is either due to the 
impracticability associated with the use of up to 254 torso electrodes or to the limited 
data available from in vivo studies with respect to the accuracy and validity of the 
estimated epicardial potentials or intramural activation times.
With the advent of magnetic resonance imaging (MRI) conditional pacemaker systems, 
the possibility of performing MRI in pacemaker patients has been introduced [6]. Besides 
for the detailed evaluation of atrial and ventricular volumes and function, MRI can be 
used in combination with body surface potential mapping (BSPM) in a non-invasive 
inverse potential mapping (IPM) strategy.
This pilot study investigated the feasibility of non-invasive focus localisation using 
a limited number of 62 electrodes in patients with an implanted MRI-conditional 
pacemaker system. Ventricular paced beats were used to simulate ectopic foci. The 
estimated site of earliest epicardial breakthrough was compared to the position of the 
ventricular lead tip, and the distance between these sites was determined.
METHODS
Patient selection
Inverse potential mapping was performed in ten male patients (mean age 64 ± 5 years 
old) with an implanted MRI-conditional DDD pacemaker system (Advisa MRI™ 
Surescan®, Medtronic Inc., Minneapolis, MN, USA) and a structurally normal heart. 
Patient characteristics are provided in table 1.
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Table 1. Patient characteristics.
Patient
Age 
(yrs)
Pacing indication
PR 
(ms)
QRS 
(ms)
QTc 
(ms)
Relevant comorbidity
1 66 Asystole 138 102 399 Hypertension
2 42 Asystole 148 96 363 Hemochromatosis
3 64 Bradycardia 180 94 384 Hypercholesterolemia
4 69 AV-block 190 180 380 -
5 70 AV-block 216 150 427 -
6 61 SSS + AV-block 314 128 411 Hypertension
7 69 AV-block 204 169 474 -
8 54 Chronotropic Incompetence 204 98 424 Paroxysmal AF
9 65 SSS† 268 100 395 -
10 79 Bradycardia 227 126 380 -
†SSS sick sinus syndrome.
The study complied with the declaration of Helsinki and received approval from the 
local ethical committee and the institutional scientific board. Written informed consent 
was obtained from all patients.
An overview of the complete workflow is provided in figure 1.
Body Surface Potential Mapping
Body surface potentials (BSP) were recorded using a 65-channel (62 torso + 3 limb 
electrodes) ActiveTwo BSPM system with passive electrodes and shielded cables 
(BioSemi BV, Amsterdam, The Netherlands). The BSP electrodes were positioned on 
the anterior thorax using a 20-mm inter-electrode distance (figure 1d) [7]. BSP were 
recorded in supine position at a sampling rate of 2048 Hz for 10 s during right ventricular 
(RV) pacing at a rate exceeding the intrinsic rate with at least 15 beats per minute (paced 
AV-delay 70 ms).
Magnetic Resonance Imaging
After BSPM, MRI markers were applied to replace all torso electrodes. These markers 
were used to locate the electrode positions on the MRI images, thereby minimizing 
the systematic error in the inverse procedure. Before entering the MRI room, pacing 
thresholds, P- and R-wave amplitude, and lead impedance were determined and the 
pacemaker system was programmed into MRI SureScan® mode [8].
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Figure 1. Complete workflow (A-F) for a non-invasive IPM procedure.
In order to control lung volume, breath holding was practiced with the patient prior 
to the examination. A stack of ECG-triggered, T2-weighted, bright blood images (slice 
thickness, 6  mm) was acquired to record the anatomy of the thorax and register the 
position of the RV lead tip and torso electrodes. Subsequently, cardiac function was 
assessed using steady state free precession (SSFP) short-axis, three- and four-chamber 
cines (slice thickness, 6  mm, temporal resolution <50  ms). All images were obtained 
during breath-hold on a Siemens Aera 1.5 Tesla MRI scanner (Siemens Healthcare, 
Erlangen, Germany). Cardiac function was analysed using CMR42® software (Circle 
Cardiovascular Imaging, Calgary, Alberta, Canada).
After the examination, pacing thresholds, P- and R-wave amplitude and lead impedance 
were determined and compared to the initial values. Finally, original programming of 
the pacemaker was restored.
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Data processing
3D thorax model
For every patient, a detailed anatomical thorax model, including a 3D whole-heart 
model, was constructed from the MRI images. Thoracic structures including the heart 
with all four compartments, lungs, liver and spleen were manually segmented directly 
in 3D using custom-written software. Conductivities were assigned to each of these 
structures as known from literature (thorax, 0.2 S/m; lungs, 0.04 S/m; liver, 0.03 S/m and 
spleen, 0.04 S/m) [9]. A triangulated 3D thorax model was reconstructed using Gmsh 
software [10].
Inverse computation
For each patient, a single paced beat within the 10 seconds acquisition window was 
selected for inverse computation. The electrograms do not require any specific editing 
prior to processing. Epicardial potentials (Pepi) were calculated from the recorded body 
surface potentials (Pbs) using Pepi = (T
T T + λ2 I)-1 TT Pbs where T is the forward transfer matrix 
and λ is the regularisation strength (0.01). Finally, an epicardial potential map of a single 
paced ventricular beat was reconstructed.
Ventricular lead tip position and the site of earliest depolarisation
An investigator (PB), blinded to the actual ventricular lead tip position, identified the site 
of earliest depolarisation on the colour-coded epicardial potential map. Subsequently, 
the distance between this site and the position of the ventricular lead tip on the MRI 
images was determined.
Correlation
In order to evaluate the reproducibility of the applied IPM method, two different 
paced beats were analysed for each patient. The epicardial potential distribution was 
reconstructed independently. Subsequently, the correlation between the epicardial 
potentials estimated from the two different beats was calculated using custom-written 
software.
Computing platform
Results are shown as mean ± SD and are expressed as absolute values. All analyses 
were performed on a 2.4-GHz quad core laptop running the Windows 8 OS. Solving the 
potential equations was delegated to an Ubuntu 12.10 virtual machine running on this 
laptop.
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RESULTS
The BSP recording and MRI examination lasted approximately 60  min. None of the 
patients reported any complaints during or after the MRI examination. Pacing thresholds 
and leads impedances remained unaffected by the MRI scan in all patients.
Despite the presence of a pacemaker, image quality was good to excellent in all patients 
and allowed for left and right ventricular function assessment (figure 2, panels A, C and 
E). MRI-derived global function measures are listed in table 2.
Table 2. MRI parameters.
Patient
LVEDV
(ml)
LVESV
(ml)
LVSV
(ml)
LVEF
(%)
RVEDV
(ml)
RVESV
(ml)
RVSV
(ml)
RVEF
(%)
1 147 60 87 59 145 55 91 62
2 133 66 67 50 172 104 69 40
3 135 73 63 46 153 94 58 38
4 193 114 79 41 151 85 66 44
5 153 89 63 41 163 107 55 34
6 175 75 100 57 165 80 86 52
7 187 108 80 43 150 85 66 44
8 157 72 84 54 209 122 87 42
9 177 92 85 48 160 90 70 44
10 113 58 55 48 166 111 55 33
LVEDV left ventricular end-diastolic volume; LVESV left ventricular end-systolic volume; LVSV left ventricular stroke volume; 
LVEF left ventricular ejection fraction; RVEDV right ventricular end-diastolic volume; RVESV right ventricular end-systolic 
volume; RVSV right ventricular stroke volume; RVEF right ventricular ejection fraction.
Figure 2 (panels B, D and F) provides typical examples of MRI images used to identify 
the position of RV lead and the RV lead tip.
Potential maps
Epicardial potentials were inversely reconstructed and the distribution was visualised 
using potential maps. For all patients, the site of earliest ventricular depolarisation 
could be identified. Figure 3 shows 3 typical examples of the potential distributions 
reconstructed from the BSP recorded during pacing from different locations.
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Figure 2. Left panel: End-diastolic frames from four-chamber (A), short-axis (C) and three-
chamber (E) Steady State Free Precession (SSFP) CINE images. Despite regional artifacts, caused 
by either the impulse generator or the pacing leads, the image quality allows for accurate 
assessment of LV and RV volumes and function. LA left atrium, LV left ventricle, RA right atrium, 
RV right ventricle, Ao aorta. Right panel: Three examples (B, D & F) of the T2-weighted, bright 
blood images used to localise the RV pacing lead (white arrows). The asterisks indicate the MRI 
markers that represent the location of the BSP electrodes.
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Figure 3. RV lead tip position and site of earliest depolarisation on the potential maps. Pacing 
from the RV apex (A & B), high in the mid-ventricular septum (C & D) and right ventricular 
outflow tract (E & F).
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In two patients (patient 4 and 8), depolarisation started in the superior part of the right 
ventricular septum. A rapid subsequent depolarisation of the right ventricular free wall 
was observed (video 1).
In two patients (patient 1 and 2), the site of earliest depolarisation was located in the 
apical region of the right ventricle. From that point, depolarisation spread rapidly to the 
basal portion of both the RV and left ventricle (LV) (video 2).
Localisation
In patients with the tip of the pacing lead close to the epicardium (apex or right 
ventricular outflow tract), the distance between lead tip position and epicardial 
breakthrough was 6.0 ± 1.9mm.
For the patients with the tip of the pacing lead implanted in the middle of the mid-
ventricular septum, the observed site of epicardial breakthrough varied substantially 
across the right ventricular free wall. In these patients, the intrinsic distance from the 
lead tip to the epicardium was relatively large (range: 5-30mm). This distance contributes 
significantly to the measured localisation error (range: 11-45mm).
Correlation
In all patients, a high correlation (r = 0.97-0.99, p < 0.001) between the epicardial 
potential distributions of two different paced beats was calculated (table 3). Correlation 
values were visualised using correlation maps (figure 4).
Table 3. Distance epicardial focus to lead tip and correlation between two different paced 
beats.
Patient Position RV lead tip Distance epicardial focus to lead tip (mm) Correlation (r)
1 Apex 4 0.996
2 Apex 5 0.997
3 Mid-septum 45 0.978
4 RVOT 6 0.997
5 Mid-septum 20 0.995
6 Infero-septum 25 0.979
7 Mid-septum 11 0.999
8 RVOT 9 0.994
9 Infero-septum 13 0.999
10 Mid-septum 43 0.966
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Figure 4. Three examples of intervals selected for correlation analysis (left panel) and the 
corresponding correlation maps (right panel). In all patients, a high correlation (r = 0.97-0.99, p 
< 0.001) between the epicardial potential distribution of two different paced beats was found.
DISCUSSION
This is one of the first in vivo studies in patients with an MRI-conditional pacemaker 
system, in which a combined MRI and IPM approach was applied to non-invasively 
determine the origin and epicardial potential distribution during pacing. In patients with 
the tip of the pacing lead close to the epicardium, a localisation error of 6.0 ± 1.9 mm 
was found.
This clinically relevant accuracy and the less cumbersome nature of the present IPM 
method may facilitate non-invasive localisation of ectopic ventricular foci in patients 
suffering from ventricular arrhythmia prior to entering the catheterisation suite.
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In addition, this offers the prospect of thoroughly investigating in vivo electrical 
and mechanical activation patterns in patients with an implanted MRI-conditional 
pacemaker system.
Novelty of this work
IPM in patients with MRI-conditional pacemaker systems
To our knowledge, this is one of the first reports on the application of IPM in patients 
with implanted MRI-conditional pacemaker systems. Most validation studies on non-
invasive mapping were performed in animal hearts using computed tomography (CT) 
or in humans during conventional electrophysiological studies [11–14].
In the past, a limited number of patients with an implanted pacemaker have been 
studied for validation purposes. In these studies, ECGI uses 254 torso electrodes and CT 
images to calculate epicardial potentials. In only one patient with an implanted cardiac 
resynchronisation therapy (CRT) device, a localisation error of 7 mm for the RV pacing 
lead and 11 mm for the LV lead has been reported [15].
NICE uses 65 electrodes and MRI images to estimate endo- and epicardial activation 
times. NICE has been applied in ten patients with an implanted CRT device [16] and 
in one patient with a CRT device and a quadripolar LV lead [17]. No localisation errors 
could be determined in these studies. Due to the non-MRI compatibility of the devices 
used, the MRI scan was performed prior to implantation of the device, whereas BSP 
were recorded after implantation. Hence, co-registration of the device, the anatomy of 
the patients and torso electrodes was not performed.
Recently, Revishili et al. [18] demonstrated the accuracy of a novel non-invasive epi- and 
endocardial electrophysiology system (NEEES) in 29 patients with implanted devices 
(26 CRT devices in three dual-chamber pacemakers). The mean distance from the 
non-invasively predicted pacing site to the anatomic reference site was 10.8 ± 5.4 mm 
for the right atrium, 7.7 ± 5.8  mm for the right ventricle and 7.9 ± 5.7  mm for the left 
ventricle. However, the authors state that members processing the NEEES data were 
not completely blinded for the exact position of each pacing lead on the available CT 
images.
Anterior concentrated electrodes
In this study, all BSP electrodes were positioned in a matrix, directly overlaying the 
heart. By concentrating the electrodes, a localisation error of 6.0 ± 1.9 mm was found for 
patients with the tip of the pacing lead close to the epicardium. The rapid positioning of 
this electrode array may facilitate the incorporation of this technique in clinical practice.
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Epicardial potentials
Currently, only epicardial potentials can be reconstructed from the recorded BSP. 
Reconstruction of both epicardial and endocardial activation would require the 
application of an a priori activation model (e.g. NICE, NEEES). Use of a priori models 
mandates various assumptions to be made and limits the number of pathology related 
activation patterns that can be represented.
As described previously by Rudy and co-workers, epicardial potentials contain 
information on intramural and endocardial activation even before the epicardium is 
activated [19]. Epicardial potentials of the complete cardiac cycle can be non-invasively 
reconstructed and isochrones or activation times can be derived from the reconstructed 
potentials [20].
In patients with implanted pacing devices, visualisation of epicardial activation 
may provide additional insight into the efficacy of the pacing strategy. Changes in 
depolarisation or repolarisation or other signs of adverse pacing effects may be detected 
at an early stage. Various studies have demonstrated that long-term ventricular pacing 
may have various unintended adverse electrophysiological and mechanical effects [21-
22]. In order to better understand the underlying (patho-) physiological mechanisms, 
it is important to further develop clinically applicable, non-invasive techniques that 
facilitate an integrated electro-mechanical assessment.
MRI
Using MRI as a reference for the RV lead tip position is a novelty. The introduction of 
MRI-conditional pacemaker systems enables the use of MRI for IPM. Unlike CT, MRI is not 
associated with radiation exposure. MRI-conditional devices can be programmed in an 
MRI safe mode, which makes the device less susceptible to the magnetic energy of the 
MRI environment and decreases the risk of hard- or software interactions.
Besides visualizing the lead position, MRI may provide valuable information on the 
mechanical activation in patients with implanted pacemaker systems. In contrast to 
CT, MRI enables the safe performance of follow-up studies. In addition, MRI is the gold 
standard for the detailed assessment of atrial and ventricular volumes, function and wall 
motion abnormalities [23]. Moreover, the presence and the extent of myocardial scar 
tissue can be determined, which may influence cardiac electrical activation patterns 
and may impact the effects of pacing [24].
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The presence of an implanted device generates image artifacts that may compromise 
image quality. By adapting the scan strategy, the amount of artifacts produced by the 
implanted pacemaker system can be kept at a minimum [25]. Ventricular function is 
usually assessed in the short-axis view. These images are mildly affected by the distortion 
caused by the presence of a pacemaker. Left and right ventricular function could be 
assessed for all patients in this study.
Limitations of the study
The site of epicardial breakthrough on the epicardial potential map was compared to 
the position of the ventricular lead tip on MRI and the distance between these points 
was determined. The position of the RV lead tip was determined using the susceptibility 
artifact caused by the lead tip on the MRI images (figures 2 and 3). Alternatively, CT may 
be used for this purpose. Nevertheless, the scattering of radiation causes the overall 
image quality to decline. In addition, the metallic artifact caused by the lead will hamper 
the localisation of the tip of lead [26].
For several patients, the reported distance from the lead tip to the site of earliest 
depolarisation on the epicardial potential maps includes the distance from the lead tip 
in the septum to the epicardium. Septal insertion of the lead tip increases the intrinsic 
distance from the lead tip to the site of epicardial breakthrough. This is a limitation of the 
reconstruction of epicardial potentials. Therefore, the localisation accuracy is probably 
severely underestimated in this group of patients.
The anterior concentration of BSP electrodes does not allow for accurate investigation 
of depolarisation on the posterior wall. This pilot study focussed on investigating the 
feasibility of performing IPM in patients with an implanted MRI-conditional pacemaker 
system. The current research did not describe the accuracy of localizing foci in the 
inferior wall of the RV or LV. Atrial stimuli were not analysed in the current study.
It has been shown that prematurity of ectopic foci can affect cardiac activation patterns. 
This was not explored in this current study by introducing different coupled extra-
stimuli during RV pacing.
The accuracy of localizing epicardial breakthrough may be affected by extensive 
scar in patients with prior infarction or severe cardiomyopathy. For this reason and in 
consideration of the limited size of the study population, additional research needs to 
be performed to further explore the clinical benefit of IPM in combination with MRI in 
patients suffering from a wide range of pathologies.
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CONCLUSION
In this study, an IPM method using a limited number of electrodes was applied in patients 
with an MRI-conditional pacemaker system. For all patients, the epicardial potential 
distribution could be reconstructed from BSP recorded during pacing. In patients with 
the tip of the pacing lead close to the epicardium, a localisation accuracy of 6.0 ± 1.9 mm 
was found. Application of this method in patients suffering from ventricular arrhythmia 
may enable accurate non-invasive localisation of ectopic ventricular foci prior to 
entering the catheterisation suite.
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ABSTRACT
Background: Inverse potential mapping (IPM) non-invasively reconstructs cardiac 
surface potentials using body surface potentials. This requires a volume conductor 
model (VCM), usually constructed from computed tomography; however, computed 
tomography exposes the patient to harmful radiation and lacks information about 
tissue structure. Magnetic resonance imaging (MRI) is not associated with this limitation 
and might have advantages for mapping purposes. This feasibility study investigated 
a magnetic resonance imaging–based IPM approach. In addition, the impact of 
incorporating the lungs and their particular resistivity values was explored.
Methods and results: Three volunteers and 8 patients with premature ventricular 
contractions scheduled for ablation underwent 65‐electrode body surface potential 
mapping. A VCM was created using magnetic resonance imaging. Cardiac surface 
potentials were estimated from body surface potentials and used to determine the origin 
of electrical activation. The IPM‐defined origin of sinus rhythm corresponded well with 
the anatomic position of the sinus node, as described in the literature. In patients, the 
IPM‐derived premature ventricular contraction focus was 3‐dimensionally located within 
8.3±2.7 mm of the invasively determined focus using electroanatomic mapping. The 
impact of lungs on the IPM was investigated using homogeneous and inhomogeneous 
VCMs. The inhomogeneous VCM, incorporating lung‐specific conductivity, provided 
more accurate results compared with the homogeneous VCM (8.3±2.7 and 10.3±3.1 
mm, respectively; P=0.043). The interobserver agreement was high for homogeneous 
(intraclass correlation coefficient 0.862, P=0.003) and inhomogeneous (intraclass 
correlation coefficient 0.812, P=0.004) VCMs.
Conclusion: Magnetic resonance imaging–based whole‐heart IPM enables accurate 
spatial localisation of sinus rhythm and premature ventricular contractions comparable 
to electroanatomic mapping. An inhomogeneous VCM improved IPM accuracy.
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INTRODUCTION
Inverse potential mapping (IPM) allows for non-invasive reconstruction of epicardial 
activation patterns. The most frequently used IPM method is based on a homogeneous 
volume conductor model (VCM) constructed from computed tomography images [1]. 
This technique is being applied increasingly for analysis of idiopathic ventricular foci 
and guidance of catheter ablation [2,3].
Although clinically useful, this computed tomography–based approach has important 
limitations. The most important limitation, besides the exposure to radiation and 
associated risk of malignancies [4], is the inability to characterise tissue in detail. 
Magnetic resonance imaging (MRI) does not have these limitations and is considered 
the gold standard for tissue characterisation, in particular for edema and fibrosis. 
Although most publications underscore the fact that both computed tomography and 
MRI can be used, MRI is less frequently used for IPM [5-7].
In addition, the use of a homogeneous VCM could also be considered a limitation 
because it may not appropriately incorporate the effects of specific tissue‐conductivity 
characteristics such as those from the lungs (ie, inhomogeneous conditions) [8].
This study investigated the feasibility of whole‐heart IPM using a VCM derived from 
MRI. The clinical applicability of this approach was evaluated in healthy volunteers and 
patients with idiopathic ventricular foci. In addition, the influence of tissue impedance 
on the results of IPM was studied using 2 different VCMs. A homogeneous thoracic VCM 
(model 1) was compared with an inhomogeneous VCM in which, in addition to thoracic 
impedance, the resistance value of the lungs was included (model 2).
METHODS
Patient population
The study population consisted of 3 healthy volunteers and 8 patients with symptomatic 
or therapy‐resistant premature ventricular contractions (PVCs). The study complied 
with the Declaration of Helsinki and received approval from the local ethics committee 
(METC Zuidwest Holland study NL38156.098.11) and the institutional scientific board. 
Written informed consent was obtained from the study participants.
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Body surface potential acquisition
An MRI scout scan was performed to approximate the position of the heart with respect 
to the thorax. Subsequently, 62 (+3 limb) electrodes were applied to each participant’s 
torso, centralised over the heart. Body surface potentials (BSPs) were acquired using a 
65‐channel ActiveTwo system (BioSemi BV). Once the acquisition was completed, the 
electrode locations were marked with MRI markers, enabling accurate identification of 
the electrode positions.
Image acquisition
MRI studies were obtained using a 1.5T Aera scanner (Siemens Healthcare). Blackblood 
imaging was performed using a half‐Fourier acquisition single‐shot turbo spin‐echo, or 
HASTE, pulse sequence to acquire 3 perpendicular stacks (axial, coronal, and sagittal) 
from the neck to the lower abdomen.
Images were acquired during free breathing using navigator gating (diaphragm) with 
a 1‐mm window. ECG gating was used to acquire images during the diastolic phase of 
the cardiac cycle. Typical imaging parameters were spatial resolution of 1.2×1.2×6 mm, 
repetition time/echo time 744/42 ms, and flip angle of 160°.
VCM and computational algorithm
The MRI images were segmented using a custom‐developed tool. This tool generates 
a script containing the geometric description (points, lines and planes, and directed 
line loops) of the segmentation. Subsequently, the script was meshed using GMSH [9]. 
Conductivity for the homogeneous VCM (model 1) was specified at 0.2 Siemens per 
meter (S/m) [10]. The inhomogeneous VCM (model 2) had a similar summation but also 
contained specific conductivity values for the lungs, specified at 0.04 S/m.10
Cardiac surface potentials were calculated from BSPs using the following equation 
in which CSP indicates cardiac surface potentials, T is the transfer matrix, and λ is the 
regularisation strength:
CSP = (TT T + λ2 I)–1 TT BSP
Electrophysiological study and catheter ablation
The electrophysiologists (H.R. and V.D.) were blinded to the IPM results. During the 
electrophysiological study, femoral venous and arterial access was established. In all 
cases, a hexapolar catheter (Supreme; St. Jude Medical) was placed in the right atrial 
appendage, and the proximal electrode located in the inferior vena cava served as the 
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unipolar indifferent electrode. In addition, a screw‐in temporary pacing lead (Medtronic) 
was placed in the right ventricle as a positional reference for the electroanatomic 
mapping (EAM) system (Ensite Velocity 3.0; St. Jude Medical). An EAM was created using 
the roving catheter. Respiratory compensation was set to automatic. No field scaling 
was performed.
If no spontaneous PVCs were present, isoproterenol and/or pacing maneuvers were 
used to provoke PVCs. After the focus location was identified, targeted ablation was 
performed using a standard 4‐mm nonirrigated ablation catheter with power delivery 
up to 50W and a temperature limitation of 50°C. Subsequently, the site of ablation was 
marked on the EAM system.
Comparison of focus localisation
Following the ablation procedure, the ectopic PVC focus location identified on the IPM 
was compared with the site of ablation specified on the EAM (gold standard). For this 
purpose, 2 experienced operators (P.B. and H.R.) independently identified the foci on 
IPM and EAM to provide a measure of interobserver variability.
This approach resulted in 3 different data sets describing the focus localisation as the x, y, 
and z coordinates: (1) IPM using the homogeneous model (data set 1), (2) IPM using the 
inhomogeneous model (data set 2), and (3) EAM (data set 3). Subsequently, Pythagoras’ 
theorem for 3‐dimensional coordinate vectors, in which the distance between 2 points 
is equal to the square root of the sum of the squared coordinate differences, was used 
to calculate the differences between coordinate data sets 1 and 3 and coordinate data 
sets 2 and 3.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics (version 22.0; IBM Corp). 
Continuous variables were expressed as mean±SD or as median and interquartile range. 
Localisation errors between the 2 VCMs were compared using the Wilcoxon signed‐rank 
test. The intraclass correlation coefficient was used to analyse interobserver agreement. 
P<0.05 was considered statistically significant.
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RESULTS
Study population
Baseline characteristics of the 3 volunteers and 8 patients (N=11) are provided in table 
1. All volunteers had normal ECGs. In both volunteers and patients, structural heart 
disease was excluded based on the MRI examination.
Table 1. Characteristics of participants undergoing inverse potential mapping.
Volunteers Patients
n 3 8
Age, y 28 ± 3 46 ± 13
BMI 22.1 ± 1.4 25.2 ± 6.7
Female (%) 1 (33) 7 (88)
LVEF (%) 55 ± 2 50 ± 3
RVOT PVCs - 6 (75%)
Duration of PVCs, months - 18 ± 12
PVC burden before procedure - 14 121 (10 432 to 22 373)
PVC burden after procedure - 17 (1 to 24)
Age, BMI, LVEF, and PVC duration are expressed in mean±SD. PVC burden before and after procedure is expressed using 
median (interquartile range). PVC burden is expressed in ectopic beats per 24 hours. BMI indicates body mass index; LVEF, 
left ventricular ejection fraction; PVC, premature ventricular contractions; RVOT, right ventricular outflow tract.
Ablation procedure
The preprocedural median PVC burden was 14 121 ectopic beats per 24 hours 
(interquartile range 10 432 to 22 373 ectopic beats per 24 hours). Average procedural 
time, including mapping and ablation, was 129±53 minutes. An average of 4468 points 
were acquired to construct the EAM. No periprocedural displacements of the EAM were 
observed.
After catheter ablation, the PVC burden was reduced to a median of 17 ectopic beats per 
24 hours (interquartile range 1 to 24 ectopic beats per 24 hours), a reduction of >99%.
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IPM in sinus rhythm
During sinus rhythm, the first point of activation on the potential map of healthy 
volunteers was located anatomically near the transition of the superior vena cava (crista 
terminalis) into the right atrium (Figure 1A, white arrow). Ventricular breakthrough 
began at the right ventricular free wall (Figure 1B), at the site at which the moderator 
band was attached to the ventricular myocardium.
Comparison between IPM focus and actual ablation site
No pacing maneuvers were required for PVC induction. Five patients required 
isoproterenol to induce PVCs. Based on invasive mapping, the ablation site was in the 
right ventricular outflow tract (VOT) in 6 patients and in the left VOT in 2 patients (Table 
2). One patient had a right bundle branch block, which was reconstructed correctly by 
IPM (Video S1).
In all 8 cases, IPM located the ectopic focus in the correct cardiac compartment (Table 
2). IPM identified all right VOT foci in close proximity to the ablation lesion (8.4±3 mm, 
n=6) defined on the EAM (Figure 2; Video S2). A similar difference was found for the 
left VOT foci (7.9±1.5 mm, n=2). IPM located 1 of the left VOT foci (Case 2) at the right 
coronary cusp; however, the ablation for this patient was performed successfully in 
the distal left VOT (Figure 3). The other left VOT focus was closely approximated to the 
actual site of ablation.
Table 2. Comparison of PVC focus identified with IPM and ablation site on electroanatomic 
mapping.
Case PVC focus IPM Ablation site
1 NCC–LCC junction LCC
2 RVOT‐septal RVOT‐septal
3 RVOT‐anterior proximal RVOT‐anterior proximal
4 RVOT‐anterior RVOT‐anterior
5 RVOT‐septal proximal RVOT‐septal proximal
6 RVOT‐anteroseptal RVOT‐septal
7 RVOT‐posteroseptal RVOT‐septal
8 NCC NCC
LCC indicates left coronary cusp; LVOT, left ventricular outflow tract; NCC, non‐coronary cusp; RCC, right coronary cusp; 
RVOT, right ventricular outflow tract.
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Comparison between homogeneous and inhomogeneous VCMs
The comparison of PVC focus between the inhomogeneous VCM and EAM demonstrated 
localisation accuracy of 8.3±2.7 mm (observer 1) and 8.2±2.8 mm (observer 2), with 
high interobserver agreement (intraclass correlation coefficient 0.812, 95% CI 0.318 
to 0.959, P=0.004). A similar comparison between the homogeneous VCM and EAM 
demonstrated accuracy of 10.3±3.1 mm (observer 1) and 9.8±2.9 mm (observer 2) and 
also showed high interobserver agreement (intraclass correlation coefficient 0.862, 95% 
CI 0.399 to 0.975, P=0.003).
The focus localisation accuracy showed significant differences between the 
homogeneous and inhomogeneous VCMs. The homogeneous VCM had a significantly 
higher localisation error compared with the inhomogeneous VCM for both observers 
(P=0.043) (Table 3). In addition, the homogeneous VCM failed to identify the focus 
in 1 right VOT case (Figure 4, case 6), in which the inhomogeneous model correctly 
identified the site of ablation.
Table 3. Localisation difference between ectopic focus identified using homogeneous and 
inhomogeneous volume conductor model compared with the ablation site marked on the 
electroanatomic mapping.
Case Homogeneous (mm) Inhomogeneous (mm) P value
1 11.1 9.3
2 9.1 9.1
3 6.4 6.4
4 14.4 12.1
5 Focus not identified 7.6
6 14.9 11.7
7 7.8 3.6
8 8.3 6.4
Median (IQR) 9.1 (7.8 to 14.4) 8.35 (6.4 to 11.1) P = 0.043
IQR indicates interquartile range.
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DISCUSSION
To our knowledge, this study is the first to investigate whole‐heart IPM using a 62‐lead 
anterior BSP recording and an MRI‐derived inhomogeneous VCM.
The evaluation of this model was performed in healthy volunteers and patients with 
idiopathic arrhythmias. Using this MRI‐based non-invasive method, it was possible 
to estimate the PVC focus location with clinically sufficient accuracy using BSPs of a 
single ectopic beat. In addition, a comparison between 2 independent observers 
demonstrated high reproducibility of the results.
Evaluation in healthy volunteers
IPM localised the origin of atrial activity near the transition of the superior vena cava 
(crista terminalis) into the right atrium. This location has been described in the literature 
as the anatomic location of the sinus node [11]. These results suggest that atrial activity 
may be assessed non-invasively using this combined MRI–IPM method.
The first ventricular epicardial breakthrough was located at the right ventricular free 
wall and corresponded with descriptions in the literature [1,12]. Furthermore, it was 
also possible to visualise abnormal ventricular activation patterns such as a right bundle 
branch block (Video S1).
These findings illustrate the potential sensitivity of IPM to detect minute changes in 
cardiac activation and demonstrate the ease of combining IPM with MRI acquisitions. 
This result offers the prospect of using this method for screening purposes.
Clinical impact in idiopathic PVC ablation
IPM successfully approximated the ablation site in 8 of 8 patients, providing a surrogate 
for the clinical PVC focus. This finding suggests that routine application of this non-
invasive technique as part of the clinical workup could have multiple benefits such as 
improved ablation planning due to accurate preprocedural identification of the PVC 
focus (target ablation site) and reduction in procedural duration (and accompanying 
radiation exposure) due to reduced invasive mapping time. This may especially be valid 
for patients with a low PVC burden and/or multifocal PVCs.
Volume conductor models
The current, most frequently used BSP mapping technique (ECVUE; CardioInsight 
Technologies Inc) uses a homogeneous torso conductor model. The clinical utility of 
this method has been demonstrated after extensive investigation [13,14] however, 
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recent research advocates the integration of the various organs with their own 
specific impedance [8,15]. This may be the case particularly in patients with high body 
surface area, pulmonary edema, or myocardial infarction. These circumstances could 
substantially influence the BSPs due to altered conductivity and resistivity conditions.
The comparison performed in this study indicated a significant difference between 
homogeneous and inhomogeneous VCMs (Table 3). These results suggest that 
although it is possible to perform IPM using a homogeneous VCM, an inhomogeneous 
VCM provides more accurate results.
Limitations
Several inherent technical limitations may have led to the observed differences between 
IPM‐identified ectopic focus and site of ablation defined on the EAM.
Although clinically more practical, the limited number of electrodes used in this study 
and the electrode positioning on the patient thorax may have affected the accuracy 
of focus localisation. In addition, movement of the ablation catheter may cause spatial 
displacement of the marked ablation site by ≈10 mm [16]. Furthermore, small and 
subtle catheter movements can also result in significant shifts within the EAM while 
using a reference catheter. All of these factors could have contributed to the differences 
in focus location between IPM and EAM.
Even if these conditions can be optimised, factors still remain that may cause 
discrepancies. These include image misregistration due to patient respiration, inaccurate 
cardiac geometry due to image acquisition during different phases of the cardiac cycle, 
and substantial regional variations in cardiac displacement during contraction and 
relaxation (ranging between 5 and 25 mm) [17,18]. In particular, the base of the heart 
moves ≥20 mm toward the apex. This is of particular importance because all ectopic foci 
were located at the basal part of the heart. Motion‐related inaccuracies will probably 
have less influence on hearts with reduced function (less movement) or when analyzing 
foci from regions less susceptible to motion. A larger study will be needed to establish 
the impact of a screening approach prior to routine implementation.
Future directions
This proposed strategy combining IPM and MRI offers the prospect of studying electrical 
activation in relation to tissue characteristics for complex ventricular or supraventricular 
tachycardias and scar‐based arrhythmias with clinically relevant accuracy.
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The design of the computational model allows for instantaneous integration of patient‐
specific characteristics such as tissue properties and their associated conductivity. These 
tissue properties can be obtained easily using MRI. Integration of these characteristics 
will enable the operator to provide more patient‐tailored therapy.
CONCLUSION
This study demonstrates the clinical applicability of an MRI‐based whole‐heart IPM 
method in patients with idiopathic ventricular foci. There was high localisation 
accuracy between the focus identified with IPM and the ablation site on the EAM. The 
interobserver agreement was high for both VCMs. IPM accuracy improved significantly 
when using an inhomogeneous VCM.
The integration of this IPM technique with EAM systems may facilitate patient‐specific 
catheter‐ablation strategies.
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General discussion and future directions
This thesis focused on the development and subsequent in-vivo application of a novel 
non-invasive MRI-based inverse potential mapping (IPM) technique. The first part of 
the thesis discussed the safety and potential risks of using MRI in patients with cardiac 
pacing devices and investigated the clinical use of MRI in this patient category. In part 
two of this thesis, the development of a new non-invasive mapping methodology was 
described. Part three illustrated the initial results after application of the novel mapping 
technique in volunteers and patients.
In this fourth part, the main findings of the studies will be summarised and discussed. 
Furthermore, directions for future research will be suggested.
A novel non-invasive MRI-based inverse potential mapping technique
Non-invasive imaging of cardiac electrophysiology is an active field of research and 
has shown rapid development in recent years. More and more attention has drifted to 
increasing the amount of information that can be obtained in a non-invasive manner, 
with the patient at a minimal risk of suffering from adverse events. Non-invasive, 
detailed imaging of mechanical processes of the heart has been incorporated in clinical 
routine for years. On the contrary, the time-consuming nature of data acquisition 
and post-processing has historically hampered detailed non-invasive imaging of the 
electrical processes of the heart. Post-processing has been accelerated by increased 
computational power and sophisticated software. Despite these developments, 
acquisition of multi-electrode body surface potentials remains cumbersome. However, 
the development of dedicated electrode-vests or electrode-strips may accelerate the 
acquisition process.
Although several non-invasive mapping techniques have been developed through 
the years [1-5], a novel variant was developed by our research group, because 1) 
current techniques were still associated with exposure to radiation since Computed 
Tomography (CT) was used to obtain anatomical information, 2) a-priori models 
(consisting of assumptions with regard to physical circumstances) were required to 
reconstruct cardiac events, 3) surface potentials were reconstructed without having 
any information about the potential distribution between surfaces of interest, 4) the 
desire to perform real-life computer simulations that could be used to test various 
hypothesis concerning the impact of electrode positioning, the effect of inclusion or 
exclusion of thoracic organs on the end-result, and to investigate whether the sizes of 
the constituents of the 3D heart model would influence the outcome.
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Clinical implications
Since patients with implanted pacemaker systems were the desired patient category, 
the first chapters of this thesis review and investigate the feasibility and safety of 
performing MRI in patients with an implanted cardiovascular implantable electronic 
device (CIED). Chapter 2 demonstrated that MRI can be safely performed in this patient 
category with appropriate monitoring and strict adherence to a safety protocol. Besides 
MRI-conditional pacemaker systems, MRI-conditional internal cardioverter defibrillators 
(ICD) and biventricular pacing systems have been introduced [6]. Most of these devices 
have a specific MRI-mode that must be activated before entering the MRI suite. The most 
important features of this MRI-mode include bipolar stimulation instead of unipolar 
pacing, increased electrical output, specific filters to prevent sensing of external non-
cardiac signals and temporarily disabling the recording of arrhythmic episodes [7].
Apart from MRI examinations in patients with an MRI-conditional CIED, an increasing 
amount of literature describes the safety of MRI in patients with conventional (i.e. non-
MRI-conditional) devices. A landmark study on this topic has been performed by Nazarian 
et al. [8] demonstrating the safe performance of 555 MRI examinations in 438 patients 
with non-MRI-conditional devices. Only small changes in programming, sensing and 
impedance were reported in this study. In patients with conventional pacing devices 
or patients who are continuously pacing dependent, it must be ascertained that the 
expected benefits outweigh the potential risks of the examination. The most important 
MRI-related complications are heating of the tip of the pacing lead (and subsequent loss 
of capture), unwanted asynchronous pacing or inhibition of pacing, battery depletion 
or changes to the software of the device. These complications have been reported in 
technical ex-vivo studies or in case-reports and small observational studies, but have 
not been observed in humans in more recent studies [9].
In a single-center study, described in Chapter 3, the incidence and safety of MRI in 
patients with an MRI-conditional device was investigated. The majority of post-implant 
MRI scans (57%) were performed to confirm, exclude or follow-up on neurological 
disease. No MRI-related adverse events were reported during the follow-up period. It 
has been calculated that approximately 75% of all patients with an implanted CIED will 
need an MRI examination during the lifetime of their device [10]. Currently, implantation 
of an MRI-conditional system is not (yet) the standard of care for all patients. Therefore, 
identification of suitable patients is mandatory. Patients with a high probability 
of requiring an MRI scan in the near future are eligible for implantation of an MRI-
conditional pacing device. Therefore, patients with neurological disorders constitute a 
group in which implantation of an MRI-conditional CIED should be strongly considered.
14867-vandergraaf-layout.indd   192 31/08/2017   09:37
193
General discussion and future directions
The mechanical function of the heart can be quantified using functional images that 
can be obtained by echocardiography or MRI. Earlier research demonstrated that global 
echocardiographic left and right ventricular function measures may be insensitive to 
early regional dysfunction, as can be observed in patients receiving long-term RV pacing 
[11]. Therefore, evaluation of myocardial contraction in relation to pacing using MRI 
may be advantageous. Local myocardial deformation including regional wall thickening 
can be quantified using a separate MRI sequence named ‘myocardial tagging’ [12]. A 
tagging sequence places non-invasive markers on the myocardium that can be traced 
during the cardiac cycle. In this way, local myocardial deformation can be quantified 
in three dimensions [13]. Unlike myocardial tagging, MRI-feature tracking does not 
require the acquisition of additional MRI images [14]. Instead, feature-tracking software 
can be retrospectively applied on routinely obtained functional MRI images [15]. To 
demonstrate a potential benefit of performing MRI in patients with implanted devices, 
Chapter 4 illustrated the feasibility of performing strain analysis on conventional 
(non-tagged) MRI function images of patients with implanted MRI-conditional pacing 
devices.
Non-invasive mapping of cardiac excitation
Chapter 5 provided an overview of the history of body surface potential mapping 
(BSPM) and the use of mathematical inverse procedures. The use of inverse procedures 
has augmented the amount of information that can be distilled from the potentials 
recorded on the body surface. However, a solution to an inverse problem is never unique 
[16]. For this reason, various assumptions are made regarding the influence of signal 
noise, bones, thoracic organs, subcutaneous fat and muscle on the potentials recorded 
on the body surface [17]. The chosen assumptions and strength of the constraint that is 
imposed on the solution is subject of constant debate [18].
Despite multiple favourable reports and experiences, non-invasive mapping of cardiac 
excitation has not yet evolved into daily clinical practice. This is most likely due to the 
time consuming nature of BSPM and the complexity of - and heavy dependence on - 
the mathematics underlying the inverse procedures. Most experience is gained with 
reconstructing epicardial potentials. From a clinical perspective, the possibility of 
reconstructing endocardial potentials would be an important breakthrough. Although 
this possibility has been claimed [2], this method relies on yet another algorithm, 
deriving endocardial data from epicardial data. The robustness of this technique and 
this reproducibility of the data has yet to be determined.
14867-vandergraaf-layout.indd   193 31/08/2017   09:37
194
Chapter 11
In Chapter 6, the possibility of generating volume meshes and body volume potentials 
(BVP) was demonstrated. Instead of solely reconstructing surface potentials, the use of 
the Finite Element Method (FEM) allowed reconstructing of volume potentials. Use of 
the FEM never advanced into clinical practice due to its time consuming and elaborative 
nature. Increased computational power and the introduction of open source software 
enabled the calculation of BVP for clinical purposes. This chapter demonstrated that 
the potential field inside a simple rectangular tank filled with an electrolytic conductor 
could be visualised. A 3D volume model was reconstructed from MRI images of the 
rectangular tank. Later, the impact of variable organ conductivity on the reconstructed 
potentials was investigated using forward simulations in a human torso model. The 
FEM enables the incorporation of different anisotropies (directional dependence), local 
tissue characteristics and sigma gradients over different regions [19]. BVP may be used 
to gain a better insight in the genesis of body surface potentials (BSP) and sources of 
local inaccuracies.
Chapter 7 described the complete workflow using the developed software. The 
possibility of performing realistic simulations resulting in body surface potentials 
(forward procedure) and reconstructing cardiac activation sequences from body surface 
potentials (inverse procedure) was demonstrated. Investigating the optimal positioning 
of 62 torso electrodes, the ability to perform realistic simulations was subsequently 
used to experiment with various electrode positions. Chapter 8 demonstrated that 
by concentrating the available electrodes (20 mm inter-electrode distance) in the area 
directly overlaying the heart, a high-resolution anterior view of the epicardial potentials 
can be obtained. In order to investigate whether this method could be used for the 
purpose of non-invasive focus localisation, it was applied in ten patients with implanted 
pacing devices. Ventricular paced beats were used to simulate ventricular ectopic foci. 
Chapter 9 illustrated that for all patients, the site of earliest epicardial depolarisation 
could be identified. When the tip of the pacing lead was implanted in vicinity to the 
epicardium, i.e. right ventricular (RV) apex or RV outflow tract, the distance between 
lead tip position and epicardial breakthrough was 6.0±1.9 mm. In Chapter 10, the non-
invasive mapping system was used to localise premature ventricular contractions in 
patients scheduled for ablation. The location of the identified focus was subsequently 
compared to the ablation site on the electroanatomic maps. The IPM-derived focus was 
3-dimensionally located within 8.3±2.7 mm of the invasively determined focus using 
electroanatomic mapping.
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DIRECTIONS FOR FUTURE RESEARCH
Application in patients with pacing devices
This thesis shows that a novel MRI-based inverse potential mapping strategy can be used 
to non-invasively study cardiac excitation and localise anterior sites of earliest epicardial 
breakthrough. In this thesis, ventricular paced beats were used to mimic ventricular 
ectopic foci. Besides focus localisation, the developed non-invasive mapping strategy 
can be used to investigate depolarisation and repolarisation during the complete 
cardiac cycle. When sequentially performed in patients with implanted pacing devices, 
this would allow detailed monitoring of long-term right or left ventricular pacing effects. 
Preferably, these observations would be combined with detailed regional function 
analyses performed using MRI. In this way, the electrical and mechanical effects of 
cardiac pacing could be studied simultaneously and sequentially.
Cardiac resynchronisation therapy
Cardiac resynchronisation therapy (CRT) is still associated with a 30% non- or adverse 
responders rate [20]. Monitoring and follow-up of electrical and mechanical activation 
times in CRT patients may increase the understanding of the pathophysiologic 
mechanisms in non- or adverse responders. In an attempt to improve the response 
rate to CRT, a more patient-specific implantation strategy has been advocated in 
recent literature. Proposed measures include the avoidance of regions of transmural 
scar and implantation of the left ventricular epicardial pacing lead at the site of latest 
electrical or mechanical activation [21-23]. Cardiac MRI is the current golden standard 
for the identification and quantification of regions of myocardial scar [24]. Currently, 
determination of the site of latest electrical activation would require an invasive EPS. This 
EPS would have to precede the implantation procedure. This would result in additional 
radiation exposure for the patient. Alternatively, the region of latest electrical activation 
could be identified using non-invasive IPM [25].
The software developed in this thesis enables the merging of the MRI data on tissue 
characteristics and mechanical activation with the data on electrical activation 
obtained using non-invasive IPM. In this way, the optimal site of lead implantation could 
be determined prior to the implantation procedure. This site could be visualised in a 
patient-specific 3D heart model that is available during the implantation procedure. 
Other research groups have demonstrated the feasibility of merging an earlier acquired 
3D heart model with the fluoroscopic images used during implantation of a pacing 
device [26-27]. In this way, the implanting physician would navigate inside the high-
resolution 3D heart model.
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Leadless pacing
Historically, the fixation site of the pacing leads is restricted to areas that are easily 
accessible with conventional pacemaker leads. Recently, leadless pacemakers were 
introduced [28]. In theory, leadless pacing would increase the number of potential 
pacing sites, since implanters are no longer hampered by the mechanical constraints 
of the pacing leads. Regions of latest electrical or mechanical activation may be easier 
to reach. In this way the chance of response to therapy could be increased. However, 
current leadless pacing devices are too big to be navigated through coronary veins and 
leadless pacing is limited to the right ventricular apex. A recent study demonstrated 
that patients with one or multiple leadless pacing devices can safely undergo MRI scans 
in both 1.5 and 3 Tesla scanners [29]. MRI and IPM will provide a detailed roadmap to 
guide implantation of cardiac devices in order to optimise patient outcome.
Application in patients with arrhythmias
The technique may be used to localise accessory pathways or the origin of atrial or 
ventricular tachycardias [30-31]. Accessory pathways or arrhythmogenic sites can be 
isolated or terminated by local ablation. Currently, ablation is preceded by an invasive 
electrophysiological study (EPS). During the EPS, the anatomy of the patient’s heart is 
reconstructed and local depolarisation and repolarizing times are registered using intra-
cardiac catheters. In this way, an electro-anatomical map is constructed. This procedure 
is associated with significant exposure to radiation and exposes the patient to risks such 
as haemorrhage and stroke.
Using non-invasive IPM, a patient-specific electro-anatomical map can be constructed 
at an earlier instance. The electrophysiological mechanisms of certain arrhythmias may 
be studied before the ablation procedure. In this way, the actual invasive procedure can 
be prepared in detail beforehand and the total procedure time may be decreased [32]. 
This may reduce the risk of complications, increase patient-safety and contribute to a 
more patient-tailored therapy.
Methodological improvements
The current research was limited to mapping the anterior surface of the heart. Increasing 
the total number of electrodes and positioning the electrodes around the torso will 
enable mapping of the complete cardiac surface. This would allow the localisation 
of ectopic foci from the inferior and posterior wall. The torso electrodes used in this 
research were organised in an easy-to-apply patch. When the number of electrodes 
would be increased, a similar strategy is needed to prevent prolonged acquisition times.
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It is anticipated that in the near future, patient-specific, 3D heart and thorax models 
will be used to guide invasive electrophysiological studies. To do so, these models must 
be as realistic as possible. Therefore, future research will focus on the incorporation of 
several variables that influence both electrical and mechanical processes in the heart. 
As mentioned earlier, the incorporation of local tissue characteristics (e.g. edema, scar, 
hypertrophy) is an important topic. A recently introduced cardiac MRI sequence named 
diffusion tensor imaging (DTI) enables the visualisation of intra-cardiac fiber orientation 
[33-34]. By incorporating this information, parameters on directional dependence can 
be further individualised in attempt to approach upmost realistic computer models.
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SUMMARY
Non-invasive imaging of cardiac excitation uses body surface potential mapping 
(BSPM), non-invasive anatomical imaging and mathematical equations to reconstruct 
electrophysiological (intra-) cardiac processes. Despite multiple favourable reports, non-
invasive imaging of cardiac excitation has not yet evolved into daily clinical practice. 
This is most likely due to the time consuming nature of BSPM and the complexity of 
- and heavy dependence on - the mathematics underlying the inverse procedures. It is 
anticipated that in the near future, patient-specific, 3D heart and thorax models will be 
used to guide invasive electrophysiological studies. To do so, these models must be as 
realistic as possible. In the work described in this thesis, a novel non-invasive mapping 
technique was developed and applied in humans.
The outline of this thesis is provided in Chapter 1. In summary, the aims of this thesis 
were to 1) investigate the safety of using MRI in patients with implanted pacing devices, 
2) develop software through which the electrical activity inside the heart and thorax 
can be realistically modelled, 3) perform simulation studies to investigate the impact 
on the end-result of using different torso electrode layouts for the recording of body 
surface potentials, 4) investigate the validity of the simulation studies by performing 
non-invasive mapping in volunteers using different torso electrode layouts, 5) apply the 
novel non-invasive mapping technique in patients with an implanted pacing devices 
and in patients suffering from premature ventricular contractions and 6) investigate the 
localisation accuracy and reproducibility of the results in these patients.
In the first part of this thesis, the feasibility and safety of using MRI in patients with 
an implanted cardiovascular implantable electronic device (CIED) was investigated. 
Chapter 2 discussed the safety concerns associated with performing MRI in patients 
with an implanted CIED. An in-house developed safety protocol was proposed to 
minimise the chance of adverse events. Chapter 3 evaluated the use of MRI in patients 
after implantation of an MRI-conditional CIED. In this study, the majority of MRI scans 
after implantation of a CIED were performed to either follow-up on or investigate 
neurological disorders. Currently, not all implanted devices are MRI-conditional. 
Therefore, patients with neurological disorders constitute a group in which implantation 
of an MRI-conditional CIED should be strongly considered. Chapter 4 illustrated the 
feasibility of using MRI-feature tracking in patients with an MRI-conditional CIED to 
evaluate regional wall motion. Normally, global cardiac function is monitored using 
transthoracic echocardiography (TTE) in this patient category. However, these global 
function measures are insensitive to early regional dysfunction. Therefore, it may be of 
advantage to use MRI in these patients. MRI-feature tracking is a relatively new tool 
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that can be applied retrospectively on regular functional MRI images. Hence, it does not 
require the acquisition of additional MRI sequences. In this study, adequate endocardial 
and epicardial delineation was possible, despite the presence of susceptibility artefacts 
induced by the CIEDs.
The second part of this thesis discussed the current status of non-invasive imaging 
of cardiac excitation. Chapter 5 provided an overview of this active field of research. 
An inverse procedure uses Body Surface Potential Mapping (BSPM), non-invasive 
anatomical imaging and mathematical equations to reconstruct electrophysiological 
(intra-)cardiac excitation. Despite multiple favourable reports and experiences, non-
invasive mapping of cardiac excitation has not yet evolved into daily clinical practice. 
A novel non-invasive mapping technique was developed by our research group, 
because 1) current techniques were still associated with exposure to radiation since 
Computed Tomography (CT) was used to obtain anatomical information, 2) a-priori 
models (consisting of assumptions with regard to physical circumstances) were used 
to reconstruct intra-cardiac events, 3) surface potentials were reconstructed without 
having any information about the potential distribution between surfaces of interest, 4) 
the desire to perform real-life computer simulations that could be used to test various 
hypothesis concerning the impact of electrode positioning, the effect of inclusion or 
exclusion of thoracic organs on the end-result and to investigate whether the sizes of 
the constituents of the 3D heart model would influence the outcome.
Chapter 6 described the first experiments using in-house developed software for the 
generation of realistic 3D volume models and calculation of volume potentials. The 
advantage of using the Finite Element Method instead of the Boundary Element Method 
is illustrated by experiments performed in a plastic tank filled with water. Volume 
potentials inside a simple rectangular tank filled with an electrolytic conductor were 
visualised. Volume potentials may be used to gain a better insight in the genesis of body 
surface potentials and sources of local inaccuracies. The impact of including or excluding 
organ conductivity parameters on the reconstructed potentials was investigated using 
forward simulations in a human torso model. Chapter 7 described the complete 
workflow using the developed non-invasive mapping software. The impact of including 
or excluding information on myocardial scar or oedema was investigated.
The third part of this thesis describes the application of the novel non-invasive mapping 
technique in volunteers and patients. In Chapter 8, the possibility of performing realistic 
simulations resulting in body surface potentials (forward procedure) and reconstructing 
cardiac activation sequences from body surface potentials (inverse procedure) was 
demonstrated. Epicardial potentials were calculated using different torso electrode 
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layouts. After deciding on a definitive electrode layout, it was applied in volunteers and 
later in patients to record potentials from the body surface. By positioning the available 
electrodes at a 20 mm inter-electrode distance in the area directly overlaying the heart, 
a high-resolution anterior view of the epicardial potentials could be obtained. The 
localisation accuracy of the novel mapping technique was investigated in Chapter 9. 
In ten patients with implanted pacing devices, ventricular paced beats were used to 
simulate ventricular ectopic foci. The site of earliest activation as identified by the non-
invasive mapping system was correlated to the actual location of the tip of the pacing 
lead on the MRI-images. When the tip of the pacing lead was implanted in vicinity to 
the epicardium, i.e. right ventricular (RV) apex or RV outflow tract, the distance between 
lead tip position and epicardial breakthrough was 6.0±1.9 mm. In Chapter 10, the non-
invasive mapping system was used to localise premature ventricular contractions in 
patients scheduled for ablation. The IPM-derived focus was 3-dimensionally located 
within 8.3±2.7 mm of the invasively determined focus using electroanatomic mapping. 
In Chapter 11, the clinical relevance of this thesis was discussed and directions for 
further research were suggested.
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SAMENVATTING
Het op een niet-invasieve manier verkrijgen van zoveel mogelijk informatie over 
fysiologische processen in het menselijk lichaam heeft de laatste jaren een vlucht 
genomen. Steeds meer wordt geprobeerd om de patiënt op die manier te behoeden 
voor risico’s die een invasieve methode (waarbij het lichaam wordt binnengedrongen) 
met zich meebrengt.
Om lokale, elektrische activiteit van het hart nauwkeurig te registreren is het noodzakelijk 
over te gaan tot een invasief elektrofysiologisch onderzoek. Dit proefschrift beschrijft 
de totstandkoming van een nieuwe methode die het mogelijk maakt om de elektrische 
activiteit van het hart op een niet-invasieve manier te onderzoeken. Het ontwikkelen 
van een dergelijke nieuwe techniek gebeurt met de overtuiging dat invasieve 
cardiologische procedures steeds meer gestuurd zullen worden door informatie die van 
tevoren op een niet-invasieve manier is verkregen.
De indeling van dit proefschrift wordt beschreven in Hoofdstuk 1. Samenvattend 
waren de onderzoeksdoelen 1) te onderzoeken in hoeverre Magnetic Resonance 
Imaging (MRI) veilig kan worden gebruikt bij patiënten met een geïmplanteerde 
pacemaker of implanteerbare cardioverter defibrillator (ICD), 2) het ontwikkelen 
van software waarmee de elektrische activiteit in het hart en in de borstkas kan 
worden nagebootst met behulp van op de borstkas gemeten potentialen, 3) het 
uitvoeren van simulaties waarbij gevarieerd wordt met het aantal en de plaatsing 
van de huidelektrodes, 4) het onderzoeken van de validiteit van de simulaties door 
verschillende elektrodeconfiguraties bij mensen toe te passen en de resultaten van 
de computer simulaties en de registraties in mensen met elkaar te vergelijken, 5) de 
nieuw ontwikkelde methode toepassen bij patiënten met geïmplanteerde pacemakers 
en bij patiënten met ventriculaire extrasystolen, 6) de nauwkeurigheid van de nieuw 
ontwikkelde methode te testen in deze groepen patiënten.
Het eerste deel van dit proefschrift gaat over het gebruiken van MRI bij patiënten met 
een geïmplanteerde pacemaker of ICD. Tot niet lang geleden was het maken een MRI-
scan bij een patiënt met een geïmplanteerd pacing systeem ondenkbaar. Hoofdstuk 
2 geeft een overzicht van de literatuur met betrekking tot gevaren en mogelijke 
complicaties die kunnen optreden wanneer een MRI-scan wordt gemaakt bij een patiënt 
met een pacemaker of ICD. Het gaat hierbij over zowel de nieuwere MRI-conditionele 
systemen (waarbij MRI veilig gebruikt kan worden mits aan strikte voorwaarden 
wordt voldaan) als over conventionele systemen (waarvan eigenlijk onduidelijk is 
in hoeverre MRI veilig kan worden gebruikt). Verder wordt een door ons ontwikkeld 
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veiligheidsprotocol geïntroduceerd. Door het volgen van dit veiligheidsprotocol 
kan de kans op complicaties worden geminimaliseerd. Nu er sinds enkele jaren MRI-
conditionele systemen worden geïmplanteerd, rijst de vraag hoeveel mensen er profijt 
van hebben gehad, met andere woorden: werden er bij deze mensen ook MRI-scans 
gemaakt? En zijn er bepaald groepen patiënten te identificeren waarbij de kans groot is 
dat zij in de jaren na implantatie een MRI-scan nodig hebben? Momenteel is het namelijk 
zo dat niet bij iedereen een MRI-conditioneel systeem kan worden geïmplanteerd. Dit 
werd nader onderzocht in Hoofdstuk 3. In ons eigen centrum werd de meerderheid 
van MRI-scans na implantatie van een pacemaker of ICD verricht in patiënten met een 
(vermoedelijke) neurologische aandoening. In deze patiëntengroep zou implantatie 
van een MRI-conditioneel systeem dus zeker te overwegen zijn. Hoofdstuk 4 toont 
de mogelijkheid om regionale wandbewegingen te analyseren middels MRI-feature 
tracking in patiënten met een geïmplanteerde pacemaker of ICD. MRI-feature tracking 
is een nieuwe techniek waarbij gebruik kan worden gemaakt van standaard MRI functie 
opnames. Omdat er geen aanvullende opnames nodig zijn, is er geen extra belasting 
voor de patiënt terwijl er in potentie wel meer informatie uit de beelden kan worden 
gehaald. In het verleden is gebleken dat echocardiografie onvoldoende in staat is om 
vroege, regionale wandbewegingsstoornissen, zoals gezien kan worden bij patiënten 
die langdurig met pacing worden behandeld, te detecteren. Dit zou met MRI-feature 
tracking wel mogelijk kunnen zijn.
Het tweede deel van dit proefschrift gaat over het ontwikkelen van een nieuwe 
methode die het mogelijk maakt om de elektrische activiteit in het hart op een niet-
invasieve manier te onderzoeken. Hoofdstuk 5 geeft een literatuuroverzicht. Het 
maken van uitgebreide elektrocardiogrammen (body surface potential maps) is al 
oud, maar door deze informatie te combineren met anatomische informatie kan 
vervolgens door middel van wiskundige differentiaalvergelijkingen meer informatie 
uit de BSPM signalen worden gedestilleerd. Op deze manier kan informatie die buiten 
op het lichaam wordt gemeten worden gebruikt om te onderzoeken wat er binnenin 
het hart gebeurt. In Hoofdstuk 6 worden de eerste experimenten met de nieuwe 
software beschreven. Een van de voordelen van de nieuwe software is dat er volume 
potentialen in plaats van oppervlakte potentialen kunnen worden berekend. Op deze 
manier kan inzichtelijk worden gemaakt wat zich in een volume afspeelt. Dit wordt 
geïllustreerd aan de hand van simulaties en experimenten met een blauwe plastic bak 
gevuld met een zoutwater oplossing. Hoofdstuk 7 beschrijft vervolgens alle stappen 
die nodig zijn om van lichaamspotentialen die bij een patiënt gemeten zijn te komen 
tot een patiënt-specifiek 3-dimensionaal hart model. Tevens wordt er in dit hoofdstuk 
geëxperimenteerd met het includeren of excluderen van littekenweefsel of oedeem 
in de hartspier. In Hoofdstuk 8 wordt geëxperimenteerd met verschillende aantallen 
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huidelektrodes. Hierbij worden de beschikbare elektrodes ook verschillend verdeeld 
over het huidoppervlak. Deze experimenten werden eerst met de nieuw ontworpen 
software uitgevoerd. Nadat er enkele optimale elektrode-configuraties waren gevonden 
werden deze vervolgens toegepast bij gezonde vrijwilligers. In Hoofdstuk 9 wordt 
de nieuwe techniek toegepast bij patiënten met een geïmplanteerde pacemaker. De 
plek van eerste activatie wordt niet-invasief gelokaliseerd met de nieuw ontworpen 
software. Vervolgens werd de locatie van eerste activatie vergeleken met de plek waar 
de ventriculaire pacemakerdraad geïmplanteerd is. Toe nu toe kan alleen epicardiale 
activatie worden waargenomen. In dit hoofdstuk wordt geïllustreerd dat epicardiale 
bronnen met een nauwkeurigheid van 6.0±1.9mm kunnen worden gelokaliseerd. In 
Hoofdstuk 10 wordt de techniek toegepast bij patienten met ventriculaire extrasystolen 
die later een ablatieprocedure zouden ondergaan. Voorafgaande aan de ablatie werd 
het arritmogene focus gelokaliseerd met behulp van het niet-invasieve mapping 
systeem. Na vergelijken van de locatie van het gevonden focus met de locatie van het 
ableerde focus werd een gemiddelde afstand van 8.3±2.7 mm gevonden. Hoofdstuk 
11 vat de belangrijkste bevindingen van dit proefschrift samen en plaatst deze in het 
daglicht van de hedendaagse literatuur. Ook worden er voorstellen gedaan voor verder 
onderzoek.
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